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ABSTRACT  
   
Lignocellulosic biomass represents a renewable domestic feedstock that can support 
large-scale biochemical production processes for fuels and specialty chemicals. However, cost-
effective conversion of lignocellulosic sugars into valuable chemicals  by microorganisms still 
remains a challenge. Biomass recalcitrance to saccharification, microbial substrate utilization, 
bioproduct titer toxicity, and toxic chemicals associated with chemical pretreatments are at the 
center of the bottlenecks limiting further commercialization of lignocellulose conversion. Genetic 
and metabolic engineering has allowed researchers to manipulate microorganisms to overcome 
some of these challenges, but new innovative approaches are needed to make the process more 
commercially viable. Transport proteins represent an underexplored target in genetic engineering 
that can potentially help to control the input of lignocellulosic substrate and output of 
products/toxins in microbial biocatalysts. In this work, I characterize and explore the use of 
transport systems to increase substrate utilization, conserve energy, increase tolerance, and 
enhance biocatalyst performance. 
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CHAPTER 1 
INTRODUCTION 
Lignocellulosic bioconversion and transport bottlenecks 
Modern society is unsustainably dependent on petroleum. For example, approximately 120 
billion gallons of gasoline were consumed in the United States in 2012 (1). Besides transportation 
fuels, many other bulk industrial chemicals, such as solvents, fertilizers, pesticides, and plastics, 
are also derived from petroleum (2). Due to escalating global energy consumption, dramatic 
changes have manifested in the atmosphere and global climate (3). To ensure the future 
advancement of human society, a sustainable supply of energy and chemicals is needed. 
Production of fuels and chemicals by fermentation-based manufacturing processes using a 
renewable feedstock is a desirable alternative to petrochemical production.  
Lignocelluloses are the most abundant renewable natural organic materials present on the 
earth (4-6). They account for more than 60% of total biomass and are renewable due to carbon 
fixing photosynthetic processes of plants, with a net productivity of 155 billion tons per year (7). 
Converting lignocellulose into fuels and chemicals does not compete with food sources since 
economic plants grown for food and other commercial purposes generate millions of tons of 
lignocellulosic waste. A wide range and variety of agricultural, forestry and industrial wastes are 
available for value-added microbial conversion. For example, approximately 731 million tons of rice 
straw is annually produced globally as an agricultural waste (8). The stems, leaves and fibers from 
agricultural crops generally have sugar content higher than 50% of their dry weight, and thus these 
agricultural waste residues represent abundant carbon feedstocks. Additionally, ample amounts of 
lignocelluloses are present in forest residues, wood sulfite waste, fruit/vegetable waste, waste 
paper and municipal solid waste (5-7). The potential for using such wastes as a renewable carbon 
source is of great importance.  
Lignocellulose is a complex matrix present in plant cell wall structures; composed of many 
different polysaccharides, phenolic polymers, and proteins. Regardless of source, most 
lignocellulosic biomass contains cellulose, hemicellulose, and lignin as three major polymeric 
components as shown in Figure 1.1. Unlike starch, lignocellulose has been evolved to resist 
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deconstruction. Cellulose fibers are encased in a covalently -linked mesh of lignin and 
hemicellulose. Cellulose (30-50% of lignocellulose dry weight) is composed of D-glucose and is 
highly resistant to deconstruction. Efficient degradation of cellulose generally requires cellulases 
(9-11). Lignin (10-25% lignocellulose dry weight) is a heterogeneous aromatic polymer and is 
difficult for microbes to use as carbon source. Three basic phenol derivatives (p-coumaryl alcohol, 
coniferyl alcohol and sinapyl alcohol), the so-called monolignols, make up almost all types of lignin 
found in nature (12, 13). Hemicellulose (20-35% of lignocellulose dry weight) is composed of a 
mixture of pentoses and hexoses mostly with D-xylose as the major sugar (Figure 1.1) (5, 6, 14). 
Fermentable sugar content of lignocelluloses occupies 50 to 70% of biomass dry weight, which is 
comparable to corn (5). However, these sugars are covalently fixed in polymeric states, and thus 
require chemical and/or enzymatic pretreatment processes to release them for microbial 
conversion (5, 15). Simple pretreatments such as steam pretreatment with dilute mineral acids (e.g. 
sulfuric and phosphoric acid) are able to depolymerize hemicellulose into sugar monomers (5, 6, 
14).   
After pretreatment, the resulting syrups contain a mixture of hexoses and pentoses, however, 
conversion of this hydrolysate to valuable products is difficult for multiple reasons. First, utilization 
efficiency of sugar mixtures by microbes is hindered by a global regulatory mechanism called 
catabolite repression (16-18). This regulation is common for most microbes used in bio-based 
production, if not all, and is tightly controlled at transcriptional and biochemical levels (18, 19). 
Glucose is often the preferred substrate by industrial microbes and its presence represses the 
catabolism of other secondary sugars in lignocellulose such xylose and arabinose (20, 21). Under 
anaerobic or micro-aerobic fermentation, complete consumption of sugar mixtures at high rates is 
difficult, especially for high sugar concentrations (100 g/L total sugars or higher) (18). This results 
in sugar loss, decreased productivity, and lower product titers for lignocellulose conversion. 
Second, microbes that can utilize xylose, such as Escherichia coli, possess transport systems that
expend energy for the uptake of xylose. In E. coli, import of xylose is catalyzed primarily by XylFGH, 
an ATP-binding cassette transporter that expends one ATP per molecule of D-xylose imported (22, 
23).  Thus, under anaerobic and microaerobic xylose fermentation conditions, the amount of ATP 
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spent on transport approximately doubles compared to glucose fermentation (22). This ultimately 
contributes to decreased fermentative production, especially under microaerobic conditions when 
ATP is scarce. Third, toxic side products, such as furan aldehydes, formate, acetate and soluble 
aromatics, are produced during sugar degradation steps in thermochemical pretreatments (6, 15). 
The aforementioned toxic side products can hinder or even be detrimental to cell growth (24). Furan 
aldehydes and aromatics are especially problematic due to both abundance and cytotoxicity (25, 
26). Although efforts targeting cytosolic toxicity mechanisms of these compounds have 
incrementally enhanced tolerance, characterization of efflux systems for expulsion of lignocellulosic 
inhibitors from cells remains largely unexplored. Overliming to pH 10 with Ca(OH)2 or other physical 
methods such as active carbon filter or vacuum treatment are able to remove inhibitors and thus 
reduce cytotoxicity of lignocellulosic hydrolysate syrups (27, 28). However, these extra steps 
increase process complexity and operational costs, thus reducing economic viability. Lastly, the 
metabolic pathways of hosts catabolizing lignocellulosic sugars are often altered to direct a high 
flux of carbon to a non-natural product that may not optimally be transported to the extracellular 
space. Both product and lignocellulosic inhibitor export from the cell is then potentially catalyzed 
by promiscuous or other non-ideal transport systems, limiting fermentative production metrics and 
imposing toxicity on the biocatalyst. Thus, for bioconversion of lignocellulose to valuable products 
to be efficient, robust biocatalysts must be developed that optimally transport and utilize the sugars 
present while tolerating the toxic effects of both inhibitors and products in the media. The 
optimization and characterization of transport systems for this purpose is the theme of my 
dissertation. 
Overview of the bacterial cell envelope 
To effectively manipulate transport systems, it is important to have a high level understanding 
of the cellular envelope of the organism of interest. The cellular envelope of bacteria consists of 
either one or two lipid membranes, a feature that discerns bacteria as either Gram positive or Gram 
negative, respectively (29). The cellular envelope of Gram negative bacteria consists of an outer 
membrane, a cell wall containing a thin layer of peptidoglycan, and an inner membrane (30, 31). In 
contrast, Gram positive cells lack an outer membrane and instead have a much thicker 
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peptidoglycan cell wall that contains covalently linked anionic polymers called teichoic acids that 
help maintain membrane structure and function (31, 32). Although different in structure, the cell 
envelope of these organisms share the same general functions to maintain cell boundaries, 
selectively allow the passage of molecules to the cytoplasm, and maintain critical electrochemical 
gradients (31). For the sake of brevity, I will only discuss the cell envelope of Gram negative 
bacteria in detail.
The outer membrane is composed of lipopolysaccharides (LPS), phospholipids and 
approximately 50% proteins by mass and serves a number of functions involving nutrient transport, 
protein translocation, signal transduction, and protection from the extracellular environment (30, 
31, 33). Similar to the inner membrane, the phospholipid composition of the outer membrane is 
~80% phosphotidylethanolamine, 5% cardiolipin, and 15% phsophotidylglycerol (34). The LPS 
anchored to the outer membrane generally consist of an external hydrophilic polysaccharide region 
followed by an internal hydrophobic core which, together, serve as an effective permeability barrier 
against hydrophobic and hydrophilic molecules (30, 35). For example it has been observed that 
LPS slow the penetration of lipophilic molecules by diffusion to ~1-2% the rate of a normal 
phospholipid bilayer (36). Thus for many molecules to effectively cross the outer membrane, they 
must enter through proteinaceous channels known as porins (37) -barrel proteins 
essentially act as both specific and non-specific molecular filters, often preventing the passage of 
molecules larger than 600-1,000 Da (33, 38). For instance, OmpF is a general diffusion porin that 
is known to prefer cation molecules less than 600 Da in size (39), whereas other ligand-specific 
porins, such as LamB, are induced by maltose/maltodextrins and are essential for uptake of these 
molecules (40).  Even hydrophobic molecules such as toluene and benzene utilize porins for 
effective uptake due to the slow rate of diffusion through the outer membrane (41-43). Thus the 
outer membrane serves as an important first step in facilitating the exclusion and uptake of nutrients 
to the periplasm. 
Once in the periplasm, molecules can enter the cytoplasm through carrier-dependent and/or 
independent mechanisms depending on the properties of the molecule. Small uncharged 
molecules (e.g. ethanol, butanol), gases (such as O2 or CO2), and, to some extent, water can cross 
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the inner membrane via carrier-independent mechanisms such as passive diffusion (44). In this 
process, the rate of transport largely depends on the concentration gradient across the membrane 
and hydrophobicity of the molecule. Due to the correlation between partition coefficients of lipophilic 
compounds in membrane-buffer systems and octanol-water mixtures (Log Pow), the relevant 
hydrophobicity of a molecule is often determined by Log Pow (45, 46).  As Log Pow increases it 
becomes easier for a molecule to traverse the hydrophobic core of the inner membrane, which has 
been linked to increases in toxicity (46). Sometimes, however, the hydrophobicity of a molecule 
can actually make it favorable to partition and reside in the inner membrane instead of completely 
diffusing into the cytoplasm (46). This is a common toxicity mechanism of many short alcohols and 
small lipophilic molecules, such as those found in lignocellulose hydrolysate (e.g. furfural, 
syringaldehyde) and as valuable metabolic end-products of biocatalysis (e.g. ethanol, phenol) (24, 
46, 47).  This accumulation within the inner membrane results in disruption of phospholipid-
phospholipid interactions which can cause alterations in membrane fluidity (45, 48). Alterations in 
membrane fluidity can result in leaky membranes, dissipating important proton (49, 50) and nutrient 
(51, 52) gradients for maintaining the cellular energy status, intracellular pH and nutrient 
homeostasis (46). Although this process is free of energy expenditures, passive diffusion is a 
relatively slow and potentially toxic process, thus some molecules capable of passive di ffusion still 
have carrier-dependent transport mechanisms to cross the inner membrane as well. 
Channels are integral membrane proteins that transport ions across the inner membrane using 
concentration or electrochemical gradients. This passive transport is thus similar to diffusion, but 
occurs on a much faster time scale. For instance, GlpF and AqpZ are known to facilitate diffusion 
of water molecules at a rate could not be achieved when considering diffusion through a membrane 
(53, 54) . This allows cells to rapidly adjust to differences in osmotic pressure, among other things. 
These channels can be gated as well to provide control mechanisms to open/close the channel 
only when certain electrochemical, physical, or chemical signals are present. Possibly the most 
well-known example of this is with voltage gated channels for generating an action potential in 
mammalian cells (55). Although these proteins are often critical for maintaining cellular 
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homeostasis of water and ions, transport of organic compounds such as sugars are primarily 
handled by membrane proteins called transporters. 
Transporters are a diverse group of membrane proteins which can transport a wide range of 
ions, organic, and inorganic compounds using primary active, secondary active, or passive 
transport mechanisms. Active transporters, as the name implies, expend some type of energy to 
transport chemicals against a concentration gradient. Primary active transporters are single or 
multi-component membrane transport complexes which hydrolyze ATP to transport a compound 
across the membrane (56). The free energy released from ATP hydrolysis allows these transporters 
to concentrate a compound against a chemical gradient, making these transporters excellent high-
affinity transporters for compounds present in low concentrations in the extracellular environment. 
These ATP-binding cassette (ABC) transporters have been reviewed extensively and are known to 
carry out many key physiological activities for both import and export in cells (56-58). For instance, 
MsbA catalyzes transport of lipid A, the hydrophobic moiety largely present in LPS from the 
cytoplasm to the periplasm (59). This is a function essential to survival for many Gram negative 
cells, as intracellular accumulation of lipid A is known to be toxic and LPS are needed to help 
protect cells from the extracellular environment (35, 60). These transporters can have diverse 
conformational changes and mechanisms that permit transport, but all of these mechanisms 
depend on ATP hydrolysis in the nucleotide binding domain (NBD), a structure that is relatively 
widely conserved within ABC transporters (56). 
Secondary active transporters are permeases which use a favorable chemical gradient of one 
chemical to help facilitate the transport of another chemical against a chemical gradient (61). In this 
manner, the co-substrate actually drives the thermodynamically favorable accumulation or export 
of the substrate. This co-substrate can either be transported in the same or opposite direction 
across the membrane, a process termed symport or antiport, respectively. Although the co-
substrate for this process can widely vary, it is common for many transporters to leverage the proton 
(H+) and electrochemical gradients (Na+, K+) of the cell to drive translocation (61, 62). For instance 
many multidrug resistance (MDR) transporters use the proton motive force (proton:subs trate 
antiport) as an energy source to drive the export of a broad range of intracellular lipophilic chemicals 
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and drugs (63-65). Import of a proton as a co-substrate has an energetic cost however of 
approximately 0.33 ATP per molecule transported due to the need for ATP synthase to hydrolyze 
ATP to maintain the proton gradient (66, 67). However, some transport systems can actually be 
electrogenic due to translocation of protons to the periplasm or net intracellular consumption of 
protons. This can be seen in lactate efflux with many Lactic Acid Bacteria (LAB). For example, 
Lactococcus lactis can catabolize sugars to lactate and use the high intracellular lactate 
concentration to drive lactate-/2H+ symport from the cytoplasm to the periplasm (68). Other non-
obvious transport mechanisms can be electrogenic as seen in malolactic acid fermentation, which 
couples malate2-out/lactate-in antiport with a proton consuming decarboxylation reaction to generate 
a net decrease in intracellular protons (69). Without the functioning of this transporter, malolactic 
acid fermentation cannot proceed, demonstrating the importance of transport mechanism on the 
cellular energy status. 
Passive transporters are uniporters (or facilitators) which facilitate the transfer of chemicals 
down a chemical concentration gradient by facilitated diffusion. In this sense, they are very similar 
to channels, but are not gated to simply open/close in response to chemical, electrical, or physical 
stimuli. Instead, they facilitate transport with conformational changes more similar to the 
mechanisms of symporters and antiporters (62, 70). For instance, GLUT1 is a well-studied glucose 
facilitator in eukaryotes which is thought to import glucose by an alternating access mechanism 
(70, 71). This is a mechanism common to many uniport, symport, and antiport transporters that 
ligand binding site facing the periplasm, and the other facing the cytoplasm (70). Similar to 
channels, this mechanism is much faster than diffusion through a membrane, and is free of 
energetic costs. It is important to note that there are not many well-characterized uniporters in 
bacteria, although there is at least one characterized sugar facilitator, glf from Zymomonas mobilis, 
which appears to function similarly to eukaryotic sugar facilitators (72). 
Finally, group translocators are a transport system that is relatively unique to bacteria and 
involves the transfer of a molecular donor to facilitate and provide energy for transport. The sugar 
phosphotransferase system (PTS) is the only very well studied member of these transporters, and 
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facilitates efficient transport of sugars from the periplasm to the cytoplasm by transferring the 
phosphoryl from phosphoenolpyruvate (PEP) to a membrane transporter complex (73, 74). One 
advantage of a group translocator system, such as the PTS, is that it can immediately transform 
the incoming substrate by phosphorylation which limits escape from the cytoplasm by a reversal of 
the uptake reaction. The PTS and other sugar transport systems of bacteria are however highly 
complex and involved in the regulation of catabolic pathways, making them an important target in 
engineering efficient utilization of sugars derived from lignocellulose (73, 75). This information is all 
summarized in Figure 1.2. 
Uptake and utilization of lignocellulose-derived sugars
In many bacterial species, the PTS facilitates the transport and concomitant phosphorylation 
of exogenous carbohydrates across the cytoplasmic membrane (75). Using Escherichia coli as an 
example, the PTS of E. coli is a multiprotein phosphorelay system consisting of two soluble and 
non sugar-specific enzymes Enzyme I (EI) and the histidine protein (HPr), encoded by the ptsI and 
ptsH genes, respectively, and the sugar-specific enzyme Enzyme II (EII) system (21) (Figure 1.3). 
EII is a multicomponent complex composed of two hydrophilic domains, EIIA and EIIB, and one or 
two carbohydrate selective transmembrane domains, EIIC and EIID (76). These mentioned 
domains of EII may occur as individual proteins or as a combination of subunits in variable order 
and number (76) (Figure 1.3). Multiple parallel EII complexes facilitate cellular uptake of different 
carbohydrates. The E. coli genome encodes for more than 20 different EII complexes, thus allowing 
for the transport and simultaneous phosphorylation of more than 20 different carbohydrates (77). 
In the PTS, relay of the phosphoryl group initiates with the autophosphorylation of EI from 
phosphoenolpyruvate (PEP) and subsequently transfers the phosphoryl group to a histidine residue 
on the HPr (His-15 in E. coli) (21, 78). HPr then phosphorylates various sugar-specific EII 
complexes. In E. coli, the glucose specific EII complex comprises of the soluble enzyme EIIAGlu
and the integral membrane permease EIIBCGlu, encoded by crr and ptsG, respectively (78). The 
reported kinetic activity of EIIGlu with glucose as substrate is reported to have a high affinity with 
Km and Vmax values of 3- -1 g-1, respectively (79, 80). Lastly, the 
gar during transport across the 
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cytoplasmic membrane (21) (Figure 1.3). With the monosaccharide phosphorylated it can now be 
catabolized through the respective pathways. For example, in E. coli glucose-6-phospate can be 
catabolized by the Embden-Meyerhof-Parnas (EMP) pathway or the Pentose Phosphate Pathway 
(PPP). Glucose transport by means other than the PTS EIIBCGlu complex has been observed in E. 
coli (Figure 1.3). There is compelling evidence that the mannose sugar specific EII complex (EIIMan) 
is a promiscuous component of PTS and is able to transport glucose, fructose and N-
acetylglucosamine. The EIIMan complex comprises of the EIIABMan homodimer enzyme encoded by 
manX and the integral membrane permease EIICDMan, encoded by manY and manZ. The 
phosphoryl group from PEP is transferred to EIIABMan and then to EIICDMan which facilitates the 
transport and concomitant phosphorylation of glucose. The reported kinetic activity of EIIMan with 
glucose as substrate is reported to 
-1 g-1, respectively (73, 79, 81). Glucose may also be transported via the galactose proton 
symporter (GalP). Upon transport of glucose via GalP, the enzyme glucokinase, encoded by glk, 
phosphorylates glucose producing glucose-6-phosphate, which can now enter EMP or PPP. The 
reported kinetic activity of GalP with glucose as substrate is reported to have Km and Vmax values 
in-1 g-1, respectively (73, 82). Transport of extracellular lignocellulose-
derived pentoses such as xylose and arabinose across the plasma membrane in E. coli occurs not 
through the PTS but through two unique set of transport systems: an ATP-binding cassette (ABC) 
and a proton symporter. The ABC transporters XylFGH for xylose and AraFGH for arabinose, 
encoded by xylFGH and araFGH, respectively, actively transport sugars with the cost of one ATP 
per sugar, whereas the proton symporters XylE for xylose and AraE for arabinose, encoded by xylE
and araE, respectively, uses a proton gradient to transport the monosaccharide across the plasma 
membrane (83-87). Both biochemical and genetic tests have suggested that XylFGH and AraE are 
primarily responsible for the uptake of their respective sugars in E. coli (22, 88). In other species 
such as Zymomonas mobilis, uniport of hexose and pentose sugars can be performed using a 
sugar facilitator Glf, encoded by glf (72, 89). 
AraE also has affinity towards xylose but its expression is repressed by xylose under normal 
conditions (88, 90). Both ABC transporters XylFGH and AraFGH exhibit a high affinity with low Km 
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values between 0.2-4 µM and 4.1-6.1 µM, respectively. The proton symporters XylE and AraE 
possess a relatively low affinity with high Km values between 63-169 µM and 150-320 µM, 
respectively (84, 91, 92). Immediately following the transport of xylose and arabinose into the cell 
both substrates are eventually converted to xylose-5-phosphate via the xylose isomerase and 
arabinose isomerase pathway (93, 94) (Figure 1.3). In the xylose isomerase pathway, xylose is 
converted to xylulose through a reversible one-step reaction catalyzed by xylose isomerase, 
encoded by xylA. Xylulose is then converted to xyulose-5-phosphate by the xylulokinase, encoded 
by xylB (95). Catabolism of arabinose begins by converting arabinose to ribulose by arabinose 
isomerase, encoded by araA. Ribulose is then phosphorylated by ribulokinase, encoded by araB, 
and finally, converted to xylulose-5-phosphate by ribulose-5-phosphate 4epimerase, encoded by 
araD (85, 94). With both xylose and arabinose converted to xylulose-5-phosphate, substrates can 
now be catabolized eventually by the EMP or PPP pathways. Many bacterial biocatalysts such as 
Z. mobilis, Pseudomonas putida, Streptomyces coelicolor, Corynebacterium glutamicum, 
Rhodococcus opacus and Lactococcus lactis, do not appear to have complete catabolic pathways 
for either xylose, or arabinose, or both (missing at least two homologues) (96-99) (Figure 1.4). 
Missing genes need to be integrated into these strains for an ideal lignocellulose conversion to use 
up all sugar content (100, 101). 
Lignocellulose-derived pentoses and hexoses are transported and preferentially selected for 
further catabolism based on accessibility and utilization that allows for optimal growth rate by 
bacteria (18, 102). Glucose commonly represses the catabolism of other secondary sugars such 
as xylose, arabinose and galactose, which causes hierarchical control of sugar mixture utilization 
(103-106). Catabolite repression is a well-studied and classic topic for bacterial global 
transcriptional regulation. In E. coli and many other enteric bacteria, catabolite repression is 
controlled by two non-mutually exclusive mechanisms: 1) operon-specific regulatory mechanisms, 
such as inducer exclusion, and 2) global regulatory mechanisms (21). Inducer exclusion is an 
operon-
A classic example is the glucose repression of the lac operon transcription through lactose 
permease transporter, LacY, in E. coli (21, 107-109). Expression of the lac operon requires lactose 
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-galactosidase forming allolactose, which can bind and inactivate the lac 
repressor. In a sugar mixture of glucose and lactose, the preferred sugar glucose at high 
concentrations causes the PTS glucose specific EIIA (EIIAGlu) to be dominantly dephosphorylated 
and EIIAGlu binds to LacY, preventing lactose transport (Figure 1.3). At low concentrations of 
glucose, the EIIAGlu is dominantly phosphorylated and cannot bind to LacY, thereby allowing lactose 
to be transported across the cell membrane, isomerized, and relieve repression of the lac operon 
by binding to the lac repressor. The EIIAGlu is an essential component of the PTS not only because 
is it a major component of catabolite repression, but it has been shown that the same mechanism 
is applicable to other secondary non-PTS carbohydrates, such as maltose, melibiose and glycerol 
(21, 78). For abundant secondary sugars in lignocellulose such as xylose and arabinose, the 
catabolite repression potentially caused by inducer exclusion mechanism remains to be 
investigated. The catabolite repression caused by global regulatory mechanisms generally involves 
global transcriptional regulators to modulate the transcription of catabolic genes for secondary 
sugars (Figure 1.3). In E. coli, the main involved global regulator is CRP (cAMP receptor protein), 
also called catabolite gene-activator protein (CAP), which is the transcriptional activator for 
catabolic genes for secondary sugars such as xylose and arabinose when bound by cAMP, an 
important intracellular signaling molecule employed in many different organisms. The membrane-
bound protein adenylate cyclase (AC) and the EIIAGlu component of the PTS are also essential 
parts of regulation (21, 73, 75, 78). At low glucose concentrations copious amounts of 
phosphorylated EIIAGlu exist and are able to bind and activate AC, leading to the synthesis of cAMP. 
As cAMP intracellular concentrations increase, the formation of cAMP-CRP complex activates 
catabolic operons such as xylAB, xylFGH and araBAD (Figure 1.3). The promoters for catabolic 
operons of secondary sugars are usually weak and require co-activation by both CRP and theirs 
own sugar-specific activators such as XylR and AraC to enhance binding of the RNA polymerase 
(Figure 1.3). In contrast, at high glucose concentrations, the cAMP level is low due to inactivation 
of AC, thereby limiting the CRP activity to increase the transcription of catabolic operons for 
secondary sugars (21, 110, 111). The global regulator CRP plays an essential role in not only 
regulating secondary catabolic genes, but also many other important biological processes such as 
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respiratory genes and multidrug resistance, with over 180 genes under its control (107, 112). The 
intricate catabolite repression mechanisms in other microorganisms are less understood. 
The inability of bacteria to efficiently consume two or more carbon sources hinders commercial 
use of lignocellulosic biomass due to increased residence time, lower product titer and productivity 
(73). In the past few decades, considerable engineering efforts have been made and successes 
have been achieved to engineer bacteria for co-utilization of lignocellulose-derived sugars such as 
glucose, xylose and arabinose. The strategies to abolish catabolite repression by inactivating the 
EIIBCGlu complex, encoded by ptsG, have been explored. For example, simultaneous uptake of 
glucose and pentoses for conversion to lactate was achieved at some degree by expressing the 
lactic acid dehydrogenase from Streptococcus bovis in a ptsG mutant yielding the FBR19 strain 
(102, 113). This strain produced a lactic acid titer of 64 g/L with a yield (g/g) of 77%. However,  
inactivation of the PTS often impairs glucose uptake and thus efforts to compensate this 
defectiveness are needed. One common strategy is to evolve PTS mutant strains for better growth 
using glucose as sole carbon source. For example, the work of Hernández-Montalvo et al. showed 
that subjecting the PTS devoid mutant (PTS- glucose- phenotype) NF6 to a continuous culture 
selective method led to revertants (PTS- glucose+ phenotype) with a specific growth rates on 
-1) comparable to a PTS+ wild-type E. coli -1 ) under aerobic 
conditions (114, 115). In these revertant mutants, catabolite repression of arabinose and xylose 
was alleviated and this allowed for simultaneous mixed sugar uptake (1 g/L glucose, xylose, and 
arabinose). Although sugar co-utilization was achieved, catabolite repression was only eradicated 
in a glucose-arabinose sugar mixture. In a glucose-xylose mixture, glucose exerted repression on 
xylose uptake. In an arabinose-xylose or a glucose-arabinose-xylose mixture, arabinose repressed 
xylose utilization (115). Additionally, it was shown that a plasmid overexpressing a non-PTS 
transport system, the galactose proton symporter (galP) and glucokinase, in a PTS-deficient strain 
(W3110 PTS-) resulted in growth rates corresponding to 89% of the growth rate for W3110 (116). 
Building upon the work of Hernández Montalvo and other colleagues, a W3110 mutant with a PTS-
glucose- phenotype was subjected to anaerobic adaptive laboratory evolution to obtain an evolved 
strain, VH30N4, capable of utilizing glucose (phenotype of PTS- glucose+). Upon transforming an 
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ethanologenic plasmid pLOI594 into VH30N4, the newly evolved strain was capable of co-utilizing 
a 5 g/L glucose-
g/L (117). These adaptive laboratory evolution approaches to obtain PTS- glucose+ mutants 
demonstrate that catabolite repression can be alleviated to allow simultaneous uptake of 
lignocellulose-derived sugar. Most recently, our lab performed adaptive laboratory evolution on an 
E. coli biocatalyst for conversion of xylose to lactate. This resulted in the finding that two point 
mutations in the xylose operon transcriptional activator, xylR, led to constitutive activation of the 
xylose catabolic operons independent of cAMP-CRP (118). Utilization of this mutation has shown 
to permit glucose-xylose co-utilization under microaerobic conditions under industrially relevant 
batch fermentation sugar concentrations (~10% w/v), thus largely eliminating the issue of catabolite 
repression in glucose-xylose sugar mixtures (118). 
Besides catabolite repression, ATP consumption of bacterial pentose transport systems has 
also been implicated as a potential limitation of achieving efficient sugar co-utilization. ATP is an 
important currency for 1) cell growth, 2) cell maintenance, and 3) metabolite transport systems. 
Under aerobic conditions, oxidative phosphorylation will generate the majority of the cellular ATP 
budget and cells grown on either glucose or xylose can generate approximately equal amounts of 
biomass even though cells growing on xylose expend approximately twice as much energy on 
transport (22). Production of renewable chemicals using aerobic processes can be desirable for 
some valuable products, but aeration significantly increases the cost of a bioprocess. This makes 
it economically more challenging to compete with many products traditionally derived from 
petroleum feedstocks, and thus microaerobic fermentation is often used to decrease operating 
costs.  However, under microaerobic conditions, the main mechanism of ATP production is 
glycolysis due to inactivation of oxidative phosphorylation, and the ATP budget of cells greatly 
decreases (22). Under these conditions, the transport of xylose consumes approximately 71% of 
the ATP budget, and cells grown using xylose show decreased biomass formation and specific 
growth rates (22). In contrast, during growth on glucose cells only allocate approximately 34% of 
the ATP budget for transport (22). Using XylFGH for substrate import would theoretically cost twice 
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as much ATP equivalents as the glucose PTS, thus further demonstrating that XylFGH is the main 
xylose import mechanism in E. coli under aerobic and microaerobic conditions. 
In comparison to catabolite repression, the burden of ATP consumption during pentose 
transport has been much less thoroughly investigated as a limitation for lignocellulose 
bioconversion, and thus robust genetic modifications have yet to be characterized. Strains 
constructed for homolactic acid fermentation under microaerobic conditions can convert glucose to 
lactate, however no growth is observed during xylose fermentation (88, 119). This is most likely 
due to the decrease in ATP budget under microaerobic conditions in combination with ATP 
consumption of XylFGH lowering the ATP/xylose yield to 0.67 (119). Work from Utrilla et al 
demonstrated that a simple inactivation of xylFGH permits growth of a homolactate strain on xylose.
Furthermore, by performing adaptive laboratory after inactivation of xylFGH, the specific growth 
rate can be further improved by ~50% after a mutation in the EIIC component of the galactitol PTS 
transport system, gatC, is gained that confers xylose transport activity (119). Multiple other studies 
have noticed a similar growth deficiency for E. coli biocatalysts converting xylose to succinate, a 
product with an inherently low ATP yield. (120-122). Similarly, inactivation of xylFGH in the 
succinate biocatalyst KJ122 led to enhanced growth and succinate production, and upon adaptive 
laboratory evolution the strain exhibited greatly increased xylose and glucose-xylose co-sugar 
fermentative production metrics (122). Although this work never characterized the causative 
mutation following adaptive laboratory evolution, work by Sawisit et al. performed a similar 
laboratory evolution without initial inactivation of xylFGH. By reverse engineering the strain, they 
found that a mutation in the galactose permease (galP G236D) that was hypothesized to confer 
xylose transport activity caused similar increases in production metrics (123). Interestingly, xylFGH 
was never identified to be inactivated in this strain however, suggesting that either galP is so highly 
expressed that a majority of xylose is imported through the mutant galP, or that more complicated 
interactions are occurring. In Chapter 2 I thoroughly probe the genetic determinants permitting 
adaptation of KJ122 for xylose fermentation and find that galP has unknown regulatory interactions 
that actually affect energy conservation during xylose fermentation. Although these pieces of work 
seem to provide general knowledge that xylFGH is an energetic burden to cells converting xylose 
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to a broad range of products and this has implications on lignocellulose bioconversion, no work to 
our knowledge has explicitly looked into engineering more energy efficient xylose transport 
mechanisms in bacterial cells released from catabolite repression. Work by Tang et al. optimized 
glucose to succinate conversion in a PTS- strain and found that overexpression of glf as an 
alternative glucose transporter resulted in increased production metrics relative to overexpression 
of galP, which could be a result of the energy saved during transport (124). Although Glf has also 
been observed to be a high velocity xylose facilitator, it can also be inhibited in the presence of 
glucose (125). Utilization of Glf for xylose uniport represents an energy efficient uptake system that 
has not been thoroughly explored in strains with catabolite repression released. In Chapter 3 I 
develop a transport deficient strain with catabolite repression released, and create variants of glf
that are capable of efficient xylose transport in the presence of glucose.  
Tolerance and efflux of pretreatment inhibitors 
Pretreatment of lignocellulosic materials is considered to be an essential unit process of a 
lignocellulosic biorefinery, accounting for 16-19% of its total investment (126). In the past few 
decades, a variety of pretreatment technologies have been developed to overcome the 
recalcitrance of lignocellulose, increase cellulase efficiency, and improve the yields of monomeric 
sugars. These different pretreatments yield varied amounts of sugars and degradation products 
and have varied effects on cellulose digestibility and lignin solubilization, which ultimately affect 
downstream bioconversion processes. It is challenging to achieve a high yield of fermentable 
sugars from lignocellulose while being economically viable however. Several physical and chemical 
pretreatment methods have been developed including dilute acid (127, 128), alkaline (129, 130), 
steam explosion (131, 132), organosolv (133, 134), ozonolysis (135, 136), ammonia fiber 
expansion (137, 138), ionic liquid (139-141) and other pretreatment technologies. The advantages 
and disadvantages of these technologies are briefly summarized in Table 1.1. 
In most pretreatments, three major categories of by-products are produced: furan aldehydes, 
small organic acids and phenolic compounds (142). Furan aldehydes include furfural and 5-
hydroxymethylfurfural (HMF), which are the dehydration products of pentoses and hexoses, 
respectively. Most phenolic compounds (e.g vanillin, syringaldehyde, etc.) are degradation 
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products from lignin (13). Pretreated lignocellulosic hydrolysates can also contain large amounts of 
organic acids, including acetic acid, formic acid, levulinic acid and lactic acid. These acids are only 
toxic at high concentrations compared to furan aldehydes (24, 143). Furan aldehydes, especially 
furfural, are able to potentiate the toxicity of other side-products and inhibit cell growth at relatively 
low concentrations (24, 143-145).The above-mentioned pretreatments in Table 1 yield different 
side product spectra even when treating the same type of biomass. Different types of biomass will 
also yield different amounts of side-products after the same pretreatment. Among these techniques, 
dilute acid pretreatment has widely been regarded as one of the most economically promising 
methods of biomass pretreatment (142, 146). The main advantages of this pretreatment method 
are that it is effective at hydrolyzing the hemicellulose fraction and increasing enzyme accessibility 
to the cellulose fraction with a relatively low operational cost. However, it also generates a wide 
variety of inhibitors, including furan aldehydes and other phenolic compounds. To mitigate the 
production of these inhibitors, downstream processes can be performed to decrease the 
concentration of inhibitors prior to fermentation. These include water washing the pretreated solids 
(147), overliming (148, 149), and reverse osmosis (150). Although relatively effective, these 
methods all introduce large additional costs at the industrial scale which are ultimately undesirable.  
Since the toxicity of side-products is a limiting factor for economically viable pretreatment 
technologies, it is desirable to have robust organisms that are capable of tolerating these 
compounds in fermentation broth. The development of biological solutions for addressing 
hydrolysate toxicity would not only be cheaper and more sustainable, but also more scalable. 
Among common toxic side-products derived from lignocellulose pretreatments, furan 
aldehydes are arguably the most studied due to their abundance, toxicity and the unique property 
to potentiate the toxicity of other side-products. Furfural and 5-HMF are formed by the dehydration 
of sugars (pentoses and hexoses, respectively) during some pretreatment processes with a 
concentration range between 0 to 5 g/L depending on the severity of the processes (25, 151). More 
specifically, furan aldehydes arrest the growth of most microbes when present above a threshold 
(~0.5-1 g/L furfural and ~2-3 g/L 5-HMF for E. coli in mineral salts medium, respectively). Due to 
the highly similar structures, furfural and 5-HMF share the same degradation pathways and 
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potential toxicity mechanisms. The genetic traits or methods proven useful for furfural are also 
effective for 5-HMF (152-154). Furfural is a potentially more important inhibitor than 5-HMF for the 
following reasons: first, dilute acid pretreatments and other pretreatment technologies yield more 
furfural than 5-HMF in hemicellulose hydrolysates (5, 14). Second, furfural is more toxic than 5-
HMF to industrial catalysts including both E. coli and S. cerevisiae. Therefore, most research about 
bacterial toxicity of furan aldehydes is focused on furfural.
In spite of the high toxicity of furan aldehydes, a number of microbes have evolved different 
strategies to deal with furan aldehydes, though with varying degrees of success. Microbes including 
S. cerevisiae and E. coli, for example, are capable of transforming furfural to furfuryl alcohol by a 
reduction reaction catalyzed by oxidoreductases (Figure 1.5A) (152). Furfuryl alcohol is a less toxic 
compound (24, 47) and is excreted into the culture medium and remains in the fermentation broth 
without further degradation (152). It was reported that a few bacterial oxidoreductases such as 
YqhD and FucO in E. coli (153, 155, 156), FudC in C. glutamicum (157), and ZMO0976 in Z. mobilis
(158) are able to reduce furfural into furfuryl alcohol using reducing factors NADH and/or NADPH 
(Figure 1.5A). This appears to be a common mechanism used by different bacteria to detoxify 
aldehydes including furfural and 5-HMF (Figure 1.5B). Without further degradation, however,  
terminal accumulation of furfuryl alcohol (especially in fed-batch operation) can itself eventually 
lead to growth inhibition. In contrast, certain other bacteria (e.g., Cupriavidus basilensis HMF14) 
have evolved a complete biodegradation pathway to fully metabolize furfural (when supplied as a 
sole carbon and energy source) under aerobic or microaerobic conditions (Figure 1.5A) (159, 160). 
Furfural is firstly oxidized into 2- -ketoglutarate that 
eventually enters TCA cycle to provide energy and biosynthetic building blocks (Figure 1.5A). In 
contrast to biotransformation, biodegradation has the potential to provide an irreversible and 
absolute solution to the problem of furfural toxicity (Figure 1.5). 
The exact mechanism of growth inhibition caused by furan aldehydes is not completely known, 
but it is thought to be multifaceted and include potential membrane damage (25, 93). Most positive 
genetic traits found thus far have focused on improving tolerance using cytosolic enzymes. One 
such approach for engineering bacterial tolerance to furan aldehydes is to improve microbial native 
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biotransformation or biodegradation abilities. Overexpression of furfural oxidoreductases confers 
tolerance to a variety of bacteria, although the actual kinetic properties could benefit from directed 
evolution (156, 161, 162). Second, the reducing cofactors play an important role for furfural 
biotransformation and cytotoxicity. Different growth conditions such as medium, aeration levels and 
carbon source influence the relative abundance of intracellular NADH and NADPH levels. For 
example, the NADPH source is relatively limited when E. coli is growing under anaerobic 
fermentative conditions using xylose as a sole carbon source. Exposure of furan aldehydes 
activates the transcription of furfural reductase genes such as yqhD (153). When E. coli cells 
overexpress the NADPH-dependent furfural reductase YqhD to reduce furfural or 5-HMF, the 
NADPH intracellular pool is depleted and cell growth is arrested (153, 155). Actually this depletion 
of NADPH by YqhD was proposed as the one of the main mechanism for furfural/5-HMF induced 
growth inhibition in E. coli under xylose fermentative conditions (153, 155, 156). With respect to the 
cofactor issue, NADH-dependent furfural reductases such as FucO are a better choice for 
anaerobic fermentation using xylose as a sole carbon source (156). The complete furfural 
degradation pathway discovered in C. basilensis HMF14 and other species (159) has not been 
introduced into common genetically tractable industrial hosts such as E. coli and S. cerevisiae. One 
caveat for this pathway is its oxygen requirement which is intrinsically conflicting with the 
anaerobic/microaerobic fermentation condition used in most bioproduction scenarios for biofuels 
and bulk chemicals. Although biological abatement can be effectively used to remove furfural from 
the media, this increases complexity and costs. After NADPH limitation was proposed as one 
toxicity mechanism for furfural, researchers have identified multiple effective methods to improve 
NADPH levels and thus to relieve furfural toxicity substantially. For example, deletion of yqhD or 
increased expression of pntAB (a transhydrogenase for interconversion of NADH and NADPH) 
increased tolerance to furan aldehydes in E. coli (154, 155, 163). DNA damage has also been 
evidenced to be a mechanism of furfural toxicity. Genomic libraries from three different bacteria 
and metagenomic libraries have been constructed and screened in separate instances that led to 
the discovery of thyA/thyX as genes which confer furfural tolerance to E. coli (164, 165). These 
genes encode thymidylate synthases, enzymes in dTMP biosynthesis, further suggesting that DNA 
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damage is a potential toxicity mechanism of these furans. A few genes such as ucpA, lpcA, groESL,
ahpC, yhiH, rna and dicA are associated with furfural tolerance and the overexpression of these 
genes individually conferred furfural tolerance at varied degrees (152, 166, 167). However, it is 
difficult to characterize how these genes are functionally linked in furfural resistance. Therefore, 
further rational engineering of cellular tolerance using these traits is limited without clear 
understanding of the resistance mechanism. Another important and effective approach used to 
improve microbial tolerance for lignocellulose inhibitors is adaptive laboratory evolution (also called 
(155, 168-170). For example, the mutations 
that cause yqhD inactivation was found in multiple furfural-resistant mutants isolated by adaptive 
laboratory evolution, suggesting that NADPH starvation induced by furfural enzymatic reduction is 
one important toxicity mechanism (153). Transcriptomic analysis of some furfural resistant E. coli
mutants showed that the transcription of multiple polyamine transporters was up-regulated 
compared to normal E. coli due to the gene multiplication at the chromosomal level as indicated by 
whole genome sequencing (171). Further tests discovered that overexpression of these polyamine 
transporter genes including potE, puuP, plaP and potABCD makes cells more resistant to furfural, 
suggesting a potential protection role of polyamine for important cellular constituents (171). Quite 
a few distinct beneficial genetic traits have been identified due to the complexity of toxicity modes 
of furan aldehydes (Table 2). It is plausible that multiple pathways need to be co-activated and 
recruited for optimization of furfural tolerance. The beneficial genetic traits mentioned above are 
summarized in Table 2.  
Besides furan aldehydes, there are two other groups of toxic side-products: small organic acids 
and phenolic compounds (142). Acetic acid and formic acid are the major organic acids after 
lignocellulose pretreatments, although others may also be present (25, 142). Generally,
lignocellulose hydrolysates need to be neutralized to a certain degree for the following fermentation 
processes if dilute acid pretreatment is used. Thus, small organic acids will be converted to salt 
forms after neutralization and the toxicity of these side products is greatly decreased. For example, 
only lower than 5 g/L acetate and formate were produced after a dilute acid pretreatment of 
sugarcane bagasse while E. coli can tolerate 12 g/L acetate or higher without significant growth 
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defect (14, 172). Furthermore, it has been shown that an ethanolgenic E. coli can tolerate up to 40 
g/L acetate after adaptive laboratory evolution (173). Researchers also have identified potential 
acetate-resistant genetic traits in different microbes such as E. coli (174, 175) and Z. mobilis (176). 
So the toxicity issue of small organic acids is often not s ignificant for industrial bacteria hosts. A 
variety of phenolic compounds are produced during some pretreatment processes (Table 1). Most 
of them are very toxic but the quantity is normally small compared to furan aldehydes and organic 
acids after pretreatments (142). Without clear understanding which phenolic compound is the 
predominant inhibitor, the research of engineering bacterial tolerance to phenolic compounds is 
limited. Recent research in Z. mobilis ZM4 showed that phenolic aldehydes were reduced into 
alcohol forms by oxidoreductases to decrease toxicity, analogous to how cells cope with toxic furan 
aldehydes by biotransformation (Figure 1.5A) (177). Conversion of these aldehydes into alcohol 
form is beneficial due to the reduced toxicity of the functional group and increasing culture inoculum 
has been shown to enhance tolerance of phenolic aldehydes (24, 47, 143). It seems reasonable to 
assume that the same approaches to engineering furfural tolerance, such as degradation, might 
be effective in engineering phenolic tolerance. However, one approach that has been widely 
overlooked for enhancing tolerance to furan aldehydes, phenolics, and even final metabolic end-
products of engineered strains has been the engineering of the cell envelope. 
In the context of lignocellulosic bioconversion, protection from the extracellular environment is 
an especially important function due to all of the lipophilic compounds that can be produced upon 
deconstruction of lignocellulosic biomass. A series of studies about the toxicity of side-products 
derived from lignocellulose suggest that the hydrophobicity of these chemicals is correlated with 
toxicity (24, 47, 143). The membrane damage caused by aromatic compounds was also proposed 
as an important toxicity mechanism (24, 25, 47, 143). Since membrane stress is a toxicity 
mechanism of potentially multiple lignocellulose-derived inhibitors, biocatalysts can benefit from 
strategies that decrease intracellular inhibitor concentrations and minimize membrane fluidity 
changes and the resulting disruptive effects (178). This can be accomplished by a broad range of 
changes, such as altering the conformation of phospholipid chains (179, 180), altering acyl chain 
length (181), modifying phospholipid head groups (182), and expressing transport proteins capable 
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of inhibitor export (183). However, very few of these have ever actually been explored in any detail 
for these molecules. One of the only pieces of work that has attempted to engineer the cell envelope 
for lignocellulose inhibitor tolerance modified phospholipid head groups to enhance tolerance to 
multiple compounds including furan aldehydes and multiple phenolics derived from lignocellulose 
(178, 182). By overexpressing a phosphotidylserine synthase, pssA, to increase the abundance of 
phosphotidylserine in the inner membrane, they managed to increase cell hydrophilicity and 
maintain a higher membrane potential than a control exposed to membrane damaging compounds 
(182). Multiple other works have demonstrated methods to alter acyl chain length and composition 
of phospholipids in the membrane to increase tolerance. However, these have been studied mainly 
with short alcohols, so it is difficult to tell how directly this will translate into tolerance for 
lignocellulose inhibitors. 
Transporters capable of lignocellulose inhibitor efflux also have yet to be discovered. MDR 
transporters are known to have broad substrate specificity for efflux of lipophilic compounds, yet 
the affinity for many industrially relevant compounds is relatively unknown (Figure 1.6). MDR 
proteins include transporters from the Resistance Nodulation Cell-Division (RND), Major Facilitator 
(MF), Multidrug and Toxin Extrusion (MATE), ATP-binding cassette (ABC), and Small Multidrug 
Resistance (SMR) families. Since most lignocellulose inhibitors are relatively lipophilic it seems 
probable that an endogenous MDR transporter may be capable of efflux. In Chapter 4 I construct 
a transporter library largely comprised of MDR transporters and screen for proteins capable of 
furfural efflux. I further extend the use of this library in Appendix B by screening for transporters 
capable of transporting a broad range of lipophilic lignocellulose inhibitors and aromatic 
bioproducts.  
Enhancing production by engineering bioproduct efflux 
Genetic systems have advanced rapidly to permit tuning of biological systems for the 
production of a diverse portfolio of compounds (184-186). In the past it was thought that 
endogenous transporters could facilitate export of a diverse array of chemicals of interest, and that 
most metabolic bottlenecks must be in the biosynthetic pathways. Although product export can be 
facilitated by promiscuous transport systems at low production metrics, as production parameters 
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increase the potential for increased intracellular accumulation of the product becomes more likely 
(187). This is supported by an increasing number of examples that have shown that modulation of 
endogenous or heterologous transport systems can increase production metrics (187-189). High 
intracellular accumulation of the metabolic end-product can be cytotoxic and potentially lead to 
regulatory changes through feedback inhibition (188). Thus, product export has been previously 
observed as a bottleneck for the bioproduction of both native and non-native products.
Engineering efficient export systems capable of enhancing production of non-native products 
is challenging for a number of reasons. One challenge is that export systems for many non-native 
bioproducts are uncharacterized and thus significant efforts are required just to identify a candidate 
transporter (190). Secondly, even once candidate proteins are identified, they may have sub-
optimal kinetics due to a lack of selective pressure from the environment to couple the transporter 
structure to the desired function (191, 192). For instance, previous work has identified the RND 
pump AcrAB-TolC as a candidate exporter for multiple non-native bioproducts, including n-butanol, 
styrene, limonene, fatty acids, and more (191, 193-195). This activity has been attributed to the 
broad substrate specificity of the inner membrane transporter, AcrB, and thus it has been proposed 
that efflux and expression may be sub-optimal for non-native products. However, the components 
of complexes like AcrAB-TolC often exist in functional ratios (3:6:3) necessitating fine tuning of 
expression for an optimal phenotype (196-198). This is demonstrated by the work of Wang et al. in 
which expression modulation of individual components of acrAB-tolC led to enhanced production 
of two separate isoprenoid molecules (198). Interestingly, the optimal ratio may not have 
necessarily been the defined 3:6:3 ratio the pump exists in, suggesting a more complex relationship 
between these genes and other tolerance genes/phenotypes (198). The expression of these pumps 
can also be modulated through native transcriptional regulators to enhance tolerance, which may 
represent a more natural way to maintain the protein functional ratios. The acrAB genes are known 
to be regulated by multiple transcription factors including marA, marR, acrR, and soxR (199-201). 
Recent work showed that simultaneous introduction of a nonsense mutation in marR and insertion 
into acrR could be used to enhance tolerance to multiple solvents including cyclohexane and p-
xylene, likely by upregulating the expression of acrAB-tolC (202). However, for an optimal 
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phenotype, transport proteins must be optimally expressed and have sufficient activity for the 
desired chemical. Directed evolution has been performed on AcrB to enhance tolerance to non-
native products such as n-butanol, n-heptanol, n-octane, 1- -pinene (191, 195, 203). 
In addition, overexpression of variants that conferred enhanced n-butanol tolerance increased titer 
in a production strain using a membrane stress sensitive expression system by ~40% (204). 
Success of these transporter engineering strategies vary widely from chemical to chemical 
however, as the same approach that was successful in isolating a mutant protein conferring 
enhanced tolerance to 1-hexene was unsuccessful for other compounds that are substrates of 
AcrB, such as styrene (195).
For many native metabolites, endogenous transporters may be present for product efflux but 
under sub-optimal transcriptional regulation. For instance, amino acids are a commonly produced 
valuable metabolic end-product with a global market volume of more than 2 million tons annually 
(205). Due to the highly regulated metabolic network surrounding amino acid biosynthesis, 
accumulation of the product of interest actually begins to inhibit the biosynthetic pathway, 
necessitating that biocatalysts be resistant to inhibition (205-207). Pathway optimization has been 
facilitated by numerous random and rational engineering approaches to achieve high titers using 
microbes for production of L-alanine, L-valine, L-phenylalanine, L-threonine, and more (206, 208-
210). Within these rational approaches, multiple pieces of work have incorporated feedback -
resistant biosynthetic enzymes to further decrease inhibitory effects during amino acid production 
(211, 212). This strategy has been wildly successful in enhancing production of multiple amino 
acids, but can potentially be limited by incomplete knowledge of all the different genetic targets that 
are affected by allosteric inhibition. Feedback inhibition has thus been further decreased non-
specifically by modulating the expression of amino acid exporters (188). To identify amino acid 
exporters, some previous studies have leveraged the toxicity of high concentration of amino acids 
or analogs to select mutants that aid in identification of the genetic determinants. For instance, to 
identify the alanine exporter, alaE, an E. coli strain incapable of L-alanine degradation was 
mutagenized and mutants with a growth deficiency were selected for in media with a toxic analog, 
L-alanyl-L-alanine (213). By creating a genomic library of the parent strain, they were able to prove 
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that alaE was capable of complementing the L-alanyl-L-alanine growth deficiency and furthermore 
that overexpression of this transporter could enhance alanine production 1.5 fold (214).  Multiple 
other amino acid pathways have achieved enhanced titers by identifying and engineering 
expression of native exporters, including threonine, cysteine, arginine, and glutamate (188, 215-
218). Modulation of exporters has also been shown to be synergistic with other rational engineering 
approaches. For example, one group engineered a threonine producing E. coli with a reduced 
genome (~14% less) that overexpressed a feedback resistant biosynthetic pathway and had 
relevant side product pathways inactivated. By inactivating threonine importers, and 
overexpressing the threonine exporter rhtA23, they achieved an ~80% increase in titer (219). 
Similar work has also been done for the modulation of transporters for short-chain carboxylic 
acids for bioproduction, especially those derived from the Tricarboxylic Acid Cycle (TCA). This 
includes products such as malate, succinate, and citrate that have multi-billion dollar markets with 
applications in agricultural, food, and pharmaceutical industries (220). Unlike the metabolic 
pathways for amino acid production, many of these pathways are actually regulated in a positive 
feedback manner, such that increases in the product actually s timulates relevant product 
biosynthetic pathways and transporters (221, 222). For instance, the expression of TCA cycle 
enzymes mdh, fumABC, and frdABCD are actually enhanced by increasing concentrations of the 
C4-dicarboxylates that they form, such as succinate (223, 224). Relevant succinate exporters such 
as dcuB and dcuC have also been demonstrated to be upregulated in the presence of C4-
dicarboxylates (225, 226). Although it might seem that positive feedback may be sufficient to 
adequately express transporters during production, modulation of actively expressed C4-
dicarboxylate transporters has been shown to further enhance production. For instance, Chen et 
al modulated the expression of dcuB and dcuC to enhance succinate titer by ~34% in an E. coli 
succinate production biocatalyst (227). In other hosts, such as fungi, this has been seen to be even 
more dramatic. For instance, the production of L-malate has been enhanced by >2-fold in S. 
cerevisiae by incorporation of a heterologous malate exporter, MAE1p from Schizosaccharomyces 
pombeii (228). This appears to be due to a lack of energy-efficient short-chain carboxylic acid 
exporters in bakers yeast, as production of lactate has also been proposed to be bottlenecked by 
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export (229). Other filamentous fungi such as Aspergillus oryzae have been able to increase malate 
production by more than two-fold just by overexpressing a native transporter homolog to MAE1p 
(189). By combining this approach along with overexpression of other important biosynthetic 
enzymes, they achieved an impressive titer of 154 g/l malate after approximately 164 h 
fermentation (189). Although E. coli has also been metabolically engineered to produce malate, 
there are no known malate exporters in Gram negative bacteria so this strategy has not been 
explored. This further highlights one of the most important challenges in engineering efflux systems 
for bioproducts, as transporters with affinity for relevant chemicals are largely unknown. 
The identification of transporters for product efflux is a particularly challenging task due to 
difficulties in performing genetic screens. One approach is to perform a genome-wide screen on 
the native cellular transport system, inactivating or overexpressing genes on an individual basis 
(190). However, if cellular efflux is not strongly linked to growth in the screening environment or if 
there are multiple transporters participating in efflux, this methodology can be ineffective. 
Transcriptomic assays can also be used to probe the native regulation of efflux pumps upon 
exposure to the bioproduct. In this screening method, transport proteins regulated by the chemical 
serve as potential candidates. For example, this method has been used to identify that expression 
of an ABC transporter, MdlB, is modulated by isopentanol and overexpression of this transporter 
can be used to moderately enhance isopentanol tolerance, suggesting a potential role in efflux 
(230). However, this type of screen relies on native transport proteins being transcriptionally 
regulated by the molecule of interest, which may not be the case for products not naturally 
encountered in the evolutionary history (66). Additionally, both of these methodologies assume that 
the host genome has an ideal efflux protein already present. Other screens have sought to 
overcome this issue by performing heterologous screens of efflux proteins. For instance one group 
screened a heterologous acrB homolog library and found multiple transporters capable of 
complementing the native function of acrB for tolerance to terpenes (193). They also demonstrated 
with this approach that acrB is important for production of terpenes, such as limonene (193). Other 
work has screened a library of heterologous ABC transporters and found that multiple homologs of 
-carotene 
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(231). In Chapter 4, I use this same screening methodology to characterize transporters for furfural 
efflux. However, in Chapter 5 I use a more targeted methodology to perform a negative screen by 
rationally selecting transporters with affinity to molecules of similar chemical structures.  
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Figures. 
 
  
Methods Potential inhibitors Advantages Disadvantages 
Diluted 
acid 
Furans; 
phenolic and 
small organic 
acids at low 
levels 
High hemicellulose 
monosaccharides 
production; increasing 
cellulose digestibility; 
relatively low cost 
Inhibitors; equipment 
corrosion; low sugar 
concentration in exit 
stream  
Alkaline Furans at low 
levels 
Some lignin 
degradation; 
increasing cellulose 
digestability 
Chemical reuse 
efficiency is low; low 
hemicellulose 
monosaccharides 
production  
Steam 
explosion 
Furans, 
acetate and 
other acids 
Increasing cellulose 
digestibility; low 
environmental impact 
Incomplete disruption 
of lignin-carbohydrate 
complex; inhibitors 
Organosolv lignin 
degradation 
products 
High efficiency for 
lignin degradation 
High operational costs  
Ozonolysis Short-chain 
carboxylic 
acids 
Low furan aldehydes; 
some lignin 
degradation; ambient 
temperature and 
pressure
Highly reactive and 
flammable; high 
energy demand and 
cost  
AFEX Small 
amounts of 
inhibitors; 
amide-
containing 
chemicals 
Decrystalization of 
cellulose; lignin 
removal
Low hemicellulose 
monosaccharides 
production; high 
operational cost  
Ionic liquid minimum 
inhibitors 
Reducing cellulose 
crystallinity and lignin 
content
High chemical costs  
Table 1.1. A summary of representative lignocellulose pretreatment technologies. 
Figure extracted from our book chapter (4).
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Figure 1.1. Composition of lignocellulose. The approximate lignocellulose 
composition is given as a percentage of total dry weight. The major carbon 
monomers of the main polymeric components for typical lignocelluloses are 
underlined in a white box. The representative sugar composition shown in the 
table was obtained from a sugarcane bagasse sample (14). Note that the 
composition of soft wood materials such as gymnosperm trees is usually different 
from this graph with higher lignin content and lower xylose content in the 
hemicellulose portion. Extracted from our book chapter (4). 
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Figure 1.2. Mechanisms of membrane transport. The outer membrane serves as 
the first layer of selective permeability in which diffusion of chemicals (blue 
triangle) through the outer membrane is difficult due to lipopolysaccharides (blue 
diamonds) and thus facilitated diffusion is mainly mediated through outer 
membrane porins (OMP). Upon entrance into the periplasmic space, cells can 
catalyze transport using 1) group translocators 2) primary activate transport 3) 
antiport, 4) symport, 5) uniport, 6) channels or diffusion (dotted line).  
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Figure 1.3. Transport, catabolism and catabolite repression mechanisms of major 
lignocellulose-derived sugars in E. coli. In E. coli, there are three known mechanisms 
for glucose transport including EIIGlu-based PTS, EIIMan-based PTS and GalP. EIIGlu-
based PTS is the predominant mechanism for glucose transport. Glucose induced-
repression is mainly caused by low levels of cAMP which leads to nonfunctional 
CRP. Without CRP activation, the transcriptional activation of most secondary sugar 
catabolism pathways cannot be achieved. Phosphorylated sugar intermediates from 
glucose, xylose and arabinose catabolism enter PPP or EMP pathways for full 
degradation. The details of the important components in E. coli are summarized in 
the table. Figure extracted from our book chapter (4). 
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Figure 1.4. Bacterial genes for xylose and arabinose catabolism, and major catabolite 
repression. Midpoint rooted cladogram of some important industrial prokaryotic biocatalysts 
is constructed using 16s rRNA sequences from the Greengenes database (96). Sequences 
were aligned using MAFFT (97), and tree construction was performed using the default 
PhyML parameters (98). One hundred bootstrap replicates were performed and confidence 
values of 60-69% (circles) 70-79% (diamonds) 80-89% (squares) and 90-100% (triangles) 
are listed at each respective node. The presence of potential gene homologs were tested in 
each biocatalyst using blastp (99). Proteins that exhibited >90% query coverage and identity 
of 40-100% (++), 25-39% (+) and <25% (-) compared to E.coli and B. subtilis homologues 
(only CcpA is from B. subtilis) were scored in the table for each respective gene. Proteins 
that had 80-89% query coverage are marked with an asterisk (*). Figure extracted from our 
book chapter (4). 
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Figure 1.5. Naturally-evolved mechanisms used by different microbes to detoxify 
furfural. A) Two native furfural detoxification mechanisms are used by different 
bacteria to relieve the toxicity. B) The presence of potential furfural detoxification 
protein homologs were tested in each biocatalyst using blastp (99). Proteins that 
exhibited >90% query coverage and identity of 40-100% (++), 25-39% (+) and 
<25% (-) were scored in the table for each respective gene. Figure extracted 
from our book chapter (4). 
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Figure 1.6. Hierarchical clustering of aromatics with a MW <400 g/mole and their 
respective transporters in the Transporter Classification Database (232) in addition to 
select aromatics of interest. Chemical similarity was compared using the Signature 
molecular descriptor (h=0,1) (233) to generate an all-against-all cosine angle distance 
(234) matrix that was clustered using complete linkage agglomeration with hclust (235) . 
Transporter family abbreviations: ABC, ATP-Binding Casette; RND, Resistance-
Nodulation-Cell Division; MFS, Major Facilitator Superfamily; MATE, Multi Antimicrobial 
Extrusion; SMR, Small Multidrug Resistance; APC, Amino Acid Polyamine-Organocation; 
ARAA/P-E, Aromatic Amino Acid/Paraquat Exporter; ARAE, Aromatic Acid Exporter; 
ARSB, Arsenite-Antimonite Efflux; BAT, 5-TMS Bacterial/Archaeal Transporter; BES, 
Bestrophin Family; BIP, Bacteriocin Immunity Protein; DAACS, Dicarboxylate/Amino 
Acid:Cation Symporter; HAAAP, Hydroxy/Aromatic Amino Acid Permease; NSS, 
Neurotransmitter:Sodium Symporter; OAT, Organo Anion Transporter; POP, Plant 
Organocation Permease; OMPP, Outer Membrane Pore-forming Protein; SSS, 
Solute:Sodium Symporter; TSUP, 4-Toluene Sulfonate Uptake Permease; MDR, Multidrug 
Resistance. Figure extracted from a co-authored review article (in revision). 
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CHAPTER 2 
REVERSE ENGINEERING ESCHERICHIA COLI FOR CONVERSION OF LIGNOCELLULOSIC 
SUGARS TO SUCCINATE BY MODULATING THE GENETIC CONTROL OF GALP 
Abstract 
Microbial conversion of lignocellulosic substrates into valuable products requires biocatalysts 
to use a mixture of sugars efficiently, especially glucose and xylose. Escherichia coli KJ122 has 
previously been engineered to produce succinate from glucose at high titer (85 g l -1), yield (0.9 g g-
1), and productivity (0.8 g l-1 h-1), but xylose utilization is surprisingly inefficient under fermentative 
conditions. To probe the potential underlying mechanism inhibiting xylose fermentation, KJ122 was 
adapted to enhance xylose utilization multiple times independently in xylose fermentation media. A 
quick adaptation repeatedly occurred within 20 generations and strains isolated after 60 
generations showed efficient succinate production from xylose (17-fold increase). Genome 
sequencing analysis of the evolved strains revealed that the convergent mutations occurred in the 
galactose regulon during laboratory adaptive evolution potentially decreasing the level or the 
activity of GalP, a galactose permease. GalP is the main substitute glucose transporter in KJ122 
since the phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS) was 
inactivated in KJ122 to improve PEP levels for succinate production. We showed that deletion of 
galP increased xylose utilization in KJ122 and wild-type E. coli, suggesting a common repressive 
role of GalP for xylose fermentation. Concomitantly, induced express ion of galP from a plasmid 
repressed xylose fermentation in wild-type E. coli. Transcriptome analysis using RNA sequencing 
indicates that galP inactivation increases transcription levels of many catabolic genes for secondary 
sugars including xylose and arabinose. In addition, many transcriptional changes facilitating 
succinate fermentative production were observed including genes involved in the anaplerotic 
reaction, the reductive branch of TCA cycle, and high-sugar osmotic stress tolerance. The 
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discovery of the repressive role of GalP for secondary sugars in E. coli suggests that utilization of 
GalP as a substitute glucose transporter may be undesirable for conversion of lignocellulosic sugar 
mixtures. 
 
Importance 
Lignocellulose is an abundant renewable feedstock that can be used for microbial conversion 
to produce renewable fuels and bulk chemicals. However, simultaneous co-utilization of 
heterogeneous sugar mixtures present in lignocellulose hydrolysates is a challenging task, 
especially when sugar concentrations are high. In this work, we discover that a commonly used 
substitute glucose transporter, GalP, represses the utilization of secondary sugars, such as xylose, 
in E. coli through transcriptional downregulation of many catabolic genes for secondary sugars, 
suggesting the presence of a novel repressive mechanism. Therefore, utilization of GalP as an 
alternative glucose transporter in PTS defective strains may hinder xylose conversion, an important 
consideration in engineering strains for bioconversion of lignocellulose to products that require the 
precursor PEP, such as C4-dicarboxylates and aromatics derived from the shikimate pathway. 
Introduction 
Lignocellulose is a complex matrix present in the cell wall of plants that makes up more than 
half of the (1). Independent of 
source, lignocellulose usually contains cellulose and hemicellulose, which can be degraded to 
glucose and pentoses for use as a feedstock for microbial conversion (2, 3). Glucose is the only 
sugar monomer in cellulose and xylose is the major sugar component for common hemicellulose 
fractions (2, 4). Simultaneous co-utilization of both sugars is desired for an efficient microbial 
lignocellulose bioconversion (5, 6). However, co-fermentation of mixed sugars often presents an 
obstacle to model microbial biocatalysts such as Escherichia coli due to a global regulation 
mechanism known as carbon catabolite repression (CCR) (6-8). For using secondary sugars such 
as xylose and arabinose in E. coli, transcriptional activation of the relevant catabolic operons needs 
1) the activated global transcriptional regulator CRP (cAMP receptor protein) bound by cAMP, 2) 
the activated transcriptional regulators specific for the secondary sugars, such as XylR for xylose 
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and AraC for arabinose, respectively (7, 8). In the presence of glucose, CRP is not activated due 
to the low cAMP levels, thereby causing glucose-induced transcriptional repression of catabolic 
genes for secondary sugars (7, 8).  
Glucose uptake and phosphorylation is mainly achieved by the phosphoenolpyruvate: sugar 
phosphotransferase system (PTS) in E. coli which is also an important component of CCR to control 
cAMP levels (6, 9, 10). Disruption of the PTS system (deletion of ptsG or ptsI) is an effective 
approach to release CCR, but glucose uptake is significantly impaired (11, 12), which necessitates 
alternative glucose transporter for optimal productivity (13-15). In addition to releasing CCR, 
inactivation of PTS also leads to more abundant PEP accumulation as PEP is used as the substrate 
by PTS to phosphorylate sugars through a phosphorylation cascade (9, 11), which is a useful 
approach to increase production of chemicals using PEP as the precursor, such as C4-
dicarboxylates using the reductive branch of TCA cycle (16, 17), and aromatic compounds derived 
from the shikimate pathway (18, 19). The galactose permease GalP, is a galactose:proton 
symporter that has glucose transport activity and has been often used as an alternative glucose 
uptake system in PTS deficient strains (13, 15, 19, 20).  
Interestingly, the mutations that inactivate PTS and upregulate of galP were acquired during 
adaptive evolution of an E. coli biocatalyst to enhance glucose-succinate conversion (17). Although 
the strain derived from this laboratory evolution, KJ122, has high succinate production metrics with 
a high titer (~85 g l-1), yield (~0.9 g g-1), and productivity (~0.8 g l-1 h-1) (21), the xylose fermentative 
growth of this strain is stunted with much lower production metrics (22). Here, to probe underlying 
genetic mechanisms inhibiting xylose utilization, we evolved KJ122 to enhance its xylose 
fermentation abilities in parallel and characterized the potential convergent genetic changes shared 
by multiple independently evolved strains. We discovered that GalP represses xylose fermentation 
in KJ122 and even in wild-type E. coli, suggesting that utilization of GalP as a substitute glucose 
transporter may be undesired for conversion of lignocellulosic sugar mixtures. 
Results 
Quick adaptation for xylose utilization in a succinate producing E. coli biocatalyst 
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KJ122 was previously developed for efficient conversion of glucose into succinate (21), but suffers 
from deficient xylose catabolism (22). Since this strain has all other fermentation and competing 
pathways disrupted, the growth and ATP production of this strain are linked to succinate 
fermentative production, thereby providing very strong growth-based selection. A quick adaption 
for using xylose was previously observed, and two evolved strains XW055 and AS1600a were 
isolated (22, 23). XW055 was isolated after ~40 generations, but the mechanism improving xylose 
fermentation remained unknown (22). For AS1600a, the causative mutation was identified as a 
point mutation in the coding region of galactose permease gene, galP (G236D). However, the 
working mechanism remains elusive. To gain deep mechanistic insights of the potential genetic 
changes inhibiting xylose fermentation, we hypothesized that characterization of independently 
evolved strains would reveal the convergent causative mechanism for this adaptation. We repeated 
the evolution of KJ122 in two independent experiments for enhanced xylose catabolism as 
previously described (22) by transferring cells during exponential growth phase into new AM1 
medium containing 10% (w/v) xylose (Figure 2.1A and 2.1B). In both evolutionary trajectories, a 
rapid adaptation occurred even at the second or third transfer that simultaneously increased xylose 
catabolism and cell growth (Figure 2.1A, 2.1B and Figure 2.2). From these two evolved populations 
(approximately 60 generations), strains LP001 and CM001 were isolated and confirmed with 
increased xylose fermentation capabilities (Table 2.2).  
Identification and characterization of convergent genetic changes occurring at the galactose 
regulon in the ancestor and evolved strains 
The genomic DNAs of the ancestor KJ122 as well as three evolved strains LP001, CM001, and 
XW055 were extracted and sequenced using Illumina paired-end sequencing. Interestingly, all 
three evolved strains have genetic differences in gal regulon including galR, galS and galP, 
compared to the ancestor KJ122 (Figure 2.1C), suggesting a result of convergent evolution to 
relieve the inhibitory mechanism for xylose catabolism in the ancestor strain. We hypothesized that 
these genetic changes in gal regulon are responsible for the increased xylose fermentation. 
KJ122 has an IS1 insertion sequence at the position 261 of galR ORF and an adenine insertion at 
the position 231 galS ORF causing frame-shift mutation, which likely inactivate both proteins 
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(Figure 2.1C). Both GalR and GalS are known to be repressors of genes needed for the transport 
and utilization of galactose, including galP, galETKM, and mglBAC (24) (Figure 2.1D). It was 
reported that expression of galP was increased to compensate the PTS deficiency in the precursor 
strain of KJ122 due to adaptive evolution for increased glucose to succinate bioconversion. 
However, the exact genetic mechanism remains uncharacterized (17). We hypothesized that these 
two mutations are responsible for enhanced galP expression that leads to higher glucose-succinate 
conversion. To test this, we reconstructed succinate producing E. coli XW01 derived from a 
previously ldhA) 
(16) and then tested of effect of the deletion of galR, galS or both on succinate production. In the 
strain XW01, pflB and ldhA were deleted to eliminate competing fermentation pathways for ethanol 
and D-lactate, respectively. The ptsI gene was deleted to disrupt PTS for increased levels of PEP, 
a precursor for succinate (16). In addition, pck expression was enhanced with an upstream 
mutation (pck::pck*; G to A at position - 64 relative to the ATG start codon) (16, 17). Fermentation 
of XW01 in glucose resulted in a succinate titer of 28 g l-1 after 96 h (Figure 2.3A). Interestingly, 
single deletion of either galR or galS decreased the succinate titer at 96 h to 24 g l-1 and 9 g l-1, 
respectively (Figure 2.3B and 2.3C). Deletion of both galR and galS enhanced production, 
increasing the titer from 28 g l-1 to 46 g l-1 after 96 h and from 62 g l-1 to 71 g l-1 after 144 h (Figure 
2.3D). Overall productivity, specific growth rate, and titer were all increased when both galR and 
galS were deleted, but all decreased by inactivation of either galR or galS (Figure 2.3). This result 
supports that galRS inactivation was the causative mutations leading to increased galP expression 
in KJ122.  
For the evolved strains, both XW055 and LP001 reverted galR back to the wild-type sequence 
during adaptive evolution while CM001 gained a nonsynonymous mutation in galP (A392D) (Figure 
2.1C). AS1600a that was evolved independently in another group also was reported to have point 
mutation in galP (G236D) (23). Given the results of single deletions of galR and galS regarding 
their effect on succinate production (Figure 2.3), the restored galR in LP001 and XW055 will 
potentially decrease galP levels, which is supported by the defective performance of glucose 
fermentation (Table 2.2). Similarly, as shown in Table 2.2 and the previous report (23), CM001 and 
  55 
AS1600a also showed decreased both glucose utilization and succinate production, suggesting 
these two point mutations probably negatively influence GalP function. It is plausible that decreased 
levels or activities of GalP are the underlying mechanism for enhanced xylose utilization by 
adaptive evolution. 
Confirmation of the inhibiting role of galP on xylose fermentation in succinate production 
E. coli biocatalysts
To test if GalP represses xylose fermentation and also to directly prove that the inactivation of 
GalP is the causative mechanism for xylose adaption in KJ122, we deleted galP in KJ122 and 
compared the resulting strain AG055 to KJ122, CM001 and LP001 in terms of their fermentation 
performance using mono- and co-sugar conditions (Table 2.2). With xylose as a substrate, AG055 
produced 70 g l-1 succinate after 96 hours, approximately 14-fold that of KJ122 (Table 2.2). This 
was comparable to the titer of the evolved strains XW055, CM001, and LP001 in the same period 
of time, producing 76 g l-1, 80 g l-1, and 77 g l-1, respectively (Table 2.2). This demonstrated that 
inactivation/repression of galP was primarily responsible for the observed phenotype in the evolved 
strain. With a mixture of glucose and xylose as substrate, titer and productivit y increased by 
approximately 25% in AG055 compared to KJ122 (Table 2.2). However, when glucose was used 
as the sole carbon source, similar to evolved strains AG055 had decreased succinate production 
(Table 2.2). This is consistent with the finding that GalP is a major glucose transporter in KJ122 
which has a disrupted PTS (17). To directly test the repressive effect of galP on xylose fermentation,
wild-type galP was cloned into a plasmid pTrc99A and galP expression was induced by 10 µM 
IPTG in AG055 to test the effect on xylose fermentation. Induced expression of galP resulted in a 
3-day lag for AG055 before any succinate production and a 3-fold decrease in succinate titer after 
96 hours (Figure 2.4).  
Transcriptomic changes caused by galP inactivation 
To understand the transcriptomic changes upon galP inactivation, we isolated RNAs for both 
galP) in early exponential growth during xylose fermentation and used 
RNA sequencing to quantify transcriptomic differences. There were 17 genes downregulated and 
75 genes upregulated at least 2-fold in AG055 compared to KJ122 (Table 2.3). First, it is noticeable 
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that many catabolic genes, especially for secondary sugars such as xylose, arabinose, ribose and 
galactose are upregulated upon galP inactivation (Table 2.3). The xylose (xylAB, xylFGH, xylE and 
xylR), arabinose (araBAD, araFGH and araC), ribose (rbsDACB, rbsK and rbsR), and galactose 
(mglBAC and galETKM) catabolic genes were upregulated 2.2, 2.0, 5.5, and 2.4-fold on average 
estimated by relative ratio of transcripts per million (TPM) (Figure 2.5). Second, many 
transcriptional changes facilitating succinate fermentative production were observed including 
genes involved in the anaplerotic reaction, the reductive branch of TCA cycle, succinate transport 
and high-sugar osmotic stress tolerance (Figure 2.5). In particular, there was a 3.5-fold increase in 
the expression of pck that encodes PEP carboxykinase known to be crucial for conserving energy 
in succinate production (17), while the competing carboxylation enzyme, ppc, was downregulated 
by 2-fold. This resulted in an increase in the ratio of TPM of pck over ppc from 1.5 to 8.5 in AG055. 
The transcripts of fumarate reductase, catalyzing the conversion of fumarate to succinate 
production (encoded by frdABCD) was upregulated 2.5-fold as well. These changes may benefit 
xylose to succinate fermentative conversion by enhancing xylose catabolism and carbon flux to 
succinate through the TCA cycle (Figure 2.5). 
GalP represses xylose catabolism in wild-type E. coli 
To test if the negative regulatory effect of galP is a common scenario not only specific to 
succinate producers, we deleted galP in wild-type E. coli W (ATCC 9637) and compared the 
resulting strain GK501 to wild-type strain for their xylose fermentation performance. Inactivation of 
galP enhanced the initial xylose consumption rate (0-24 h) by 140%, suggesting that the repressive 
effect of galP is commonly present in wild-type E. coli (Figure 2.6A). Cell growth of GK501 was also 
increased compared to wild-type with 66% more biomass at 24 hours (Figure 2.6A). As a 
complementary test, galP expression was induced from a plasmid in wild-type E. coli W to test the 
effect on xylose fermentation. Induced expression of galP resulted in much slower growth and
xylose utilization with only approximately half biomass accumulated for 24 and 48 hours compared 
to the empty vector control (Figure 2.6B). 
Discussion 
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Characterization of microbial control mechanisms for sugar preference will help engineering 
efficient sugar co-utilization, which is desired for lignocellulose microbial conversion. In this work, 
we discovered a novel mechanism that natively represses xylose fermentation through a galactose 
permease, GalP. The reverse engineering of xylose adaptation mechanisms for multiple 
experimental evolutionary trajectories of an E. coli succinate production strain revealed that a set 
of convergent causative mutations disrupting galP enhanced xylose fermentation. The 
transcriptomic analysis suggests that the improved fermentation is likely due to the increased 
expression of the genes involved in secondary sugar catabolism and succinate fermentative 
production. 
Succinate, a C4-dicarboxylic acid with a multi-billion dollar market, can be used to make many 
commodity chemicals in plastics and solvents (25). Many efforts have been made to both isolate 
and engineer biocatalysts for succinate production with varying success (26). A series of efficient 
E. coli strains, such as KJ73 and KJ122, have been engineered using a combination of metabolic 
evolutions and chromosomal deletions of competing pathways, ultimately producing succinate at a 
high titer (85 g l-1), yield (0.9 g g-1), and productivity (0.8 g l-1 h-1) from glucose (21, 27). In these 
strains, GalP was found to be more abundant (a 20-fold increase at transcriptional levels) compared 
to wild-type strain and serve as the dominant glucose transporter in evolved strains (17). However, 
the mutations increasing galP expression remain elusive until this reported work: inactivation of 
both galR and galS is required for increased GalP activities serving an effective glucose uptake 
system in the PTS deficient background (Figure 2.1 and 2.3). Six defined chromosomal 
ldhA galR galS) in wild-type E. coli ATCC8739 without any 
experimental adaptation yielded efficient succinate production with a titer at 71 g l -1, a yield at 1.0 
g g-1, a productivity at 0.50 g/ l-1 h-1 for 6-day simple batch fermentations (Figure 2.3).  
GalR and GalS are homologous dimeric repressors of the galactose regulon in E. coli (28). 
Genes encoding the ATP-dependent galactose transport system mglBAC, the Leloir pathway 
operon galETKM, and the galactose:proton symporter galP are repressed by GalR and GalS, and 
meanwhile activated by the presence of CRP bound with cAMP (24, 29). Our data suggest the 
presence of either GalR or GalS was sufficient to repress galP at some degree, leading to low 
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glucose consumption (Figure 2.3), which agrees with the evolved mechanism to restore only one 
copy of repressors, galR, in LP001 and XW055 (Figure 2.1). The restored galR is due to the 
removal of IS1 element which was strongly selected for higher fitness during xylose adaptation. In 
general, IS elements increase genome dynamics and cause genome rearrangements, which could 
be beneficial for cells to adapt to new environments (30). 
A GalP mutation (G236D) was previously identified using a similar approach, but the exact 
working mechanism is unclear (23). Although it is possible that galP 
mutation making GalP an efficient xylose transporter, the strain with a complete galP deletion in 
the same background (KJ122) showed very similar fermentation performance compared to the 
strain with galP (G236D) mutation (Table 2.2) (23). In addition, the glucose transport function of 
GalP (G236D) is also disrupted (23), which is also similar to the strain with the galP deletion and 
all other three evolved strains (Table 2.2). Characterization of the convergent genetic basis for 
three independently evolved strains f -of-
galP is likely the convergent mechanism for this quick xylose adaptation. This strategy 
of investigating parallel evolutionary trajectories is very effective to comprehensively understand 
underlying molecular mechanisms for the improved phenotypes.  
Besides CCR occurring at the transcriptional level, the activities of some sugar transporters 
can be biochemically regulated through protein-protein interactions to achieve the control of sugar 
utilization preference (8, 31-33). Different from this type of biochemical regulation, the galP-induced 
repression seems to modulate global transcriptional regulation of many catabolic genes for 
secondary sugars as characterized by the RNA sequencing (Figure 2.5). The exact mechanism is 
still elusive, but global regulators such as CRP and Cra in control of secondary sugar catabolism 
may play a role in this process since many relevant catabolic genes are transcriptionally changed 
due to deletion of galP.  
 Transcriptomic data also suggests that there are beneficial changes for succinate production 
when galP is deleted. First, expression differences were observed in ppc and pck which encode 
two anaplerotic enzymes catalyzing carboxylation of PEP to form oxaloacetate (Figure 2.5). 
Compared to Ppc, Pck was found to conserve energy (generating one net ATP) and increased pck
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expression enhanced succinate production in E. coli (16, 17). The relative ratio of pck to ppc 
transcripts between KJ122 and its galP deletion mutant was changed from 1.5:1 to 8.5:1, 
presumably conserving more energy during the conversion of PEP to oxaloacetate. Modulating the 
relative abundance of Pck and Ppc has been shown to enhance glucose to succinate conversion 
(34). Similarly, overexpression of pck in combination with a ppc inactivation was needed to 
effectively convert xylose to succinate (35, 36). The net energy gained from utilization of xylose is 
less than that of glucose (37). The distribution of metabolic flux between these two enzymes to 
maximize energy conservation could be important for xylose to succinate conversion. The need for 
conservation of energy for xylose to succinate conversion is further supported by a recent finding 
that inactivation of xylFGH (an energy intensive xylose transporter) enhances xylose to succinate 
conversion (38). Second, the expression of fumarase and fumarate reductase genes was increased 
upon galP inactivation, which would enhance carbon flux in the reductive branch of TCA cycle. 
Third, upregulation of a betaine ABC transporter, proVWX, was also observed upon galP 
inactivation. Osmotic stress is present in fermentation with 10% (w/v) sugar and previous evidence 
has shown that addition of the osmolyte betaine to AM1 mineral salts media can significantly 
increase production metrics (39). Thus, enhanced import of betaine could also play a role in 
enhancing productivity in AM1 mineral salts medium during succinate production by reducing 
osmotic stress.  
Inactivation of the PTS has been widely used as an engineering strategy in bacteria to increase 
metabolic flux downstream of PEP and relieve carbon catabolite repression for a variety of 
products, but results in a deficiency in glucose uptake and utilization (12, 13, 15, 19). In many 
studies, galP was overexpressed to compensate the PTS defectiveness and enhance substrate 
uptake (13, 40). However, these strains are not often tested for xylose or glucose-xylose 
fermentation yet, and reported strains may be sub-optimally designed for conversion of sugar 
mixtures derived from lignocellulose because of the repressive effect of galP, especially under a 
galP overexpression scenario. Although galP inactivation can increase xylose and co-sugar 
utilization, glucose consumption remains low in these strains due to the defective PTS. Thus, 
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further work may look into the use of heterologous glucose transporters presumably without 
repressive effect on secondary sugars, such as Glf from Zymomonas mobilis (41). 
 
Materials and Methods 
Strains, plasmids and Cultivation Conditions 
All strains and plasmids used in this work are listed in Table 2.1. The plasmid encoding galP
was constructed by assemble the fragment containing the native ribosomal binding sit e, coding 
region and terminator of galP with the backbone of pTrc99A at the multiple cloning site using the 
circular polymerase extension cloning (CPEC) method (42). Primers for plasmid construction are 
listed in Table 2.4. The constructed plasmid was verified using Sanger sequencing. For strain 
construction, all manipulations were done in Luria Broth (10 g l-1 Difco tryptone, 5 g l-1 yeast extract, 
and 5 g l-1 NaCl) at 30°C, 37°C, or 39°C as needed with rotation at 180 rpm when in liquid culture. 
During genetic manipu -red recombinase 
expression.100 mg l-1 ampicillin, and/or 50 mg l-1 chloramphenicol were supplemented as needed.
Genetic Methods                                                                                                               
-red recombinase based two-step recombination 
method as previously described (21, 43, 44). Briefly, strains transformed with pKD46 were grown
in LB media supplemented with 5% arabinose (w/v) to an OD ~0.3 - 0.5 before being washed with 
ice-cold water and electroporated with a linear DNA fragment with homology to the region of 
interest. The DNA fragment used in the first-step integration was made by amplifying the cat-sacB
cassette from pXW1 (44) with 50 bp of homology to the target gene. The second-step integration 
was performed using linear fragments generated using fusion PCR (45) with 500 bp homology at 
each end. Chloramphenicol resistance and colony PCR were used to select the successful clones 
for the first step integration. For the second step integration, counter selection was performed in 
media supplemented with 10% (w/v) sucrose. Gene deletion then was verified using colony PCR. 
Primers for generation for all cassettes are listed in Table 2.4.  
Fermentation 
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Pre-inoculum for fermentation was generated by transferring cells freshly grown on AM1 
mineral salts (46) agar plates supplemented with 2% glucose into a 250 ml flask containing 100 ml 
AM1 media supplemented with the appropriate sugar (2% w/v) and incubating for approximately 
18 hours (37ºC, 120 rpms). All batch fermentations were performed using AM1 mineral salts media 
supplemented with the appropriate concentrations of sugar in fermentation vessels with 300 ml 
working volume as previously described (21). 100 mM potassium bicarbonate was included in the 
fermentation medium for succinate fermentative production (21). Co-sugar fermentation was 
performed using 5% glucose and 5% xylose (w/v). An initial inoculum of 0.022 g cell dry wt (CDW) 
l-1 (0.05 as OD550nm) was used for all fermentation tests. 100 mg l -1 
-D-1-thiogalactopyranoside (IPTG) were included if fermentation used the strains with plasmids. 
Fermentations were performed at 37°C and pH was controlled at 7.0 by automatic addition of base 
solution (2.4 M potassium carbonate and 1.2 M potassium hydroxide) as previously described (16, 
21). 
Laboratory Evolution 
The strain KJ122 was consecutively transferred 10 times (~60 generations) during 
approximately logarithmic growth into new fermentation vessels with fresh AM1 medium 
supplemented with 10% xylose and 100mM potassium bicarbonate. An initial inoculum of 0.022 g 
CDW l-1 was used for all transfers. This was performed for two independent trajectories until xylose 
utilization became stable (~10 transfers for each trajectory). The final population was saved as in 
a cryogenic tube (-80 °C) and individual isolates were re-fermented to confirm stability of the 
phenotype. CM001 and LP001 were selected from each evolved population for further investigation 
along with another previously evolved strain XW055 (22). 
Genome sequencing and variant calling 
Genomic DNAs were extracted from KJ122 and all evolved strains (CM001, LP001, XW055) 
using the Promega Wizard genomic DNA purification kit according to manufacturer instructions. 
Purified DNAs were fragmented to an average size of 500bp and libraries were generated with a 
TruSeq DNA sample preparation kit (Illumina). Sample preparation and paired-end sequencing was 
performed with technical duplicates using an Illumina MiSeq (2 x 300 bp) by the DNASU 
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Sequencing Core at Arizona State University. Reads were trimmed with Trim Galore 
(https://github.com/FelixKrueger/TrimGalore), aligned to the Escherichia coli ATCC 8739 reference 
genome using BWA (47). Sequencing duplicates were removed with Picard 
(https://github.com/broadinstitute/picard), and variants were called using GATK HaplotypeCaller 
(48). Duplications, deletions, and other sequence junctions were called using CNVnator (49) and 
breseq (50). 
Transcriptomic profiling by RNA sequencing 
Strains KJ122 and AG055 were grown to an OD ~0.7 under 10% xylose (w/v) fermentation 
conditions and had total RNA extracted using a Qiagen RNAeasy kit according to the manufacturer 
instructions. Two pools (2 biological replicates for each pool) of total RNAs for each strain were 
prepared by combining equal amounts of RNA for each replicate. Samples were depleted of 
ribosomal RNA using a RiboZero kit (Illumina). Random hexamer priming was used to generate 
cDNA and libraries were prepared using a Nextera library prep kit (Illumina). Sample preparation 
and sequencing using an Illumina NextSeq (2x150bp) was performed by the DNASU Sequencing 
Core at Arizona State University. Reads were trimmed with Trim Galore, aligned to an Escherichia 
coli ATCC 8739 reference using STAR (51) and had differential gene expression analysis 
performed using edgeR (52). 
Analyses  
Sugars and organic acids in fermentation broth were measured by high-performance liquid 
chromatography (HPLC) using an Aminex® HPX-87H column (Bio-Rad) and 4 mM sulfuric acid as 
the mobile phase, as previously described (44). Cell dry weight was calculated from the measured 
optical density at 550 nm (0.44 g cell dry weight l-1 when OD550nm is 1.0).  
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Table 2.1. Strains and plasmids used in Chapter 2 
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Table 2.2. Fermentation parameters KJ122 and its derived strains in AM1 
supplemented with indicated carbon sources after 96 hours 
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Functional 
categories 
Downregulated 
genes 
       
Upregulated 
genes   
Carbon 
metabolic 
genes pck ygcE ydjI
 maa dmlA  lpxL agp sucD ykgEFG 
 glgC ppc  frdA,B,D aspA rbsK rbsD 
        
Regulator for 
carbon utilization   cstA araC rbsR  
        
Sugar and acid 
transporters   xylH yqcE glpT yedE 
    rbsABC mglBC btsT dcuA 
        
Amino acid 
metabolism nepI lysA  ilvN mtr ansB pepE 
 asd   fucO trpE oppB  
        
Regulatory function unrelated to 
carbon metabolism     
 ada yihI  yrbL ygiM nuoHM rpoE 
    ychH caiF   
        
Other 
unrelated 
functions mutM truC  proVWX (betaine uptake)  
 yqcC alkB alkA ssuABCDE pspE    
 
phoE 
(porins)  (sulfonate-sulfur utilization)  
    abgA,ybcF, ylbF, fdrA, allCD   
    (allantoin/nitrogen catabolism)  
    ompW, ompF (porins) uspF 
    aslA cutC pstA ydeM 
        
Unclassified ydjO yigI  ucpA preAT ydeP ybhG 
 gspG   ybhF ybhR ybhQ ylbE 
        ybaE       
Table 2.3. Differentially expressed genes with greater than a 2-fold change in 
expression and a false discovery rate (FDR) < 0.1. 
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Table 2.4. Primers used in Chapter 2 
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  Figure 2.1. KJ122 was adapted for xylose fermentation by serial transfers of 
cultures in AM1 supplemented with 10% (w/v) xylose. This adaptive laboratory 
evolution was performed independently two times, from which A) LP001 and B) 
CM001 were isolated. Used xylose was determined for each transfer during 
fermentation. C) Primary convergent mutations were characterized using 
genome sequencing for CM001, LP001 and XW055, a previously evolved strain 
(24). In comparison to these three strains, a previously evolved and 
characterized strain AS1600a (30) was also summarized. D) Schematic drawing 
of the transcriptional repression of galP by both GalR and GalS. Inactivation of 
galS was by an adenine insertion at the position 231 in galS ORF, whereas 
inactivation of galR was by an IS1 element inserted at the position 261 in galR 
ORF. The given size does not reflect real proportions  
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Figure 2.2. KJ122 was adapted for xylose fermentation by serial transfers of cultures in 
AM1 supplemented with 10% (w/v) xylose. This adaptive laboratory evolution was 
performed independently two times, from which A) LP001 and B) CM001 were 
isolated. Adaptive evolution increased biomass for both evolutionary trajectories.   
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Figure 2.3. Fermentation of a rationally designed succinate producer A) XW01 
and its derivatives with inactivation of B) galR, C) galS, and D) galRS in AM1 
medium supplemented with 10% glucose (w/v). Symbols for all: biomass (open 
circle), glucose (filled square), succinate (filled triangle). 
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Figure 2.4. Fermentation of AG055 transformed 
with A) an empty vector pTrc99A  or B) a 
plasmid encoding GalP in AM 1 medium 
containing 10% (w/v) xylose and 10 M IPTG . 
Symbols for all: biomass (open circle; dotted 
lines), xylose (filled circle ; solid lines), succinate 
(filled triangle ; solid lines).
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Figure 2.5. Differential expression analysis of relevant pathways relevant to 
succinate bioproduction in AG055. The genome-wide expression of AG055 
is compared to KJ122 and relative fold change is expressed using a Log2 
scale. Abbreviations: F-6-P, -D-fructose-6-phosphate ; G-3-P, D-
glyceraldehyde-3-phosphate; X-5-P, xylose-5-phosphate; Xu-5-P, xylulose-
5-phosphate; Ru-5-P, ribulose-5-phosphate ; R-5-P, ribose-5-phosphate; S-
7-P, sedoheptulose-7-phosphate; E-4-P, erythrose-4-phosphate; PEP, 
phosphoenolpyruvate; OAA, oxaloacetate; Pyr, pyruvate; Ac-CoA, acetyl-
CoA; Ace-P, acetyl phosphate; Suc-CoA, succinyl-CoA; PTS, 
phosphotransferase system.
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Figure 2.6. Effect of galP in wild-type background on xylose fermentation using 
AM1 medium supplemented with 10% xylose (w/v). A) wild-type E. coli W (solid 
lines) and GK501 (E. coli galP; dotted lines). B) E. coli W with empty vector 
pTrc99A (solid lines) and with a plasmid encoding GalP (dotted line). 10 M IPTG 
was used to induce galP expression. Symbols for all: biomass (circle), xylose 
(triangle). 
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CHAPTER 3 
DIRECTED EVOLUTION TO RELEASE GLUCOSE INHIBITION OF GLF FOR LOW-ENERGY 
IMPORT OF LIGNOCELLULOSIC SUGARS 
Abstract 
Cellular import of D-xylose, the second most abundant sugar in lignocellulosic biomass, has 
been evidenced to be an energetic burden using the native transport systems of multiple bacterial 
biocatalysts. The glucose facilitator of Zymomonas mobilis, glf, is capable of high velocity xylose 
uniport, but is known to be inhibited by D-glucose, potentially limiting the utility of this transporter 
in sugar mixtures derived from lignocellulose. In this work we developed an E. coli transport 
deficient platform strain that is incapable of glucose catabolism (Glc -) for the screening of glucose 
resistant variants of Glf. Using this platform, we isolate variants by enrichment derived from both 
random and rational mutagenesis with a 60-210% increase in the D-xylose consumption rate in co-
sugar medium, demonstrating the utility of this approach. Mutations relieving glucose repression 
from this approach are diverse and include previously described mutations such as a conserved 
asparagine of sugar porters in TM8, as well as novel point mutations that target residues specific 
to glucose coordination, cause subtle changes in TM12, and more. Furthermore, fermentation of 
these variants in a Glc+ background demonstrates that these mutations do not inactivate glucose 
import but appear to increase the preference for xylose in co-sugar fermentation. These findings 
suggest that these transporters may be energy-conservative alternatives to the native transport 
systems of many bacterial biocatalysts for fermentation of lignocellulose-derived sugars. 
Importance 
Glucose and xylose are the two most prevalent sugars in lignocellulosic biomass, a renewable 
carbon feedstock that can potentially be used for bioconversion to valuable compounds. Xylose 
transport, one of the first steps in xylose catabolism, is known to often be catalyzed by transporters 
that unnecessarily expend ATP and/or are inhibited by glucose. This work develops a multitude of 
variants of a glucose facilitator, glf, for xylose uniport that has been relieved of glucose inhibition. 
The use of this transport system theoretically allows an E. coli biocatalyst to reduce xylose 
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catabolism ATP expenditures by 50% during consumption of glucose-xylose mixtures reminiscent 
of lignocellulose hydrolysate. Additionally, mutations gained that confer this phenotype provide 
interesting insights into the similarity of structure/function mechanisms of the MFS sugar porters.  
Introduction 
Bioconversion of lignocellulose represents a renewable production route for many petroleum 
derived chemicals that does not compete with food crop production. However, the utilization of 
lignocellulose by microbes is limited by both the toxicity and sugar composition of lignocellulose 
biomass following chemical pretreatment strategies (1). Independent of feedstock, this sugar 
composition mainly consists of glucose and xylose, and co-consumption of these sugars impose 
challenges for D-xylose uptake systems and microbial regulatory pathways through carbon 
catabolite repression (CCR) for a broad range of biocatalysts (2-4). This results in sequential and 
mechanistically sub-optimal utilization of these sugars, which ultimately decreases important 
production metrics such as titer, productivity and yield (5). Recent findings in our lab discovered 
mutations in a xylose transcriptional activator, XylR, which essentially eliminates CCR for co-
utilization of glucose/xylose sugar mixtures and is transferrable to multiple production backgrounds 
(6). Thus, circumventing energy expenditures and glucose inhibition during D-xylose uptake is one 
of the major remaining challenges in utilizing lignocellulose sugars. 
Transport of D-xylose in bacteria is generally catalyzed by either primary or secondary active 
transporters, which results in unnecessary energy consumption. In E. coli the cell has two major 
xylose uptake systems that can be induced by xylose, XylFGH and XylE (7-9). XylFGH is a high 
affinity ATP-binding cassette transporter (ABC) which hydrolyzes ATP for substrate import and is 
known to be the main importer of xylose under fermentation conditions (8, 10, 11). XylE is a low 
affinity xylose:H+ symporter and although more energy efficient it appears to catalyze much less of 
the physiologically relevant transport (7, 11). Following import, xylose is isomerized and 
phosphorylated before proceeding into the pentose phosphate pathway. Utilization of this native 
transport system however has been shown to approximately double the amount of ATP spent on 
substrate uptake relative to other efficient sugar uptake systems, such as glucose import (10, 12). 
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Since ATP is limited under microaerobic fermentation conditions due to inactivation of oxidative 
phosphorylation, this deprives the biocatalyst of energy, decreasing biomass and specific growth 
rates (10). This has been shown to be particularly problematic in biocatalysts with pathways that 
have been engineered to remove side products (e.g. acetate) which help to increase ATP yields. 
For instance, xylose to lactate conversion in E. coli has been shown to be inhibited due to the low 
ATP/xylose molar yield (0.67) of the pathway using XylFGH (11, 13). Inactivation of XylFGH 
immediately improves fermentative production, and by performing adaptive laboratory evolution 
(ALE) the cells activate a new transport system which presumably does not use ATP for import 
(13). Other fermentation products, such as succinate, have low a ATP yield which require energy 
conserving mechanisms in the pathway to even facilitate production from glucose (14). Thus 
mutations that increase ATP conservation, such as activation of the phosphoenolpyruvate 
carboxykinase, pck, through both direct and indirect methods have been shown to enhance both 
xylose and glucose-xylose to succinate conversion (14-16).  The previous strategy of inactivating 
XylFGH coupled to ALE has been used to enhance xylose to succinate conversion as well, although 
the exact transport mechanism of these newly activated transporters remains unknown (17). More 
ideal would be the incorporation of a xylose uniporter to catalyze uptake without expending cellular 
energy, although these types of transporters appear to be rare in bacteria. 
Some organisms such as Zymomonas mobilis and many eukaryotes have uniporters from the 
Major Facilitator Superfamily (MFS) which catalyze facilitated diffusion of monosaccharides (18). 
These transporters belong to the same family as many bacterial sugar symporters such as XylE 
and contain 12 transmembrane spans (TMS) that potentially recognize sugars at the C-terminal 
domain and facilitate translocation by a rocking mechanism in the N-terminal domain (19, 20). The 
substrate spectra of a broad range of eukaryotic uniporters has been characterized (21), however 
many of these transporters have low transport kinetics for xylose, are difficult to express in bacterial 
hosts, and are in general inhibited by glucose (19, 21, 22). The kinetics of these transporters have 
previously been improved in work by Young et al. who enhanced xylose uptake of multiple 
importers by modifying residues in a G-G/F-XXX- G motif that is widely conserved among sugars 
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porters (SP) in the MFS (22). In particular, this elucidated the importance of hydrophobic residues 
in this motif and found that a G-G/F-XX-F-G motif was particularly enriched in uniporters that 
effectively translocated xylose (22). However, these transporters still were inhibited by glucose. 
This inhibition results in sequential sugar utilization and decreased production metrics for multiple 
biocatalysts in glucose-xylose mixtures, and thus has been the target of protein engineering 
techniques (9, 23, 24).
The glucose facilitator, glf, of Z. mobilis is a desirable candidate to replace the native bacterial 
xylose import system since it has been functionally expressed in E. coli, already has the G-G/F-
XX-F-G motif associated with xylose uptake, and has a high velocity for xylose import (18, 25). 
Additionally, previous work has found that mutations Glf-A18T and Glf-V275F can be used to 
enhance pentose import, suggesting that the specificity for xylose can be easily modified (26). 
However, like other MFS uniporters, it too is inhibited by glucose (27, 28). Previous work has found 
that structural interactions in TMS4-8 may be important in preventing efficient xylose and glucose-
xylose co-utilization in this protein (28). Recent work has elucidated a high resolution of structure 
of XylE bound to both xylose and glucose (29). Within this structure, residues involved in 
coordination of the 6-hydroxymethyl group of glucose that are not involved with xylose coordination 
were found that reside with TM5, TM8, and TM10 (29). Additionally work by Farwick et al. and 
others have found mutations in TM5 and a conserved asparagine in TM8 that are important for 
releasing glucose inhibition of fungal xylose uniporters potentially by altering the binding pocket 
near the 6-hydroxymethyl group of D-glucose (30). However, many of these mutants have not often 
been tested under relevant fermentation conditions, or with biocatalysts that are relieved from 
catabolite repression (28, 30, 31). This may result in sub-optimal performance, thus emphasizing 
the importance of an optimized catabolic pathway released from CCR in the optimization of sugar 
porters for xylose uptake.
To create a bacterial xylose uniporter released from glucose inhibition we first created a 
platform strain to facilitate effective screening. We thus inactivated the known glucose and xylose 
transport systems in a strain relieved from CCR (xylR::xylR*). By further inactivating glucose 
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catabolism (-glk) we created a strain with a selective advantage for xylose transport that is relieved 
from glucose inhibition. We then created multiple transporter libraries both by random mutagenesis 
and by targeting residues involved in glucose coordination with site saturation mutagenesis. By 
performing a pooled enrichment, we isolated 10 transporter variants that enhance xylose utilization 
under co-sugar fermentation conditions. We then find two potentially distinct mechanisms by which 
cells are relieved from glucose repression and that these alterations enhance xylose transport 
preference in mutant transporters. 
Results 
Construction of a screening platform for glucose resistant glf 
To create a strain background to facilitate rapid identification of glucose resistant Glf variants, 
we sought to create a glucose and xylose transport deficient strain that would only be able to 
catabolize xylose, as has been done previously in yeast (30). We began by using a xylose 
specialist, AF11A, derived from E. coli ATCC 9637 that had been developed in previous work by 
our lab (publication pending). This strain has the major glucose uptake systems inactivated 
ptsI ptsG galP), resulting in almost no glucose consumption over 96h in a 10% (w/v) glucose 
fermentation even while catabolic pathways are present. Additionally, this strain has point 
mutations in xylR (xylR*) which relieves the cell from CCR of xylose in the presence of glucose. 
We further developed this strain by inactivating known xylose importers xylFGH, xylE, and the 
arabinose importer, araE. Inactivation of xylFGH decreased the initial xylose consumption rate (0-
24h) by ~50% (Figure 3.1A). By inactivating xylE in this background, we further decreased the 
xylose consumption rate to ~25% the parent strain (Figure 3.1A). Finally, inactivation of araE in this 
background decreased initial xylose consumption to ~8% of the parent strain (Figure 3.1A). 
Although inactivation of these transporters provided a strong selective pressure for efficient xylose 
transport, we found that additional xylose transporters facilitated uptake after 24h. To attempt to 
identify these transporters, we inactivated other potential xylose importers, araFGH and gatC. 
Fermentation of this strain, EG29, using xylose or arabinose as a carbon source resulted in no 
change in xylose uptake and demonstrated that there are uncharacterized pentose transporters 
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that facilitate a significant amount of sugar uptake, especially for arabinose (Figure 3.1). We then 
inactivated glucose kinase in this strain to prevent catabolism of glucose for transporters acting 
preferentially on this sugar. By fermenting this strain, EG51A, in the presence and absence of 
glucose while overexpressing glf, we find that overexpression of glf results in complementation of 
the xylose utilization rates to be equivalent to AF11A (Figure 3.2). However, xylose 
transport/catabolism catalyzed by Glf is almost completely inactive in the presence of glucose, and 
thus cells consume a similar amount of xylose as those carrying an empty vector (Figure 3.2). In 
the absence of glucose, cells have a greater than 2-fold increase in biomass at 24 h, thus we 
determined this co-sugar fermentation to be an ideal selective condition for enrichment (Figure 3.2).
Identification of Glf variants resistant to glucose 
To create variants of Glf, we took a two pronged approach employing both random and site 
directed mutagenesis. For random mutagenesis, two different variant pools of ~12,000 variants 
were created using error prone PCR (ePCR). To create a site saturation mutagenesis library, we 
specifically targeted sites that either were involved in the coordination of glucose, but not xylose in 
the XylE crystal structure. By performing a an alignment of XylE, and Glf using the Clustal Omega 
algorithm (32) and constructing a homology model of Glf we selected residues that corresponded 
to glucose coordinating residues Q175, F383, and G388 in XylE in Glf (A165, F374, and G379)
(Figure 3.3). We also chose I172 in between the glucose binding residues I171 and Q175 (in XylE) 
due to the finding that mutation of this corresponding residue was capable of releasing glucose 
repression in multiple yeast uniporters (30, 33). This resulted in targeting V162 in Glf as well for 
site saturation mutagenesis (Figure 3.3). We also constructed and tested two variants that had 
been previously identified to enhance pentose utilization, Glf-A18T and Glf-V275F (26). Following 
the creation of these mutant constructs we pooled all site saturation mutagenesis constructs into a 
single tube at equimolar amounts to create a pool.  Each pool was then transformed into EG51A to 
at least 5x coverage and immediately transferred from plates into fermentation media 
supplemented with a mixture of glucose and xylose. By transferring these fermentation cultures 
into a new vessel with fresh media every ~24h we enriched for mutants that could transport xylose 
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in the presence of glucose. This resulted in the identificat ion of 10 unique variants after enrichment, 
in addition to the previously described mutants (Figure 3.4A). We retransformed these variants into 
EG51A to eliminate potential beneficial mutations gained during enrichment and fermented them 
in the same media used for enrichment. Of these, nine variants demonstrated enhanced xylose 
utilization by 60-210% in the presence of glucose, suggesting glucose inhibition was relieved 
(Figure 3.4B). GK14, GK3 and GK7 appeared to have the highest xylose consumption rate in the 
presence of glucose with ~190-210% increases in consumption compared to wildtype Glf (Figure 
3.4B). GK2 and SM1 had the lowest increase in xylose utilization rate, with only a 60-80% increase 
in utilization between 0 24h (Figure 3.4B). Variants A18T, V275F, and GK6 did not release Glf 
from glucose inhibition, and thus were not analyzed further (Figure 3.4B). 
Glf variants have enhanced preference for xylose transport 
To test if the in-vivo substrate preference of these transporters was altered we tested each 
variant in EG29 to permit simultaneous consumption of glucose and xylose in a co-sugar 
fermentation. Simply expressing wildtype Glf in the transport deficient strain greatly increased both 
glucose and xylose utilization, indicating that the transporter still does actively transport xylose
during glucose import (Figure 3.4C). However, cells expressing Glf variants had an increased 
xylose utilization rate relative to a strain expressing the wildtype Glf, ranging from a 22% - 74% 
increase (Figure 3.4C). Of these GK14 and SM1 had the lowest increases in xylose utilization of 
approximately 20%. The best performing variants corresponded to SM3 and GK8 for total xylose 
utilization in 24h, with an increase of approximately 70% each (Figure 3.4C). Additionally, the 
substrate preference of these transporters appeared to be altered. Cells expressing wildtype Glf 
consumed on average approximately 0.7 g xylose per g glucose (Figure 3.5). All variants had 
increased this ratio to be between 0.9 - 1.4 g xylose per g glucose. The lowest of these was SM1
who only had a 0.9 g xylose per g glucose ratio (Figure 3.5). This suggests that SM1 is only partially 
relieved of glucose inhibition of xylose transport, as was seen previously (Figure 3.4B). Other 
mutants such as GK1 and GK4 also had lower sugar preference for xylose, suggesting incomplete 
release for glucose inhibition or sub-optimal xylose transport kinetics (Figure 3.5). Variants GK14, 
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GK2, GK3, GK7, GK8, and SM3 all appeared to have the greatest relief from glucose inhibition with 
a 1.3  1.4 g xylose per g glucose ratio (Figure 3.5). According to these fermentation results and 
structural investigations, we determined GK3, SM3, and GK8 to be the most ideal xylose uniporters 
to investigate further since they maintain high preference and kinetics for xylose and are composed 
of only 1-3 amino acid changes.  
Structural locations of amino acid mutations suggest multiple mechanisms of overcoming 
glucose inhibition 
To gain more information on the potential structural consequences of these mutations, we 
constructed a homology model of Glf. Since the crystal structure of XylE was recently solved with 
both glucose and xylose bound and has a high degree of identity to Glf (~43%) we selected this 
structure as a template (PDB ID: 4GBY). The structure of Glf appears to consist of twelve TMS, 
two extracellular helices (EC), five intracellular helices (IC), in addition to one kinked region of TM1 
that may reside on the extracellular side (TM1e) (Figure 3.6A). Similar to XylE most putative sugar 
coordinating residues are located in the C-terminal region of the transporter. However, variants 
released from repression were found to have a wide range of mutations with no clear bias for 
enrichment of mutations in the N- or C-terminal domain (Figure 3.6B). We investigated if mutations 
in TM helices that are known to coordinate the 6-hydroxymethyl group of D-glucose in XylE are 
enriched in the nine variants. These include TM5, TM8, and TM10. Variants in these locations 
account for 66.6% of variants suggesting that this region is important. Mutations in TM5 and TM8 
were the most prevalent with 44.4% and 33.3% of variants having mutations in these features, 
respectively (Figure 3.6B). Notably, almost all residue contacts in XylE for xylose or glucose 
recognition are conserved between XylE and Glf (Figure 3.6C). The only exception is Q175 (A165 
for Glf) which is potentially capable of forming a hydrogen bond with the 6-hydroxyl group of glucose 
in XylE (Figure 3.3). Mutant SM3 has a mutation in A165 (A165M), which is predicted to extend 
directly into the sugar coordinating pocket near the 6-hydroxymethyl group of glucose. Since this 
is a larger side chain than alanine, this may potentially hinder glucose from preferentially entering 
the binding pocket. Besides SM3 multiple other mutants were isolated with mutations that 
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potentially alter the size or structure of the binding pocket. Among the many mutations in GK7 is a 
mutation in a phenylalanine (F374S) that is involved in glucose coordination and is structurally 
conserved in Glf (Figure 3.3 and 3.7). Additionally, two variants (GK1 and GK8) had mutations in 
both a conserved asparagine residue in TM8 of sugar porters (N316 S/D) and a C-terminal lysine 
(K458 R/I) residue. This asparagine presumably protrudes into the binding pocket and although 
not directly involved in binding, has been shown to alter sugar substrate specificity in multiple 
transporters. Similarly to previous reports, the N316 side chain of Glf appears to extend into the 
translocation pocket near the 6-hydroymethyl coordinating region of glucose in our model, and thus 
mutations in this residue may alter the size or structure of the pocket (30) (Figure 3.7). The C-
terminal lysine residue however appears to be positioned directly below the cytoplasmic extending 
junction between TM8 and TM9 which may be indicative of an interaction between this residue and 
residues in TM8-9. It is not clear if these two mutations are needed however to permit release of 
glucose repression. Other mutants had less obvious mutations that may be involved in interactions 
difficult to predict. GK2 had a mutation in TM8 (G313S) that is homologous to a described mutation 
in Glut1 (G314S) known to cause decreased glucose transport without affecting cation permeability 
(34) (Figure 3.8). Based on our model, this residue extends towards TM5 near the binding cavity
(Figure 3.7). SM1 was isolated with mutation (V162G) that is positioned similarly in TM5 extending 
towards TM8 (Figure 3.3 and 3.7). These two variants may also potentially affect the size or 
structure of the translocation pocket. The L445I mutation in GK3 is possibly one of the most subtle 
mutations with no obvious structural consequences. On the basis of the homology model, this 
residue points outward from the protein core on TM12 and does not have any obvious interactions 
that may be disrupted by a mutation to isoleucine (Figure 3.7). No known mutations affecting 
glucose transport have been described for any of the variations in GK4. The likely causative 
mutations of these variants seem to point to two main potential mechanisms 1) alteration of the 
translocation pore, particularly in the area around residues coordinating the 6-hyroxymethyl group 
of D-glucose or 2) unknown interactions in the C-terminus (Figure 3.7). 
Effects of Glf on co-sugar to succinate conversion 
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Our lab previously created AG055, a strain capable of presumably conserving energy during 
xylose to succinate fermentation (Chapter 2). This ATP conservation results in an increase in 
fermentative production using glucose/xylose mixtures as a substrate as well. However, it is 
unknown if additional ATP conservation may further increase succinate titer and yield by 
decreasing the need for generation of unwanted side products, such as acetate. Thus, we 
fermented AG055 overexpressing an empty vector, wildtype Glf or variant GK3 for 120h. AG055 
overexpressing GK3 has an approximately 24h lag in growth and production compared to the other 
strains (Figure 3.9). This may be due to a sub-optimal xylose utilization pathway, as GK3 may 
preferentially transport xylose but release of catabolite repression is incomplete in this strain, as it 
does not possess xylR*. After 120h the titer and yield of all strains is approximately comparable 
(Figure 3.9).  
Discussion 
For effective lignocellulose bioconversion, biocatalysts need to be able to efficiently transport 
and utilize the main sugars present in woody biomass, glucose and xylose. Previous work has 
largely focused on the issue of CCR, which now has multiple robust solutions, while ignoring issues 
in energetic expenditures during the uptake of xylose using ABC transporters like XylFGH (1, 3). 
Although the use of xylose uniporters would be more efficient, these proteins are known to be 
inhibited by glucose thus constraining the effectiveness of overexpression of heterologous 
transporters in co-sugar mixtures. In this work, we sought to create a glucose-resistant xylose 
facilitator, Glf, to overcome sub-optimal transport mechanisms in the presence of sugar mixtures. 
By deleting all known glucose/xylose uptake proteins and inactivating glucose kinase, we were able 
to create a strain that confers a selective growth advantage for xylose transporters resistant to 
glucose. This resulted in the isolation of nine Glf variants that were at least partially released from 
glucose inhibition and had an enhanced preference for xylose uptake compared to the wildtype 
protein. This is likely due to alterations in the sugar translocation pocket that are responsible for 
coordinating the 6-hydroxymethyl group of D-glucose, although it appears other more complex 
mechanisms may also be present. These findings suggest that these proteins may be useful for 
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incorporation into strain engineering strategies to help conserve ATP during lignocellulose 
bioconversion. 
In general, many MFS transporters are known to be inhibited by glucose, including the E. coli 
xylose symporter XylE (21, 29). Previous work has looked at releasing this inhibition mainly in 
eukaryotic transporters in fungi, since it is known that xylose catabolism can be bottlenecked by 
transport in these organisms (35, 36). Our work finds that many of the residues used to release 
glucose inhibition in these eukaryotic uniporters also works to release inhibition in Glf, suggesting 
broadly conserved mechanisms of inhibition. For instance, in fungal MFS transporters Gxs1 (from 
Candida intermedia), Gal2, Hxt7, Hxt5, Hxt11, and Hxt3, mutation of the conserved asparagine in 
TM8 (Glf-N316) has been observed to release glucose inhibition, with varying success (24, 30, 33, 
37). Similar to our observation, this residue has been predicted to release glucose inhibition in 
variants GK1 and GK8 by potentially altering the structure of the sugar coordinating pocket, 
especially near the 6-hydroxymethl group of D-glucose. We also find that Glf-V162G partially 
releases glucose repression, a discovery that is corroborated by findings that mutations in the 
corresponding residue in the Gxs1, Gal2, Hxt7 and Hxt5 results in a similar effect (30, 33). This 
work also finds that a mutation of Glf-A165M, which is normally a glucose coordinating residue in 
other proteins (such as XylE) can be used to release glucose inhibition while maintaining high 
xylose utilization efficiency in vivo. Other mutations we find that may have a role in releasing 
glucose inhibition mainly seem to be located in a hotspot of TM5, TM8 and TM10, all of which are 
potentially involved in disruption of the coordination of the 6-hydroxymethyl group of glucose 
(Figure 3.3, 3.6, and 3.7). This seems to suggest that disruption of the interactions coordinating the 
unique molecular side chain of D-glucose relative to D-xylose is a common mechanism to release 
glucose inhibition. Other mutants are still present however that do not appear to have a direct role 
in this mechanism such as GK3 (Glf-L445I). Work by Li et al has observed that truncation of the C-
terminal region of Gxs1 can decrease glucose inhibition and can be combined with a mutation of 
the conserved asparagine in TM8 for an additive effect (33). This may further suggest that there at 
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two distinct mechanisms which can release glucose inhibition, or that this subtle mutation might be 
capable of creating more drastic structural changes than may be predicted.  
It has been observed that incorporation of these mutations only enhances co-utilization 
significantly when strains have been released from CCR, emphasizing the importance of this quality 
in a testing strain (31). Utilization of a strain free from CCR allowed us to probe the efficacy of these 
transporter variants without being constrained by metabolic regulation. This allowed us to discover 
that multiple of these transporters such as GK14, GK2, GK3, GK7, GK8, and SM3 actually prefer 
xylose to glucose now when given the option for consumption. Another interesting finding is that 
none of these mutations disrupt glucose utilization. A matter of fact, all of the mutants except GK14
appear to retain relatively wildtype glucose utilization rates. This finding further provides evidence 
that the mechanism of glucose inhibition is independent of transport function. This is corroborated 
by findings by Young et al that eliminating glucose transport but enabling xylose transport does not 
simply release glucose inhibition in Gxs1 (22). This is also observed in XylE, which is inhibited by 
glucose even though it does not actively transport the molecule (29). Farwick et al was able to show 
however that by changing the conserved aspargine in TM8 to a phenylalanine, glucose transport 
can be blocked presumably by hindering entrance in the binding pocket while still releasing glucose 
inhibition (30). One interesting idea might introduce a mutation of N316F into mutant GK3 to attempt 
to decouple glucose and xylose transport and thus create a more specific xylose uniporter.  
Since it is known that ATP conservation during microaerobic fermentation of xylose is important 
for efficient bioproduction (11, 13), we tried to overexpress one mutant transport (GK3) in an 
optimized succinate producer, AG055, to attempt to increase production. However, this strain 
already gained a mutation that activated energy conserving pathways, making it unc lear whether 
ATP conservation is still a metabolic bottleneck. Our results suggest that ATP conservation may 
not be a bottleneck anymore in this strain, but also that strains may require a xylR* mutation to 
effectively use these glucose-resistant uniporters. This is due to the 24h lag that is observed upon 
overexpression of GK3, possibly due to a lack of adequate expression of xylose catabolism genes 
(Figure 3.9). Also, these cells still retain a native copy of XylFGH, which may interfere with energy 
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conservation depending on the amount of xylose that is taken up by the transporter. More ideal to 
test our hypothesis may be to overexpress these mutant transporters in the precursor strain KJ122 
with a xylFGH inactivation and xylR* mutation to eliminate influence of XylFGH on energy 
conservation and enable efficient co-utilization.  
In conclusion, this work describes multiple variants of Glf that represent effective bacterial 
xylose uniporters that can be used in the presence of mixed sugars, similar to lignocel lulose 
hydrolysate. The exact causative mutations of some mutants such as GK1, GK2, GK7, GK8 and 
GK14 remain unknown, however we hypothesize that many of them may be involved with mutations 
that alter the structure of TM5, TM8, and TM10 coordinating the 6-hydroxymethyl group of glucose. 
Future directions may improve this work by combining mutations found in this work, especially 
those targeting potentially distinct mechanisms (e.g. N316 and L445). Additionally , this work could 
be expanded to further characterize the single point mutations required to release glucose inhibition 
in some of these variants, and to further characterize the molecular mechanisms which lead to 
glucose inhibition of MFS transporters. 
Materials and Methods 
Strains and Media 
All strains used in this work are listed in Table 3.1. All genetic manipulations were performed 
by growing cells in Luria Broth (10 g l-1 Difco tryptone, 5 g l-1 yeast extract, and 5 g l-1 NaCl). Cells 
in liquid culture were grown at 30°C, 37°C, or 39°C with rotation at 180 rpm. During genetic 
manipulations, 5% arabinose (w/v) was added to induce recombination and ampicillin (100 mg l -1), 
chloramphenicol (50 mg l-1), or kanamycin (50 mg l-1) were supplemented as needed. 
Genetic Methods 
Gene inactivation was performed using either one-step inactivation or two-step recombination 
as previously described (38, 39). After cells were transformed with pKD46, 10-12 colonies were 
inoculated into 25 ml activation media incubated until OD550 reached 0.3-0.5. Cells were washed 
three times with nanopure water before being electroporated with ~100 ng of linear DNA for 
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integration into the region of interest. Linear DNA for integration was amplified from pKD4 for 
primary integration (FRT-kan-FRT) or pXW01 (cat-sacB) for secondary integration. All linear DNA 
fragments were flanked by 50 bp of homology to the region of interest. The kan cassette was 
remove from integrated cells by transformation with pCP20. The cat-sacB cassette was removed 
by repeating the integration with a linear fragment created using Fusion PCR to encode ~1 kb of 
homology to the flanking regions (40). Cells were then incubated in LB supplemented with 10% 
(w/v) sucrose to select for positive integrations. All genetic manipulations were verified using colony 
PCR. All primers can be found in Table 3.2. 
Plasmid variant pool construction and enrichment 
Circular polymerase extension cloning (CPEC) (41) was used to create all plasmids in Table 
1. All primers used are in Table 2. The glf gene was amplified from Zymomonas mobilis CP4 with 
~20 bp homology overhangs for a linearized pTrc99a backbone. To mutagenize glf we performed 
error-prone PCR using the GeneMorph II (Agilent), according to the manufacturer instructions to 
create two separate libraries (~20,000 variants) with low (0-3 mutations/kb) and medium (4-7 
mutations/kb) mutation frequencies. To generate mutants for site saturation mutagenesis, we used 
Fusion PCR to generate NNK variants at codons that corresponded to Glf162, 165, 332, and 374. 
Glf variants relieved of glucose inhibition were enriched by transforming one of the three plasmid 
variant pools (low, medium, NNK) into EG51A and fermenting in TB2 (publication in preparation) 
supplemented with 6.6% glucose (w/v) and 3.4% xylose (w/v). Fermenting cells were transferred 
into fresh media every ~24h for approximately 20 generations before being plated onto LB agar 
supplemented with ampicillin and isolated for individual colonies. Plasmid was isolated from these 
variants and Sanger sequencing used to confirm unique variants. All unique variants were 
retransformed into selected strains for further testing. 
Fermentation 
Colonies were incubated for ~18 h under microaerobic conditions (gassed with argon) on LB 
agar before being transferred into 100 ml LB in supplemented with 100 mM MOPS in 250 ml flasks. 
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These seed flasks were incubated for ~18h before being transferred into 300 ml AM1 (single sugar 
fermentation) (42) or TB2 (co-sugar fermentation), supplemented with 10% total (w/v) of the 
appropriate sugar(s) in 500 ml fermentation vessels (37°C, 150 rpm). When performing co-sugar 
fermentations a ratio of 6.6% glucose and 3.4% xylose was used. Initial inoculum for fermentation 
was always OD550 = 0.05. All fermentations had pH controlled at 7.0 with automatic additions of 6M 
potassium hydroxide.
Homology modeling and structural analysis 
Homology models of Glf were constructed using SWISS-MODEL (43) with the crystal 
structures of XylE bound to glucose (PDB ID= 4GBZ) or xylose (PDB ID= 4GBY) as template. 
Structures were viewed and edited using the Chimera software suite (44). The location of predicted 
structural features was overlaid onto an Clustal Omega alignment of Glf and XylE. Visualizations 
of the alignment similarity and identity were generated using the Multiple Alignment Show tool from 
the Sequence Manipulation Suite (http://www.bioinformatics.org/sms2/).  
Analysis 
Quantification of sugars was performed using high-performance liquid chromatography (HPLC) 
using an Ultimate3000 equipped with an Aminex HPX-87H column (Bio-Rad). As described 
previously (6), we used 4mM sulfuric acid as mobile phase at a flow rate of 0.4 ml minute-1. Optical 
density was quantified using a Beckman Coulter DU 730 spectrophotometer.  
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 F´lacIq, Tn10(TetR) mcrA mrr-hsdRMS-mcrBC) lacZ M15 lacX74 recA1 araD139 
ara leu) 7697 galU galK rpsL 
(StrR) endA1 nupG
 
 
 
 
 
 
 
 
 
ATCC 8739, pck*, ptsI*, ldhA, adhE, ackA, 
focA- ) mgsA, poxB, tdcDE, citF, 
aspC, sfcA
 
 
 
 
 
 
 cat-sacB cassette with the sacB native terminator cloned into a modified vector 
pLOI4162
 
Ptrc bla oriR rrnB lacIq  
Table 3.1. Strains and plasmids used in Chapter 3 
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Table 3.2. Primers used in Chapter 3 
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Figure 3.1. Construction of a screening platform deficient in both glucose and xylose 
transport. A) Xylose consumption rates of AF11 and its derivatives engineered by 
consecutive inactivation of known and putative xylose transporters during the initial 24 
hours fermentation. Fermentation of AF11 (solid lines with filled symbols) and EG29 
(dotted lines with open symbols) using AM1 media supplemented with B) 100 g/L xylose 
or C) 50 g/L arabinose. Symbols for all: OD550nm (circle), xylose (triangle), arabinose 
(square). 
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Figure 3.2. Xylose transport of Glf is inhibited by glucose. Fermentation of EG51A 
(EG29 glk -) transformed with empty vector (EV) pTrc99A (triangle symbols; black 
lines) or pTrcGlf (square symbols; blue lines) using AM1 media containing 34 g/L 
xylose only (solid lines and filled symbols) or sugar mixtures (dotted lines and 
open symbols) containing 66 g/L glucose and 34 g/L xylose, as well as 10 µM 
IPTG to induce glf expression. A) Cell optical density (OD550nm), and B) xylose 
concentrations were determined. 
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Figure 3.3. Glucose coordination of Glf. Contacts forming 
hydrogen bonds (residues in sky blue) or hydrophobic contacts 
(residues in salmon) with D-glucose (black) according to the XylE 
crystal structure (PDB ID: 4GBZ) are displayed in the image. All 
glucose coordinating sites except A165 are conserved in the D-
glucose binding pocket of XylE. Residues V162, A165, F374 and 
G379 were selected for site saturation mutagenesis to potentially 
disrupt glucose coordination are in aquamarine.  
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Figure 3.4. A) Glf variants isolated after fermentation enrichment in TB2 
supplemented with 6.6% glucose and 3.4% xylose (w/v). Sugar consumption rate 
(0-24 h) of B) EG51A or C) EG29 overexpressing Glf variants fermented in TB2 
supplemented with 6.6% glucose and 3.4% xylose was evaluated(w/v). 
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Figure 3.5. Ratio of sugars consumed between 0-24h of sugar transport 
deficient E. coli (EG29) expressing Glf variants fermented in TB2 
supplemented with 6.6% glucose and 3.4% xylose (w/v). 
  99
 
 
  
Figure 3.6. Structural information for mutagenesis of Glf. A) A homology model of Glf 
depicts a similar structural organization to XylE consisting of 12 TMS, 2 periplasmic 
helices (PH), and 5 intracellular helices (IH). B) Positional distributions of point 
mutations from identified positive Glf variants among the structural components in the 
homology model. C) Protein sequence alignment of Glf and XylE using Clustal Omega 
ighlighted. 
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Figure 3.7. Predicted or causative mutations of variants that enhance 
xylose consumption in glucose/xylose mixtures. 
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Figure 3.8. Protein alignment of Glut1 and Glf using Clustal Omega 
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Figure 3.9. Fermentation of AG055 in TB2 supplemented with 6.6% glucose 
3.4% xylose and 100mM potassium bicarbonate overexpressing either A) an 
empty vector B) pETG1 or C) pGK ), xylose ( ), 
and succinate ( ) were measured over time and D) titer and yield were 
compared at 120h. 
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CHAPTER 4 
BIOPROSPECTING OF NATIVE EFFLUX PUMPS TO ENHANCE FURFURAL TOLERANCE IN 
ETHANOLOGENIC ESCHERICHIA COLI
Abstract 
Efficient microbial conversion of lignocellulose into valuable products is often hindered by the 
presence of furfural, a dehydration product of xylose in hemicellulose sugar syrups derived from 
woody biomass. For a cost-effective lignocellulose microbial conversion, robust biocatalysts are 
needed that can tolerate toxic inhibitors while maintaining optimal metabolic activities. A 
comprehensive plasmid-based library encoding native multidrug resistance (MDR) efflux pumps, 
porins and select exporters from Escherichia coli was screened for furfural tolerance in an 
ethanologenic E. coli. Small multidrug resistance (SMR) pumps, such as SugE and MdtJI, as well 
as a lactate/glycolate:H+ symporter LldP, conferred furfural tolerance in liquid culture tests. 
Expression of theses SMR pumps potentially increased furfural efflux and cellular viability upon 
furfural assault, suggesting novel activities for SMR pumps as furfural efflux proteins. Furthermore, 
induced expression of mdtJI in the presence of furfural and 5-hydroxymethylfurfural enhanced 
ethanol fermentative production of LY180, further demonstrating the applications of these pumps. 
This work described an effective approach to identify useful efflux systems with desired activities 
for non-native toxic chemicals and provides a platform to further enhance furfural efflux by protein 
engineering and mutagenesis. 
Importance 
Lignocellulosic biomass, especially agricultural residues, represents an important potential 
feedstock for microbial production of renewable fuels and chemicals. During the deconstruction of 
hemicellulose by thermochemical processes, side products such as furan aldehydes are generated 
which inhibit cell growth and production, limiting cost-effective lignocellulose conversion. Here, we 
developed a new approach to increase cellular resistance by identifying MDR pumps with putative 
efflux activities for furan aldehydes. The developed plasmid library and screening methods may 
facilitate new discoveries of MDR pumps for diverse toxic chemicals important for microbial 
conversion. 
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Introduction 
Lignocellulose represents one of the most abundant carbon resources on the planet, with an 
estimated net photosynthetic productivity of 155 billion tons per year in the biosphere (1). Since 50-
70% of lignocellulose dry weight is composed of fermentable sugars, the abundance and low cost 
of lignocellulose has made it an attractive renewable feedstock for bioconversion (2-4), although 
multiple bioprocessing barriers currently impede its cost effective conversion. Most of the utilizable 
monosaccharides of lignocellulose are locked up in recalcitrant structures such a cellulose and 
hemicellulose which need to be denatured and depolymerized prior to fermentation. Chemical 
pretreatment of lignocellulose to release fermentable sugars is an essential process of t ypical 
lignocellulosic biorefineries (5), but cost-effective pretreatment strategies (e.g. dilute acid 
hydrolysis) are known to release multiple inhibitors into the resulting broth (3, 6). Inhibitors released 
during this process include furan-aldehydes (e.g. furfural, 5-hydroxymethylfurfural), small organic 
acids, and soluble aromatics which have a broad range of toxicity for multiple biocatalysts (7-9). To 
reduce additional costs to the pretreatment unit process, it is desirable to engineer robust 
biocatalysts that can tolerate relevant concentrations of these inhibitors. Of the inhibitors produced 
during this process, furfural (a dehydration product of pentoses) is particularly important due to its 
abundance in hemicellulose hydrolysates, strong cytotoxicity, and the unique property to potentiate 
the toxicity of other side-products (10-12).  
Although the exact mechanism of furfural toxicity remains elusive, it is thought to be 
multifaceted (9, 10). Some evidenced toxicity mechanisms include co-factor starvation during 
furfural reduction to the less toxic furfuryl alcohol (13-15), membrane damage (16) and DNA 
damage due to oxidative stress (17-19). Thus, previous work on engineering microbial tolerance to 
furan aldehydes has focused on the use of alternative oxidoreductases (20-22), increasing the 
cellular pool of NADPH (14, 23), altering membrane properties (24), and enhancing DNA repair 
systems (25, 26) as the main mechanisms among other general strategies for increasing stress 
tolerance (9, 27). However, many of these beneficial traits do not have a simple cumulative synergy 
(9, 28), thus making further combinatorial optimization of furfural resistance traits a challenging 
task.  
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Microbial efflux is an important mechanism utilized by many bacteria to acquire antimicrobial 
resistance (29, 30), heavy metal tolerance (31, 32), and recently enhanced tolerance for renewable 
chemical production (33, 34). Engineering microbial efflux systems represents a novel route to 
reduce cytotoxicity of hydrophobic molecules like furfural (Log Kow= 0.41) and may have a positive 
epistatic interaction with other tolerance traits due to a distinct working mechanism. However, no 
exporters or efflux pumps have been described with activity for furfural. Multidrug resistance (MDR) 
efflux pumps are a group of active transporters that that include proteins from the major facilitator 
superfamily (MFS), small multidrug resistance (SMR), resistance-nodulation-cell division (RND), 
ATP-binding cassette (ABC), and multidrug and toxin extrusion (MATE) families (35, 36). Each of 
these families are known for their ability to expel a broad range of lipophilic compounds such as 
antimicrobial agents and solvents (32, 36, 37).  
Despite the great potential of MDR pumps in industrial applications, only some members from 
RND and ABC families have been thoroughly investigated as tools for improving tolerance to 
renewable fuels and/or chemicals in heterologous systems (33, 34, 38). In this work, we 
comprehensively screened a library containing all known native MDR efflux pumps, porins, and 
other selected transporters in E. coli for their ability to enhance furfural tolerance. Using a two-step 
screening method we discovered two SMR transporters (sugE and mdtJI) and one lactate/glycolate 
permease (lldP) which conferred tolerance to furfural. Increased expression of these SMR genes
can enhance furfural tolerance and thus ethanol fermentative production in an ethanolgenic E. coli. 
Furthermore, furfural tolerance conferred by the SMR pump is evidenced to be due to its efflux 
activity. 
Results 
Screening and identification of native export systems in E. coli to enhance furfural tolerance
A small plasmid library (n = 103) encoding all reported MDR pumps, selected exporters of 
interest (defined or putative exporters for various substrates based on EcoCyc database (39)), and 
porins from E. coli was constructed based on the ASKA plasmid collection which includes 
presumably all single ORFs from E. coli K-12 (40) (Figure 4.1A). For multi-component transporters, 
individual genes were added on the existing ASKA plasmid in the same manner using c ircular 
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polymerase extension cloning (CPEC) method (41). Plasmids were individually transformed into 
ethanologenic E. coli LY180 and a two-step screening process was employed to identify candidates 
that confer furfural tolerance during fermentative growth (Figure 4.1B).  
As the first step, a plate-based assay was used to thoroughly evaluate all individual members from 
the constructed plasmid library for their abilities to confer furfural tolerance by comparing visible 
differences in colony size upon exposure to 0.9 gL-1 furfural. Cells with higher furfural tolerance will 
grow faster and thus yield a larger colony size (Figure 4.1C). LY180 with empty vector or a plasmid 
encoding pntAB (14) was used as a negative and a positive control, respectively (Figure 4.1C). 
Two concentrations of inducer -D-1-thiogalactopyranoside (IPTG) were used to test the 
effect of these candidate genes under different expressional levels since there is a known trade-off 
between the beneficial effect of membrane proteins and cytotoxicity associated wit h their 
overexpression (42). Similar to the positive control, the colony size of strains with constructs 
encoding two SMR pumps (sugE and mdtJI), two glycolate/lactate permeases (glcA and lldP) and 
two RND pumps (acrA and acrEF-tolC) were larger than that of the strain with the empty vector 
4.1A). Enhanced growth was not observed when 
acrA, acrEF-tolC, or glcA 
constructs. 
As the second step of the screening process, LY180 transformed with the empty vector 
pCA24N or the potential positive constructs was grown in liquid cultures using AM1 mineral salt 
 is known that 
gelling agents for solid media can contain variable elemental contaminants that can potentially 
effect transcriptional activity (43), this second assay is more representative of relevant fermentation 
growth conditions. Induced expression of sugE, mdtJI, and lldP  IPTG increased cell 
growth after 48 hours in the presence of 1.0 g L-1 furfural by ~4-5 fold compared to the empty vector 
control (Figure 4. sugE conferred a minor 
increase in cell growth (Figure 4.2C). The increased IPTG concentration possibly resulted in 
cytotoxicity associated with membrane protein overexpression and thus offset the beneficial effect. 
In addition, increased IPTG concentrations were observed to influence cellular furfural sens itivity 
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even for the cells with empty vector (Figure 4.2C), which was consistent with previous results (44). 
Constructs from the ASKA collection have short stretches of artificial sequences at both the N- and 
C-terminus (Figure 4.2A). Although some scattered evidence suggests that these artificial 
sequences may not disrupt the localization and function of membrane proteins (40), we cloned the 
wild-type ORFs of positive candidate genes sugE, mdtJI and lldP omitting the artificial sequences 
into a pTrc99A (different replication origin and antibiotic resistance from pCA24N) to test the 
potential influence of ASKA artificial sequences and plasmid backbone. Induced expression of 
native sugE, mdtJI, and lldP 
of furfural after 48h by approximately 3.4, 5.4, and 5.3-fold, respectively (Figure 4.2D). Similar to 
the ASKA-
much smaller beneficial effects for SMR pumps or even a negative effect for LldP compared to 
4.2D and 4.2E), suggesting that optimal beneficial effects require 
suitable expression levels for these transporter genes due to known trade-off (34). Cells with 
plasmids pTrc99A and pCA24N showed different baseline furfural sensitivity likely due to different 
copy numbers and antibiotics used in the medium (Figure 4.2). 
Since overexpression of lldP was more toxic than sugE and lldP under different culture 
conditions (Figure 4.2E and 4.3) and wild-type sugE had a consistently smaller beneficial effect 
than mdtJI (Figure 4.2D and 4.2E), mdtJI was selected for further investigation. 
Induced expression of mdtJI shortens fermentation lag phase caused by furan aldehydes 
To investigate if increased expression of mdtJI could enhance ethanolgenic fermentation under 
furfural stress, we fermented LY180 containing empty vector or the plasmid encoding wild-type 
mdtJI with IPTG induction at 1  in the presence or absence of 1.25 g L-1 furfural. Without furfural, 
there was essentially no difference between cells with and without mdtJI in terms of cell growth and 
4.4). With furfural, the increased 
expression of mdtJI led to significant biomass production after 72 hours, whereas cells with the 
empty vector took 96 hours to accumulate significant biomass (Figure 4.4A). Thus, overexpression 
of mdtJI shortened the furfural-induced lag phase by approximately 24 hours. Due to the decreased 
lag time, productivity was higher over 96 h in mdtJI overexpressing cells at 0.42 g L-1 h-1, in 
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comparison to 0.19 g L-1 h-1 in the empty vector control (Figure 4.4B). Since many genetic traits that 
enhance furfural tolerance also enhance tolerance to 5-hydroxymethylfurfural (HMF) (15, 45), 
another important inhibitor derived from lignocellulose, we tested if induced expression of mdtJI
increased tolerance to this chemical as well. Similarly, overexpression of mdtJI enhanced ethanol 
productivity and decreased fermentation lag time when exposed to 1.75 g L-1 HMF (Figure 4.5).  
Functional overexpression of mdtJI enhances survival under furfural stress and furfural 
extracellular accumulation 
To test if the tolerance phenotype was actually due to efflux activity of MdtJI, we disrupted its 
transport function by introducing a previously described point mutation (E19Q) into mdtI, This 
disrupts the conserved glutamate residue at position 19 of MdtI that is essential for proton-coupled 
transport activity of the heterodimer MdtJI transporter (46). It was reported that disruption of this 
conserved glutamate residue in E. coli native SMR pumps yielded stable mutants with severely 
hindered transporter activity (46-49). Introducing this mutation into mdtJI eliminated the furfural 
tolerance phenotype, suggesting the transporter activity is involved in enhanced furfural tolerance 
(Figure 4.6A). We then hypothesized that the efflux activities of MdtJI may increase cell viability 
upon furfural exposure. Cells were incubated at toxic concentrations of furfural and their viabilities 
were measured over time. Induced expression of wild-type mdtJI increased the cell viability during 
48 and 72 hours of incubation, with a 4.5-fold and 2.6-fold increase in colony viable counts, 
respectively (Figure 4.6B). Induced mdtJI mutant (E19Q in mdtI) did no increase cell viability upon 
furfural exposure (Figure 4.6B). This increase in viability caused by MdtJI is likely due to a decrease 
in intracellular furfural if mdtJI functions as a furfural efflux pump. To further test this hypothesis, 
cells with empty vector or plasmids encoding wild-type MdtJI and its E19Q mutant were incubated 
with furfural and the extracellular furfural concentrations were measure at different time intervals. 
The main metabolic route for furfural in E. coli is to be reduced to furfuryl alcohol by native furfural 
reductases (45). To prevent any furfural-induced changes in proteome that may interfere with our 
assay, chloramphenicol was added to stop protein synthesis before furfural exposure. If furfural 
enters at the same rates for different cells, the same reduction rates will be observed because the 
native furfural reductases such as YqhD (50) and FucO (20) should be at equivalent levels due to 
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the addition of chloramphenicol. If furfural efflux pumps are active, slower furfural reduction rates 
will be observed as more furfural will be expelled and accumulated in the medium. Over 60-min 
incubation time, furfural reduction is slower for cells with induced expression of wild-type mdtJI. 
After sixty minutes incubation, the reduced amount of furfural in the broth was 225% greater in cells 
with an empty vector compared to those overexpressing wild-type mdtJI (Figure 4.6C). Consistent 
with all previous results, no significant difference was found in extracellular furfural reduction 
experiments between the empty vector and plasmid containing mdtJI E19Q (Figure 4.6).  
Chromosomal integration of mdtJI enhances furfural tolerance and potential synergy of 
mdtJI and other beneficial genetic traits
Since plasmid-based expression is not economically desirable at the industrial scale due to 
genetic instability, metabolic burden, and the costly requirement of antibiotics and inducers (51-
53), we integrated mdtJI into the frdBC locus in LY180 to develop a plasmid-free system. The frdBC 
genes are already deleted in LY180 and mdtJI expression will theoretically be active under the 
promoter of the frdABCD operon, which is known to be upregulated under fermentation conditions 
(54, 55). This also sought to remove any influence that the plasmid, antibiotic, or inducer may have 
on furfural tolerance. The integrated strain, YR105, was then assessed for furfural tolerance using 
the same liquid assay for plasmid-based tests. After 48 h, YR105 demonstrated a 5.7-fold increase 
in biomass compared to LY180 upon furfural stress (Figure 4.7A). We then tested to see if mdtJI 
could be combined with other known furfural tolerance genes, using a previously developed 
furfural-tolerant ethanologenic E. coli XW129 containing three beneficial genetic traits (deletion of 
yqhD, overexpression of fucO and ucpA) (28). Induced expression of mdtJI increased biomass 
after 48h in the presence of 1.75 g L-1 furfural by 50% compared to an empty vector control (Figure 
4.7B). A similar improvement of cell growth was observed during fermentation, especially at 48 h 
(Figure 4.8). However, the improvement of cell growth at small degree did not significantly improve 
ethanol production (Figure 4.8), suggesting that further improvement of efflux activity may be 
needed to achieve a significant synergy for furfural tolerance.   
Discussion 
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In this work, we comprehensively interrogated a plasmid library of all known E. coli MDR efflux 
pumps as well as other selected exporters and porins for their abilities to enhance tolerance to 
furfural using a two-step screening process. Two SMR pumps (mdtJI and sugE) and one 
glycolate/lactate permease (lldP) were identified to enhance furfural tolerance in an ethanologenic 
E. coli strain. We further demonstrate that the transport function of SMR pump MdtJI is required for 
enhanced furfural tolerance and its increased expression shortens the lag time for ethanol 
fermentative production during batch fermentations.  
Researchers have performed a variety of genome-scale screening methods to identify furfural-
resistant genetic traits. For example, genomic libraries from different bacteria and metagenomic 
libraries have been constructed and screened that led to the discovery genes such as thyA that 
confer furfural tolerance to E. coli (25, 26). MDR pumps and other membrane proteins were rarely 
identified as positive traits at least partially because their beneficial effect is sensitive to the 
expression level, and often eliminated when the expression level is high as observed for this work 
(Figure 4.2). However, most reported work employed the screening methods with high copy 
plasmids and high induction conditions (25, 26). Careful evaluation of transporter genes with 
different expression levels may yield new candidates for microbial tolerance engineering. 
The SMR family is a group of small (~100 amino acids) inner membrane transporters that in E. 
coli has four members, SugE, EmrE, MdtJ, and MdtI (56). Of these, EmrE and SugE are thought 
to form functional homodimers and MdtJI a heterodimer to enhance tolerance to a number of 
lipophilic, quaternary ammonium compounds (QACs), and cationic drugs (57, 58). The SMR pumps 
are proposed to be H+/substrate alternating access antiporters (59) and their efflux activity is 
dependent on a conserved glutamate residue (E14 of EmrE, E19 in MdtI) (47, 48). The introduction 
of a well-studied point mutation (E19Q) (46, 49) in mdtI disrupted transport mechanism and thus 
the furfural tolerance phenotype, indicating that transport is necessary for the furfural tolerance 
phenotype. Besides sharing several of the substrates with other SMR pumps, MdtJI is also an 
evidenced H+/spermidine antiporter in E. coli (46). This is important in the context of furfural 
resistance, as it has been discovered previously that import and supplementation of polyamines 
such as putrescene enhances furfural tolerance (44). Although it is possible that the enhanced 
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furfural tolerance phenotype is due to polyamine transporter activity of MdtJI, it is unlikely to be the 
main mechanism. This is evidenced by the observation that sugE overexpression enhanced furfural 
tolerance as well (Figure 4.2), and was not found to have polyamine transport activities (46). In 
addition, the extracellular concentration of furfural was increased in cells overexpressing mdtJI, 
suggesting that MdtJI is actively transporting furfural out of the cytoplasm to confer the tolerance 
(Figure 4.6). In addition, recent work has also found that upregulation of mdtJI may confer tolerance 
to ionic liquids, suggesting that SMR pumps may be useful for tolerance to different toxic chemical 
associated with lignocellulose conversion (60). It is plausible that furfural (uncharged, hydrophobic) 
is not the preferred substrate for SMR proteins (QACs and cationic chemicals as defined 
substrates). Improvement of the activities of SMR pumps towards furfural by mutagenesis will 
further enhance the furfural tolerance of biocatalysts. 
The lactate permease family is a group of inner membrane transporters (~550aa) that is known 
to consist of LldP and GlcA in E. coli (61). Induced lldP overexpression enhanced furfural tolerance 
to a similar extent as sugE or mdtJI (Figure 4.2). However, lldP overexpression was more toxic to 
the cells than sugE or mdtJI (Figure 4.3). Overexpression of membrane proteins can overwhelm 
membrane translocation machinery and quickly dilute essential membrane proteins being 
integrated into the membrane (62). The increased toxicity of LldP is most likely due to its 4-fold 
larger size than SMR transporters, thus interfering with membrane translocation machinery at a 
higher degree. 
We demonstrate here that the increased expression of native SMR enhanced tolerance to 
furfural. Interestingly, the microarray data of the same ethanologenic strain upon furfural exposure 
in the previous reports (14, 50) shows no significant change in expression of sugE, mdtJI, and lldP 
upon exposure to furfural (less than 2-fold changes). This suggests that the MDR pumps or other 
exporters are able to transport non-native toxic chemicals due to the promiscuous substrate 
specificity although the transcriptional 
Indeed, the bioprospecting strategy presented here may be broadly applicable to a wide range of 
non-native inhibitors, and this plasmid library can be expanded to other microbial exporters and 
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even metagenomic libraries. Other biocatalysts may benefit from similar investigations for other 
industrially relevant chemicals.  
Materials and Methods 
Strains and Cultivation 
All strains used in this work listed in Table 4.1. During strain construction, transformation and 
genetic manipulations were performed in Luria Broth (10 g L-1 Difco tryptone, 5 g L-1 Difco tryptone, 
and 5 g L-1 NaCl) at 30°C, 37°C, or 39°C as needed and with rotation at 180 rpm when in liquid 
culture. During chromosomal integration experiments, 5% (w/v) arabinose and 10% (w/v) sucrose 
-red recombinase induction from pKD46 and counterselection of sacB negative 
strains, respectively. Ampicillin (100 mg L-1) and/or chloramphenicol (50 mg L-1) were 
supplemented if selection was needed.  
Strain, Plasmid and Library Construction 
-red recombinase-mediated two-step method was used as previously described (63, 64) to 
integrate mdtJI into frdBC locus in LY180. Briefly, a cat-sacB counter-selection cassette from 
pXW001 (64) and mdtJI from E. coli LY180 flanked with 50 bp of homology to the frdBC gene locus 
were amplified by PCR using the primers in Table 4.2. This cat-sacB fragment was integrated into 
the frdBC locus and validated by colony PCR before being subjected to a second round of 
integration. After integration of the mdtJI cassette, the cells were incubated in media supplemented 
with 10% (w/v) sucrose to enrich for the correct clones (sacB negative). The final positive clones 
were verified by colony PCR and Sanger sequencing.  
To construct a plasmid library containing target genes, single ORF plasmids were isolated from the 
previously constructed ASKA collection (40). For multi-component transporters, genes were 
assembled into the ASKA vector backbone pCA24N in approximately the same fashion as all single 
ORF plasmids using the circular polymerase extension cloning (CPEC) method (65), with assembly 
specifications included in the primer description (Table 4.2). Positive hits identified from the 
screening process were re-cloned into EcoRI/XbaI sites of pTrc99A using conventional cloning 
method. LY180 genomic DNAs were used as PCR template to get native ribosomal binding sites, 
coding sequences and terminator regions without ASKA artificial sequences. The plasmid encoding 
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mdtJI (E19Q) was made by site-specific mutagenesis using overlapping PCR extension. All 
constructed plasmids were verified using Sanger sequencing.  
Two-step Screening Process  
All library constructs including empty vector control were transformed individually into 
ethanolgenic E. coli LY180 (50). These transformants were streaked to form individual colonies on 
AM1 2% (w/v) xylose agar plates supplemented with 0.9 g L-1
transformant was compared to empty vector control independently at least twice. Only if the colony 
size of transformants was consistently larger than that of empty control, they were scored as 
positive candidates for the plate-based assay and further tested using liquid a culture test.   
Testing furfural toxicity in liquid cultures was the second-step screening process and was 
performed as previously described (20). Tube cultures (13 mm by 100 mm) contain 4.0 mL of AM1 
medium with 50 g L-1 xylose, 50 mg L-1 chloramphenicol for pCA24N-based constructs or 12.5 mg 
L-1 ampicillin for pTrc99A-based constructs, various concentrations of furfural, and 10 or 100 µM 
IPTG. An initial inoculum of 44 mg dry cell weight (dcw) L-1 (0.1 as OD550) was used for all liquid 
assays and optical density of cultures was measured at 550 nm after incubation for 48 h with 120 
rpm shaking speed at 37°C.  
Fermentation 
Fresh colonies were grown microaerobically on AM1 agar plates (66) supplemented with 2% 
xylose (w/v) and antibiotics in a container filled with argon gas, and then were transferred into 100 
mL AM1 2% xylose (w/v) medium with antibiotics in a 250mL flask. After growth at 37°C 120 rpm 
for approximately 16 h, this culture was used as the seed inoculum for fermentation. Fermentation 
was performed in 500 mL fermentation vessels containing 300 mL AM1 medium supplemented 
with 10% xylose (w/v) (37°C, 120 rpm) as previously described (20, 45, 50). Fermentations were 
maintained at pH 7.0 by the automatic addition of 2.0 M potassium hydroxide and an initial inoculum 
of 44 mg dcw L-1 (0.1 as OD550) was used for all fermentations. Furfural or HMF were added at the 
beginning of the fermentati -1 ampicillin was included in both 
seed cultures and batch fermentations. 
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Analysis 
All quantification of xylose and ethanol was performed using high performance liquid 
chromatography (HPLC) as previously described (64, 67). More specifically, compounds were 
separated and quantified with an UltiMate3000 (Thermo Fisher) using an Aminex HPX-87H column 
(Bio-Rad) and 4 mM sulfuric acid as the mobile phase. Furfural was quantified us ing a described 
UV absorbance method on a Beckman Coulter DU 730 spectrophotometer (68).
Cell Viability Assay 
Cells were grown on AM1 2% xylose ampicillin agar plates before being transferred into 100 
mL AM1 2% xylose medium supplemented with 10 -1 ampicillin and 
incubated for 16 hours. 6.6 mg cells were harvested from this liquid culture and was then 
resuspended in 30 mL fresh AM1 2% xylose supplemented with 3.5 g L-1 
12.5 mg L-1 ampicillin in a sealed glass tube (16 x 150mm). This culture was then incubated at 37°C 
120 rpm for 72 h with viable cell counts being performed at selected intervals using AM1 2% xylose 
plates.  
Furfural accumulation 
Cells were grown microaerobically on AM1 2% xylose ampicil lin agar plates before being 
-1
ampicillin. After 16 hour incubation at 37°C 120 rpm, 50 mg L-1 chloramphenicol was added and 
cells were incubated for an additional 1.5 hours to stop protein synthesis. 2.2 mg cells were 
harvested from this culture by centrifugation and resuspended in AM1 2% xylose medium 
supplemented with 12.5 mg L-1 ampicillin, 50 mg L-1 chloramphenicol, and 3.5 g L-1 furfural. At 
designated intervals, supernatants were collected and extracellular furfural concentrations were 
measured. 
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Figures 
  
Strain/Plasmid Relevant characteristics Reference 
Strains     
LY180 frdBC::(Zm frg celYEc FRT) ldhA::(Zm frg casABKo) 
adhE::(Zm frg estZPp FRT) ackA::FRT rrlE::(pdc 
adhA adhB FRT)  mgsA::FRT 
(50) 
YR105 LY180 frdBC::mdtJI This study 
XW129 yqhD ackA::PyadC fucO-ucpA (28) 
Top10F' F´{lacIq, Tn10(TetR)} mcrA mrr-hsdRMS-mcrBC) 
lacZ lacX74 recA1 ara ara leu) 
7697 galU galK rpsL (StrR) endA1 nupG 
 
Plasmids     
pKD46 bla,  (Red recombinase) (69) 
pTrc99A Ptrc, bla, lacI
q (70) 
pTrc99A-sugE sugE cloned into pTrc99A This study 
pTrc99A-mdtJI mdtJI cloned into pTrc99A This study 
pTrc99A-lldP lldP cloned into pTrc99A This study 
pTrc99A-
mdtJIE19Q 
mdtJI (mdtIE19Q) cloned into pTrc99A This study 
pCA24N Empty vector for ASKA collection; PT5-lac, cat, lacI
q (40) 
pCA24N-emrKY emrKY cloned into pCA24N This study 
pCA24N-emrAB emrAB cloned into pCA24N This study 
pCA24N-macAB macAB cloned into pCA24N This study 
pCA24N-mdtJI mdtJI cloned into pCA24N This study 
pCA24N-aaeAB aaeAB cloned into pCA24N This study 
pCA24N-cusBA cusBA cloned into pCA24N This study 
pCA24N-mdtEF mdtEF cloned into pCA24N This study 
pCA24N-acrAB acrAB cloned into  pCA24N This study 
pCA24N-acrAD acrAD cloned into  pCA24N This study 
pCA24N-acrEF acrEF cloned into  pCA24N This study 
pCA24N-mdtAB mdtAB cloned into pCA24N This study 
pCA24N-mdtABC mdtABC cloned into pCA24N This study 
pCA24N-acrAB-
tolC 
acrAB-tolC cloned into pCA24N This study 
pCA24N-acrAD-
tolC 
acrAD-tolC cloned into pCA24N This study 
pCA24N-acrEF-
tolC 
acrEF-tolC into pCA24N This study 
pCA24N-mdtH acrAB-tolC into pCA24N This study 
pCA24N-mdtEF-
tolC 
acrAD-tolC into pCA24N This study 
pCA24N-slp slp into pCA24N This study 
ASKA Plasmids Indicated genes in Fig. 1A cloned into pCA24N (40) 
Table 4.1: Bacterial strains and plasmids used in this study 
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Primer Sequence
pCA24n CPEC cloning 5' GGGTCGACCTGCAGCCAA
5' TTAGCGGCCGCATAGGC
5' TTGGCTGCAGGTCGACCC
5' TCAGAACTCCATCTGGATTTGTTC
5' GTCGACCCTTAGCGGCCGC
5' GCTGCAGGTCGACCCTTAGCG
5' CTGCAGCCAAGCTTAATTAGCTGAGC
emrKY ASKA cloning 5' GCCTATGCGGCCGCTAACAACATTATTTCGCATAATGGACAACTTTAATGAGAGGATCTCACCATCACCATC
emrAB ASKA cloning 5' GCCTATGCGGCCGCTAACTAACGCTGGCTAATCCAGAGGTGCGTGTGATGAGAGGATCTCACCATCACCATC
macAB ASKA cloning 5' GCCTATGCGGCCGCTAAGATTGGTGAGGCCAAACCAGGAGCTGCACAATGAGAGGATCTCACCATCACCATC
mdtJI ASKA cloning 5' GCCTATGCGGCCGCTAATTAAAATAATTCTCTTGCAGGAGAAGGACAATGAGAGGATCTCACCATCACCATC
aaeAB ASKA cloning 5' CATCGCCTGCGTGAGTTTGGTTAATCACGATGGGTATTTTCTCCATTGCTAACCAACATATTC
cusBA ASKA cloning 5' GAAAGTGCTACCCATGCGCATTGAGGGAATAACCAATGATTGAATGGATTATTCGTCGCTCGG
mdtEF ASKA cloning 5' GCCTATGCGGCCGCTAACAATAACGTTGCAGGCTTAAGGGGACTTTCATGAGAGGATCTCACCATCACCATC
acrAB ASKA cloning 5' GCCTATGCGGCCGCTAACTTAAACAGGAGCCGTTAAGACATGAGAGGATCTCACCATCACCATC
acrAD ASKA cloning 5' GCCTATGCGGCCGCTAACGATACGCAGAAACACGAGGTCCTCTTTTAATGAGAGGATCTCACCATCACCATC
acrEF ASKA cloning 5' GCCTATGCGGCCGCTAAAGATACTGCATCGAAGTAAGGTAATCTGACATGAGAGGATCTCACCATCACCATC
mdtABC ASKA cloning 5' CGAATACGCGAAAAAAGGAGCACGCTCCTGATGAGAGGATCTCACCATCACCATC
5' CGCTAAGGGTCGACCTGCAGCGCTTTGCCCGTCATGAAGAGGAGGCGTAAATGAGAG 
GATCTCACCATCACCATC
5' GGAGTCCAAGCTCAGCTAATTAAGCGCCGCATAGGCTCGGTTACC
tripartite tolC ASKA cloning 5' CTAAATACTGCTTCACCACAAGGAATGCAAATGAGAGGATCTCACCATCACCATC
5' GCATTCCTTGTGGTGAAGCAGTATTTAGGCTGCAGGTCGACCCTTAG
5' CTGCAGCCAAGCTTAATTAGCTGAGCTTGGACTCCCTAAATACTGCTTCACCACAAGGAATGC 
AAATGAGAGGATCTCACCATCACCATC
5' GGCGTGCTTGCTGATAAACTT (for sequencing)
sugE pTrc99a cloning 5' CGTACGAATTCTGCAAACGCCTCTTTTCACCG
5' ACACTCTAGACCGCGACTACCTGTGGATACTC
lldP pTrc99a cloning 5' CGTACGAATTCGATGAGCAACAGACTCATTACACG
5' GAGATCTAGAAGTTGCATCGCCAGTTGGC
mdtJI pTrc99a cloning 5' CGTACGAATTCACTTTGGTTTCGCTGAATTAAGC
5' ACACTCTAGAAACTGTCGCAAAAATAATGTTCAAACG
for cat-sacB integration 5' AGCGGATGCAGCCGATAAGGCGGAAGCAGCCAATAAGAAGGAGAAGGCGATCGAGTGTGACGGAAGATCA
5' ATACCGGTTCGTCAGAACGCTTTGGATTTGGATTGATCATCTCAGGCTCCTTAGCCATTTGCCTGCTTTT
for mdtJI integration 5' AAACGCGTTTACGGTGGCGAAGCGGATGCAGCCGATAAGGCGGAAGCAGCACTTTGGTTTCGCTGAATTA
5' ATACCGGTTCGTCAGAACGCTTTGGATTTGGATTAATCATCTCAGGCTCCCAACTGTCGCAAAAATAATG
5' TATCTACCGTACGCCGGAAC
5' AGCAAATGTGGAGCAAGAGG
Table 4.2: Primers used in this study 
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Figure 4.1. Screening procedure and identified positive candidate transporters. A) 
List of genes tested. Positive plasmids identified in the plate-based screen with 10 
M IPTG induction are indicated in bold. The genes are underscored if the plate-
based results are still positive with 100 M IPTG induction. Candidates are displayed 
with boxes if the following liquid culture screen results are positive. *Cassettes were 
assembled manually in the same manner as single ORF plasmids in ASKA 
collection. B) Ethanologenic E.coli LY180 was transformed with individual members 
of a plasmid library encoding MDR pumps, porins and exporters of interest, and then 
subjected to two screens under furfural stress conditions. C) Plate based screening 
was scored according to an empty vector control (negative control) and a known 
furfural resistance trait (overexpression of pntAB) (positive control). Strains 
displaying larger colonies in two independent tests were scored positive 
  122 
 
  
Figure 4.2. Identified genes confer furfural tolerance to LY180. A) Schematic 
drawing of a typical construct in ASKA collection shows artificial N and C-
terminal sequences. The given size does not reflect real proportions. The optical 
density at 550 nm of LY180 with the positive ASKA plasmids after 48 hours 
growth in AM1 medium containing 5% xylose (w/v) and 1.0 g liter-1  furfural in the 
wild-type 
candidate genes, the constructed pTrc99A-based plasmids were transformed 
into LY180 and the optical density at 550 nm of LY180 with native genes were 
measured after 48 hours growth in AM1 medium containing 5% xylose (w/v) and 
1.25 g liter-1  
different plasmids and antibiotics influenced furfural sensitivity of LY180. 
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Figure 4.3. Effects of overexpression of sugE, mdtJI and 
lldP on cell growth using LB medium. The cultures were 
grown in 25 mL LB broth supplemented with 50 mg L-1 
ampicillin with the starting OD is 0.1 in shake flasks at 37 
C° and overexpression of tested genes were induced by 
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Figure 4.4. Induced expression of mdtJI in LY180 increases furfural resistance 
during ethanol fermentation. Batch fermentations were conducted in pH-controlled 
vessels in the absence and presence of 1.25 g liter-1 furfural. Expression of mdtJI 
from pTrc99A-mdtJI 
the empty vector (EV) controls (pTrc99A; solid lines) using LY180 as the host.  A) 
Cell growth indicated by OD550nm. B) ethanol production was measured by HPLC 
and compared to controls without furfural. 
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Figure 4.5. Induced expression of mdtJI in LY180 increases 5-hydroxylmethyl 
furfural (5-HMF) resistance during ethanol fermentation. Batch fermentations 
were conducted in pH-controlled vessels in the absence and presence of 1.75 g 
liter-1 5-HMF. Expression of mdtJI from pTrc99A-mdtJI 
IPTG (dotted lines) was compared to the empty vector (EV) controls (pTrc99A; 
solid lines) using LY180 as the host.  A) Cell growth indicated by OD550nm. B) 
ethanol production was measured by HPLC. 
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Figure 4.6. Comparison of wild-type MdtJI and its nonfunctional mutant (E19Q in 
mdtI) in terms of furfural resistance, survival ability under furfural stress and 
potential furfural export. A) Growth of LY180 transformed with indicated plasmids 
after 48 h in AM1 medium containing 5% xylose, 1.25 g L-1 furfural, and 10 M 
IPTG. B) viabilities upon furfural exposure (3.5 g L-1) were measured by colony 
forming unit, and C) extracellular furfural were evaluated upon exposure to furfural 
(3.5 g L-1). 
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Figure 4.7. The chromosomal integration of mdtJI and potential 
synergy confer furfural resistance. A) Growth of LY180 and YR105 
(LY180 frdBC::mdtJI) after 48 h in AM1 medium containing 5% 
xylose and 1.0 g L-1 furfural. B) Growth of XW129 transformed with 
either empty vector pTrc99A or plasmid encoding mdtJI after 48 h 
in AM1 medium containing 5% xylose, 1.75 g L-1 furfural and 10 M 
IPTG.. 
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Figure 4.8. Induced expression of mdtJI in XW129 increases furfural resistance 
during ethanol fermentation. Batch fermentations were conducted in pH-
controlled vessels in the absence and presence of 1.75 g liter-1 furfural. 
Expression of mdtJI from pTrc99A-mdtJI 
lines) was compared to the empty vector (EV) controls (pTrc99A; solid lines) 
using XW129 as the host.  A) Cell growth indicated by OD550nm. B) xylose 
and ethanol in fermentation broth were measured by HPLC. 
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CHAPTER 5 
CHEMICAL SIMILARITY SEARCHING USING THE SIGNATURE MOLECULAR DESCRIPTOR 
IDENTIFIES A NETWORK OF NATIVE MALATE EXPORTERS IN ESCHERICHIA COLI 
Abstract 
Identification of transporters of valuable end-products is essential to metabolic engineering 
efforts for biocatalysis of renewable chemicals, especially as production parameters increase. The 
identification of transport proteins for various metabolites is an arduous task however, often 
involving manual combing of literature/biological databases, and performing genetic screens. One 
way to rationally identify transport proteins of a desired function is to target proteins with chemically 
similar substrates in genetic screens, as many transporters are known to exhibit substrate 
promiscuity. In this work, we prospected for malate exporters using a cheminformatics approach in 
a previously developed Escherichia coli L-malate biocatalyst, XZ658. To do this, we first took a 
traditional approach and inactivated dcuABC to demonstrate that the major L-malate uptake system 
only contributes minimally to efflux. Using the Signature molecular descriptor to compare chemical 
similarity to our target molecule, we found citrate, tartrate, and succinate to be the most similar 
known transportable C3-C7 di- or tricarboxylate metabolites to malate in E. coli. Inactivating known 
transporters of these compounds in addition to dcuABC revealed that ttdT and citT decrease 
extracellular malate titer after 48h by 56% and 65%, respectively. Inactivation of dcuA, citT, and 
ttdT decreased malate titer, growth rate, and resulted in a swollen cell physiology, suggesting these 
transporters form a malate exporter network. Although export of malate does not appear to be an 
immediate bottleneck in this biocatalyst based on biochemical analysis, this work demonstrates the 
utility of chemical similarity methods to hasten identification of transporters capable of efflux of 
target products of metabolism.  
Importance 
With the advent of synthetic biology, incorporation of metabolic pathways leading to a diverse 
non-native product portfolio has outpaced our ability to identify cellular export systems for 
molecules of interest. Transporter promiscuity however often permits the export of products from 
biocatalysts, but as production parameters increase, the probability of an export -based bottleneck 
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also increases. This work investigates if comparison of target compound similarity coupled to 
biological database mining can be used to identify transporters with export activity for a non-natural 
accumulation product of E. coli, L-malate. We find that annotated transporters for metabolites with 
similar molecular signatures to L-malate have promiscuous transport activity for malate export, 
demonstrating the utility of this approach. Additionally, we show that the major uptake system of L-
malate is not the same as export, implying that a literature search may have led to only partial 
identification of transporters catalyzing export in this case. 
Introduction 
Over the last decade technological advances in the field of synthetic biology have permitted 
rapid and complex modification of metabolic pathways in a wide variety of hosts. Tools such as 
multiplex automated genome engineering (1) and CRISPR-based genome editing (2) now permit 
high-throughput genome manipulations, the biological effects of which being quantifiable using 
(3, 4). Additionally, computational tools and metabolic models have been 
developed to probe biochemical pathways in silico, permitting optimization of metabolic flux (5), 
design of heterologous biosynthetic pathways (6), and more with less experimental cost. Utilizing 
a combination of these tools, it is now possible to create biocatalysts capable of a diverse product 
portfolio and quickly optimize metabolic pathways for enhanced production of many target 
molecules. However, many of these valuable products are not normally overproduced by the 
desired host, leading to various potential shortcomings in the native host machinery for optimal 
production metrics. 
One of these potential genetic shortcomings is a lack of transport systems for efficient export 
of the non-native products to the extracellular space. Native transport systems can facilitate product 
export at low production metrics, but the kinetics and/or expression may be sub-optimal at 
economically relevant metrics. Thus, export has been previously observed as a bottleneck for the 
bioproduction of non-native products, and engineering export systems has enhanced production 
metrics for multiple compound classes including biofuels (7-9), diamines (10), amino acids (11, 12), 
and C4 dicarboxylic acids (13-15). Although elucidation of bioproduct transporters is important to 
enhance rational metabolic engineering strategies, it remains a relatively understudied area due to 
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difficulties in rationally predicting transport activity and designing genetic screens. However, since 
many transporters exhibit substrate promiscuity for chemically similar substrates, it may be possible 
to identify transporters by choosing genetic targets based on ligand similarity to the target molecule.
Chemical similarity searching has been widely applied to elucidate molecules of similar 
biological activity to target compounds in the pharmaceutical industry (16, 17). This similarity 
searching is performed by using a molecular descriptor to transform structural and chemical 
information of a compound into a quantifiable format which can then be compared to a database of 
compounds transformed in the same manner. Although there are a multitude of potential 
descriptors to represent chemicals, fingerprint methods have been shown to yield biologically 
meaningful results for prediction of enzyme-substrate promiscuity (18), and thus are of interest in 
predicting transporter promiscuity. The Signature molecular descriptor (19) is a fingerprint method 
that has previously been successfully used to design and characterize small molecule protein 
inhibitors (20) (21), polymers (22), as well as to investigate the potential 
for substrate promiscuity of enzymes (23). Thus, this descriptor may be useful in predicting 
transporter promiscuity for a cheminformatics-based targeted genetic screen. 
L-malate is a C4-dicarboxylate that has been identified by the Department of Energy as a 
compound with a multibillion dollar market that can be renewably derived using biomass sugars 
(24). For many hosts, L-malate is a non-native metabolic end-product and thus may be subject to 
export bottlenecks. Although multiple biocatalysts have been engineered for L-malate production 
(14, 25-27), high titer formation has only been achieved in multiple hosts after overexpression of a 
fungal L-malate exporter, MAE1p (13, 14). In E. coli, multiple transporters have been characterized 
to be responsible for promiscuous uptake, exchange and export of C4-dicarboxylates under 
microaerobic conditions, however no L-malate exporters have been identified. These often 
promiscuous carriers include proteins from the Dicarboxylate uptake (Dcu), Dicarboxylate uptake 
C (DcuC), Divalent anion-sodium symporter (DASS), Auxin efflux carrier (AEC), Tripartite ATP-
independent periplasmic (TRAP), Acetate uptake transporter (AceTr), and Dicarboxylate/amino 
acid cation symporter (DAACS) families (28). Of these, Dcu transporters are responsible for L-
malate uptake during malate respiration (29), and are postulated to contribute to export via a 
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reversal of the uptake mechanism (28, 30, 31). Thus, these transporters represent targets for a 
traditional literature based genetic screen to discover the malate export system.  
In this work, we used a reverse genetics approach to characterize the L-malate export system 
of Escherichia coli using an engineered L-malate producer. To begin we inactivated the major 
microaerobic L-malate uptake system (dcuABC) to demonstrate that the uptake system is not solely 
responsible for L-malate export. Thus five other candidate L-malate exporters were chosen by 
evaluating chemical similarity of malate to other transported metabolites. By inactivating 
transporters of compounds with similar molecular fingerprints to malate, DcuA, CitT, and TtdT were 
characterized to play a role in the malate export system, and inactivation of all three transporters 
led to reductions in extracellular malate. We further demonstrate that L-malate export does not 
appear to be a bottleneck for malate production in this host. 
Results 
Identification of candidate genes for native malate export. 
 To assess the role that the major anaerobic malate importers play in L-malate export, the 
genes dcuA, dcuB, and dcuC were inactivated both individually and in combination in the L-malate 
biocatalyst XZ658 (25). Inactivation of these three genes resulted in an ~20% decrease in 
extracellular malate production after 48 h, and a decrease in biomass in the first 48 h (Figure 5.1). 
This suggests that DcuA, DcuB, and DcuC only contribute minimally to malate export, and that a 
reversal of uptake may not be the main mechanism for malate export. Thus, we decided to use 
chemical similarity searching to select new candidates for our reverse genetics approach.  
To generate a new list of candidate exporters, we prospected for transporters capable (or 
predicted) of having catalytic activity for metabolites that are the most chemically similar to malate. 
We chose to use the Signature molecular descriptor for chemical comparisons (19) and developed 
a pipeline to compare all transportable C3-C7 di- or tricarboxylate metabolites to malate, according 
to the Transporter Classification Database (TCDB) (32). This analysis found citrate, tartrate and 
succinate to be the most similar compounds to malate with E. coli transporters using this descriptor 
(Figure 5.2). Of these, citrate had a similarity of 95.5%, tartrate 95.4% and succinate 91.8%. Other 
compounds such as isocitrate had a higher similarity to malate, but no known E. coli transporters 
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(Figure 5.2A). By allowing transporters with unknown substrates to inherit the substrates of E. coli 
proteins in the same TCDB family we found nine transporters that had known/inherited catalytic 
activity for the top three metabolites, including dcuA, dcuB, dcuC, dcuD, dauA, dctA, ybhI, citT, and 
ttdT (Figure 5.2B). Expression and transport of C4-dicarboxylates by dctA is not active under 
microaerobic conditions, and it was therefore removed from the target list (33). We then inactivated
the remaining transporters in this list (citT, ttdT, ybhI, dauA, and dcuD) in a dcuABC knockout 
background. An additional succinate transporter, satP, was discovered and incorporated into the 
TCDB after our initial evaluation, but for experimental purposes was not included in our analysis 
(34).
DcuA, CitT, and TtdT contribute to malate export. 
To first discern which member of DcuA, DcuB, and DcuC was responsible for the 20% decrease 
in the malate titer seen initially (Figure 5.1), we inactivated each gene individually in XZ658. After 
48 h only DcuA resulted in a 23% decrease in malate titer, approximately equivalent to GK153 
(Figure 5.3). We then proceeded to inactivate all candidate malate exporters individually in GK153 
and fermented all strains. This demonstrated that inactivation of citT or ttdT resulted in 56% and 
65% decreases of extracellular malate titer after 48h compared to XZ658, respectively (Figure 5.3). 
However, most of this deficiency recovered by 96h, suggesting that additional malate exporters 
were still present (Figure 5.4). All other candidate malate exporters exhibited no significant 
difference in malate production compared to GK153 (Figure 5.3 and 5.4). To investigate which 
transporter had the greatest physiological relevance, all potential combinations of dcuA, citT, and 
ttdT inactivations were evaluated. All individual inactivations presented deficient phenotypes at 48 
h suggesting each transporter contributes to malate export (Figure 5.5A). However, inactivation of 
ttdT, dcuA, or citT resulted in a 31%, 18%, and 10% decrease in titer at 96h, respectively, 
suggesting ttdT is most important for achieving final malate titer. Furthermore, simultaneous 
inactivation of dcuA and ttdT was found to generate a deficient phenotype similar to the triple 
knockout (GK1TC), with a 73% decrease in titer (Figure 5.5B). This is greater than the titer 
decrease attributed to the individual inactivation of either dcuA or ttdT, suggesting that there is a 
synergistic relationship between these two transporters. Individual inactivation of citT only 
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presented deficient phenotypes at 48h (Figure 5.5A), suggesting that it may only be important for 
early growth/production. These results demonstrate that relevant exporters for malate may follow 
a hierarchy from greatest to lowest impact of ttdT > dcuA > citT.  
Transport deficient mutants have defects consistent with export deficient cells.  
To further understand the effects of transporter inactivation in GK1TC, we fermented this strain 
and compared the cell physiology, growth, and intracellular metabolite profile to XZ658. This 
transporter deficient mutant was found to have a large decrease in growth rate under microaerobic 
conditions and a 50% decrease in maximum biomass accumulation after 96 h (Figure 5.6A and B). 
However, this growth deficiency was not observed during aerobic growth in rich or minimal media 
(Figure 5.7), when metabolism favors pyruvate accumulation. We hypothesized that this deficiency 
may be due to an accumulation of malate which may be capable of altering metabolic flux to less 
desirable fermentation end-products under anaerobic conditions, such as citrate, isocitrate, and 
pyruvate (Figure 5.6C). To better understand the metabolic changes upon inactivation of these 
transporters, we extracted and quantified intracellular metabolites of both XZ658 and GK1TC at 48 
h. We found that intracellular malate concentrations were equivalent between the two strains, 
however an ~2-fold increase in the concentration of pyruvate, citrate, and isocitrate could be 
observed in the transport deficient cells (Figure 5.6D). During fermentation, transporter deficient 
cells were also observed to have an enlarged phenotype at 48 h, corresponding to an 
approximately 50% increase in cell length relative to XZ658 (Figure 5.8). This increase in cell size 
also corresponded to a decrease in cell viability (Figure 5.8). To investigate if these putative malate 
exporters could be applied to enhance malate production in XZ658, we overexpressed each of 
them individually on a plasmid construct in XZ658. Overexpression of each transporter individually 
did not improve L-malate titer, productivity or yield in XZ658 when fermenting in NBS supplemented 
with 5% (w/v) glucose (Figure 5.9). 
Discussion 
In this work, we originally prospected for the L-malate exporter in E. coli by taking a limited 
literature-based reverse genetics approach and targeting active importers of malate under 
microaerobic conditions. This essentially investigated if a reversal of the malate uptake reaction 
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was the main mechanism of export. We found that this only identified dcuA as a putative malate 
exporter. A cheminformatics approach of selecting candidates based on chemical similarity to the 
target compound was effective in finding other transporters, citT and ttdT. A triple mutant of dcuA, 
citT, and ttdT was found to be growth deficient under microaerobic conditions, had decreased 
extracellular malate, and had altered cell physiology. Furthermore, it appeared that potentially 
intracellular malate may be being shuttled to other metabolic end-products in these transport 
deficient cells, suggesting that accumulation of malate may be toxic to these cells. This all suggests 
that these transporters function as malate export proteins in E. coli. 
Of the Dcu and DcuC family proteins, only DcuA was found to have significant catalytic activity 
for malate export. This protein is known to catalyze the electroneutral exchange of L-malate, 
fumarate, succinate and aspartate by antiport of succinate from the cytoplasm, but has been shown 
to be capable of proton mediated uptake as well in the absence of a counter-substrate (29, 35). 
Interestingly, DcuB is a paralog of DcuA known to share these same transportable substrates, 
however only DcuB and DcuC are responsible for physiologically relevant succinate export (15). 
Since dcuA is known to be constitutively expressed (36), this difference in substrate specificity is 
hypothesized to not be due to differences in expression. Likewise, we find in our work that DcuA is 
capable of putative malate export, but not DcuB, further suggesting that these two proteins have 
significant differences in substrate specificity. We do not believe this is due to glucose repression 
of dcuB (36), as previous work has observed that both DcuB and DcuC are functionally active in 
glucose fermentation conditions with a C4 dicarboxylate production strain (15).  
CitT and TtdT are both proteins belonging to the DASS protein family, a group known to be 
capable of transport of multiple organic di- and tricarboxylate substrates. More specifically, CitT 
has been shown to function as a citrate/succinate antiporter during citrate fermentation, and can 
potentially use citrate or fumarate as alternative counter-substrates (37). TtdT has been described 
as a L-tartrate/succinate antiporter, but can potentially use fumarate or succinate as counter-
substrates as well (38). This work demonstrates that CitT and TtdT both likely function in L-malate 
export during glucose fermentation, although the mechanism of export remains uncharacterized. 
CitT, TtdT, YbhI and SOT1 (a spinach 2-oxoglutarate:malate translocator), form a cluster within the 
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DASS family and maintain a sequence identity >33% between each other (37). SOT1 has been 
characterized to catalyze exchange of 2-oxoglutarate for stromal malate, succinate, 2-oxoglutarate, 
or fumarate from the inner membrane of chloroplasts (39, 40), further supporting that these 
transporters may all function in malate export. Although YbhI had no evidenced role in malate 
export and has no evidenced di-/tricarboxylate substrates, this may be due to a lack of expression.  
In the malate producer XZ658, dcuA, citT, and ttdT all appear to play a functional role in malate 
export. Our combinatorial deletions suggest that malate export is mainly performed by ttdT and 
dcuA, while citT is of lesser importance. Although engineering export of L-malate has previously 
been demonstrated to be an effective strategy for increasing production in fungi (13, 14), we 
observed no improvement in production while overexpressing dcuA, citT, or ttdT. This suggests 
that either the L-malate transport system of E. coli is sufficient for current production metrics, or 
there is a limitation of counter ions for antiport. However, it is notable that  cells are capable of 
maintaining ~45% final titer (144 h) even with inactivated transport systems. This might suggest 
that there are still multiple other promiscuous transporters for L-malate in E. coli and that export 
may not be the immediate bottleneck. 
For metabolic engineering, the use of chemical similarity searching provides another tool to 
help elucidate enzymes with promiscuity for desired substrates. We demonstrate here that 
annotated transport function for the most chemically similar substrates to malate reveals citT and 
ttdT to be top candidates for a genetic screen, and that these candidates have activity for the target 
compound. One limitation of this approach for transporter discovery however is that the tested 
substrates during enzyme characterization of transporters are often few and of a relatively narrow 
chemical space (18). This emphasizes the importance of using algorithms to intelligently select 
substrates that will maximize information gained on enzyme versatility during characterization. 
Additionally, this approach may also be further improved by incorporating sequence data to allow 
comparisons of both chemical and sequence similarity of a global dataset to the desired organism 
proteome.   
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Materials and Methods 
Strains, and Cultivation Conditions 
All strains used in this work are listed in Table 5.1. A previously engineered Escherichia coli
malate producer, XZ658 (25), was used for genetic manipulations.  For strain construction, all 
manipulations were done in Luria Broth (10 gL-1 Difco tryptone, 5 gL-1 yeast extract, and 5 gL-1
NaCl) at 30°C, 37°C, or 39°C with rotation at 180rpm when in liquid culture. During genetic 
manipulations, 5% arabinose (w/v) was added and ampicillin (100 mg L-1), kanamycin (50 mg L-1), 
and/or chloramphenicol (50 mg L-1) were supplemented as needed. 
Genetic Methods 
Gene inactivation was performed as previously described using Red recombinase technology 
and either two-step recombination (41) or one step inactivation (42). Chromosomal integration was 
performed using PCR products amplified to encode either a cat-sacB counter selection cassette 
from pXW1(43) or a FRT-kan-FRT casette from pKD4 flanked with 50bp of homology to the target 
gene of interest. Primers for the generation of all inactivation fragments and plasmid constructs can 
be found in Table 5.2. For plasmid construction, circular polymerase extension cloning (CPEC) (44)
was used to generate complete plasmids from linear PCR products using a pTrc99a vector 
backbone. All plasmids had the insert sequence verified using Sanger sequencing. Chemical 
cells. 
Chemical similarity comparisons 
To compare compound similarity to malate, we used the Signature molecular descriptor. 
Generating a molecular signature decomposes each metabolite into a vector of atomic signatures. 
These atomic signatures are a representation of the subgraph of each atom and all of its connected 
bonds/atoms up to a predefined dis (19, 45). Thus the vector for comparison is a count of 
the occurrences of each atomic signature (both h=0 and h=1) within the molecule. We retrieved all 
data from the Transporter Classification Database (32) and extracted all substrate:transporter pairs 
where the substrate contained a substructure of a C3-C7 backbone and two or three terminal 
carboxyl groups (excluding malate). If a transporter in TCDB had listed unknown substrates or a 
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molecule class substrate related to our target substrates (e.g. dicarboxylates), we used transporter 
accession numbers to allow the transporter to inherit all substrates of E. coli transporters within the 
same family. This metabolite list then had their signature vectors compared to malate and similarity 
scored using a cosine similarity score. We considered the top three most similar metabolites (with
designated substrates for an E. coli transporter) to be our top hits and used the transporters linked 
to these metabolites as new targets for putative malate exporters.
Fermentation 
Fresh colonies grown microaerobically on NBS (New Brunswick Scientific) mineral salts (47)
agar supplemented with 2% glucose (w/v) were transferred into 100 mL NBS 2% glucose (w/v) in 
a 250 mL flask. After growth for approximately 16 h (37°C, 120 rpm), this culture was used as the 
seed inoculum for fermentation. Fermentation was performed in continuously stirred 500 mL 
fermentation vessels containing 300mL NBS supplemented with 5% glucose (w/v), 100 mM 
potassium bicarbonate, and 10 mM sodium acetate (37°C, 120rpm). An initial inoculum of 0.1 OD550
was used for all fermentations. Medium pH was maintained at 7.0 during fermentation by automatic 
additions of base (2.4M potassium carbonate and 1.2M potassium hydroxide). 
Light Microscopy 
During fermentation, 1.25mL of cells from the bioreactor were extracted and centrifuged for 5 
minutes at 7,000 x g. The resulting pellet was resuspended in approximately 100 
supernatant and a drop transferred onto the surface of a glass slide. Cells were covered with a 22 
x 22-mm glass cover slip before being viewed with a Axioskop microscope (Carl Zeiss, Thornwood, 
NY) using differential interference contrast optics (Plan-Neofluar 100 ; 1.3-numerical-aperture oil 
immersion objective lens and 1.4-numerical-aperture oil immersion condenser lens). Scale bars 
were added prior to taking images using a Hamamatsu C3200-07 video camera coupled to an 
analog camera control unit (Hamamatsu Photonic Systems Corporation, Bridgewater, NJ) and an 
Argus 10 image processor digitally enhanced the contrast in real time. Using ImageJ, a scale bar 
was calibrated to the original scale bar and bacteria in random fields of multiple samples from each 
culture were selected for cell measurements of length and width (n =100 cells). 
Viable cell counts 
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To determine viable cell counts 1.0 ml of fermentation broth was extracted over the course of 
fermentation and normalized to an OD = 0.1 before being subjected to a 10-fold serial dilution in 
Luria broth. Serially diluted cells were plated on LB and incubated for 24 h at 37°C prior to being 
manually counted. To account for difference in cell size influencing optical density, cells density 
and diameter were evaluated using a Multisizer 3 particle counter (Beckman Coulter). Duplicates
of XZ658 and GK1TC were normalized to an OD0 = 0.6 
each normalized sample was diluted in 10 mL of ISOTON® II Diluent (Beckman Coulter) and cell 
density and average cell diameter w . 
Intracellular Extraction
To quantify intracellular metabolites, we used a modified version of a previously described 
protocol (48). Briefly, 1 OD of cells was extracted from the fermentation and centrifuged at 7,000 x 
g for 5 minutes at 4°C. The supernatant was removed and cells were washed once with 1 ml of 1X 
phosphate buffered saline before being resuspended in a methanol-water mixture (80/20) chilled 
at -80°C and mixed vigorously. After 30 minutes of incubation at -80°C the mixture was centrifuged 
at 7,000 x g for 10 minutes and the soluble fraction was transferred into a new tube. We then 
resuspended the pellet in another 500  methanol-water mixture and incubated for 15 minutes at 
80°C before the cells were centrifuged at 7,000 x g for 10 minutes. The remaining soluble fraction 
was then transferred to the same tube used previously and dried prior to GC-MS analysis. 
HPLC 
All quantification of glucose and organic acids was performed using high performance liquid 
chromatography (HPLC), as previously described (43). More specifically, compounds were 
separated and quantified with an UltiMate3000 (Thermo Fisher) using an Aminex HPX-87H column 
(Bio-Rad) and 4mM sulfuric acid as the mobile phase. 
GC-MS 
For quantification of intracellular metabolites we used GC-MS and followed the general 
procedures for the Agilent Fiehn GC-MS Metabolomics RTL library (51, 52), with minor changes 
incorporated to improve detection sensitivity. A solution of myristic acid-d27 ( ) from the Fiehn 
GC/MS Metabolomics Standards Kit was added as an internal standard for retention time locking. 
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For the derivatization process, the samples were first oximated by adding 3 -
methylhydroxylamine hydrochloride solution (in pyridine) at 30oC for 90 min. The samples were 
then derivatized using 7 -methyl-n-trimethylsilyltrifluoroacetamine with 1% 
chlorotrimethylsilane (MSTFA+1% TMCS) at 37 oC for 30 min. Subsequently, the solution was 
gently vortexed and transferred to a GC-MS glass vial for analysis. 
GC-MS experiments were performed on an Agilent 7820 GC-5977 MSD system (Agilent
Technologies, Santa Clara, CA) by injecting prepared samples in the splitless mode. 
Helium was used as the carrier gas. The separation of metabolites was achieved using an Agilent
DB5-MS+10m Duraguard Capillary Column (30 m . The column temperature 
was maintained at 60 oC for 1.00 min, then increased at a rate of 10 oC/min to 325 oC, and held at 
this temperature for 10 min. Mass spectral signals were recorded after a 4.90 min solvent delay.    
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Figures 
  
F´lacIq, Tn10(TetR) -
hsdRMS-
 recA1 
7697 galU galK rpsL 
(StrR) endA1 nupG 
cat-sacB cassette with the sacB 
native terminator cloned into a 
modified vector pLOI4162 
Ptrc bla oriR rrnB lacIq 
Table 5.1. Strains and plasmids used in Chapter 5 
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Table 5.2. Primers used in Chapter 5 
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dcuA dcuB dcuC) 
using 5% (w/v) glucose in NBS mineral salts medium. A) Cell optical density 
(OD550nm), and B) L-malate concentrations were determined. Error bars 
represent SEM with at least three independent experiments. 
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Figure 5.2. Chemical similarity of all C3-C7 di- or tricarboxylate substrates in TCDB with 
known transporters compared to malate using the Signature Molecular Descriptor. A) 
Grey circles indicate substrates with no known E. coli transporter. Similarity based on 
pairwise distances between the chemical signatures of malate and all indicated 
chemicals is shown at each note with values of >95% (asterisk), 95-90% (circle), 90-85% 
(square), and 85%> (diamond) (Detailed data in Table S1). The length of solid lines also 
represents the relative similarity to malate. Abbreviations: MAL (malate), ISC (isocitrate), 
CIT (citrate), MLO (malonate), TAR (tartrate), TRC (tricarballylate), CTM (citramalate), 
ACO (trans-aconiate), SUC (succinate), OAA (oxaloacetate), ASP (aspartate), GAL 
(galactarate), AKG (2-oxoglutarate), URS (ureidosuccinate), NAG (N-acetylglutamate), 
GLU (glutamate), GLT (glutarate), 2-OX (2-oxoadipate), MSC (mesaconate), FUM 
(fumarate), and ADI (adipate). B) Candidate malate exporters selected based on 
substrate similarity to malate using Signature Molecular Descriptor and information from 
the previous literature. Three di/tri-carboxylates most similar to malate are highlighted in 
bold. 
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Figure 5.3. Extracellular malate titer of strains fermented in NBS/5% glucose 
measured at 48 h with gene knockouts corresponding to indicated transporters. 
Abbreviations: Suc (succinate), Cit (citrate), and Tar (tartrate). *Transport activity 
inferred from transporter family member from TCDB. 
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Figure 5.4. Extracellular malate titer of strains fermented in NBS/5% glucose 
measured at 96 h with gene knockouts corresponding to indicated 
transporters. Abbreviations: Suc (succinate), Cit (citrate), and Tar (tartrate). 
*Transport activity inferred from transporter family member from TCDB. 
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Figure 5,5. Extracellular malate titer of strains fermented in NBS 
medium supplemented with 5% (w/v) glucose measured at A) 48 h 
and B) 96 h with gene knockouts corresponding to indicated 
transporters. Abbreviations: Mal (malate). 
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Figure 5,6. Extracellular malate concentrations and significantly changed 
intrace dcuA citT 
ttdT). Cells were fermented in NBS medium supplemented with 5% glucose. A) 
Cell optical density (OD550nm), B) L-malate concentrations were determined. 
C) The relative change of intracellular metabolites between GK1TC and XZ658 
was determined by GC-MS for cell extractions. Error bars represent SEM with at 
least three independent experiments 
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Figure 5,7. dcuA citT 
ttdT) under non-fermentative conditions. A) Shake flasks at 200 rpm in LB 
media under aerobic conditions, B) Shake flasks at 200 rpm in NBS media 
supplemented with 2% glucose under aerobic conditions. 
  155 
  
Figure 5,8. The morphological and viability changes of strains XZ658, and 
GK1TC (XZ65 dcuA citT ttdT) under fermentative conditions. A) 
micrographs of XZ658 (top) and GK1TC (bottom). B) The cell width, C) 
length and D) diameter was estimated by counting >100 cells on micrograph 
images and diameter readout from a cell counter. D) Viability of XZ658 and 
GK1TC was measured by counting colony forming units (CFU) per mL on 
LB agar plate with a serial dilution. The different cell numbers per OD were 
normalized using a cell counter.   
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Figure 5,9. Malate titer at 144 h of XZ658 fermented 
in NBS supplemented with 5% glucose and 10 µM 
IPTG overexpression either dcuA, citT or ttdT    
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CHAPTER 6 
CONCLUSIONS AND FUTURE DIRECTIONS 
Conclusions  
A commercially successful lignocellulose conversion requires cost-effectiveness at all steps: 
liberating sugars, converting sugars into target products at high titer, yield and productivity, and 
downstream product recovery. There have been a lot of developments in pretreatment technologies 
and metabolic engineering strategies for sugar co-utilization and microbial robustness in the past 
few decades (1). In spite of so many research efforts, challenges such as sugar utilization, 
degradation recalcitrance, product toxicity, and lignocellulosic toxicity still remain at different 
degrees, thereby limiting further commercial developments. 
Metabolic engineering strategies targeting membrane transport mechanisms for enhancing 
lignocellulose conversion have been scarce in literature, however multiple potential transporter 
bottlenecks exist. First, an abundant sugar in lignocellulosic biomass, xylose, is inefficiently 
transported in most bacterial biocatalysts. This results in a decrease in the energy budget which 
can be detrimental under microaerobic production conditions (2-6). Second, inhibitors such as 
furfural in lignocellulose hydrolysate impose cellular toxicity (1, 5, 7). Although cellular efflux has 
been identified as an important way that many bacteria survive other cytotoxic molecules, such as 
antibiotics, lignocellulose inhibitor efflux systems have not been identified (8). Third, engineering 
efflux of target products has shown to increase production metrics, however identification of efflux 
transporters is notoriously difficult. My work contributed to this field by investigating potential 
transporter mediated solutions for enhancing lignocellulosic bioconversion. By rationally attempting 
to probe 1) routes for efficient xylose uptake 2) inhibitor efflux solutions and 3) methods for 
identifying product exporters, this work has helped lead to the following conclusions. 
Energy can be conserved by engineering native and heterologous sugar transporter 
systems 
Although ATP yield has been shown to be decreased under xylose fermentation conditions due 
to inefficient transport mechanisms, very few robust solutions have been implemented to improve 
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this (2). The main solution has been to inactivate XylFGH and/or allow adaptive laboratory evolution 
to naturally edit the genome to enhance ATP conservation (3, 4). Although this previously identified 
a mutation in galP that enhanced xylose to succinate conversion, the authors previously attributed 
this to enhanced xylose transport affinity by GalP (9). In Chapter 2, I have shown that this 
conclusion is incorrect, and that the true mechanism enhancing xylose to succinate conversion in 
KJ122 is repression of GalP. I have further shown that inactivation of GalP likely enhances the ATP 
yield by modulating expression of the anaplerotic enzymes (Ppc and Pck) and shifts carbon flux 
towards Pck to enhance ATP conservation upon conversion of PEP to OAA. I demonstrate that the 
transcriptomic changes upon inactivation of GalP have implications not only for xylose to succinate 
conversion, but also for xylose catabolism in general. This further suggests that utilization of GalP 
in PTS- strains for lignocellulose bioconversion may be a non-ideal method to enhance glucose 
utilization, and suggests that heterologous transporters without unknown regulatory mechanisms 
may be more ideal. However, this does not necessarily fix the issue of ABC catalyzed ATP 
utilization during xylose import. In Chapter 3, I attempt to provide a robust solution for this issue 
by engineering a sugar facilitator, Glf, to create an energy efficient xylose uptake system. I rationally 
created variants of a sugar facilitator, Glf, that are resistant to glucose inhibition to circumvent 
issues of substrate inhibition of uniporters in industrially relevant sugar mixtures. I further show that 
many of these mutant transporters maintain wildtype transport efficiency for glucose and xylose in 
vivo, but have shifted sugar preference to prefer xylose over glucose. The causative mutations for 
relieving glucose repression appear to be diverse, but suggest that there may be multiple ways to 
release glucose inhibition and that these mechanisms may be widely conserved with other MFS 
sugar porters. These transporters may serve as an engineering tool to enhance ATP conservation 
during glucose-xylose fermentation without sacrificing production metrics associated with glucose 
repression. 
SMR transporters can function for furfural efflux to enhance furan aldehyde tolerance 
Pretreatment of lignocellulose is known to generate multiple inhibitory compounds including 
furan aldehydes, aromatics, and organic acids (1, 7). The inhibitory effects of furfural are known to 
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be particularly detrimental to biocatalysts however due to the ability to potentiate the toxicity of 
other chemicals (10). Although multiple cytosolic enzymes have been engineered to enhance 
furfural tolerance by targeting toxicity mechanisms, no work yet has found a transporter to efflux 
this chemical from the cytoplasm (1). However, furfural is a relatively hydrophobic compound and 
MDR transporters are known to efflux a broad range of lipophilic compounds, suggesting these 
transporters may be prospective candidates (8, 11). In Chapter 4, I focused on screening a library 
of MDR transporters to discover potential furfural efflux proteins. From this work I found that 
overexpression two SMRs (sugE, mdtJI), and one lactate permease (lldP) enhance furfural 
tolerance under xylose fermentation conditions. I further demonstrated that MdtJI can be used to 
enhance xylose to ethanol conversion in the presence of furfural under relevant production 
conditions. Furthermore, I show that this enhanced tolerance appears to be due to an increase in 
the viable cell population during furfural stress, likely due to decreased intracellular stress. This 
decrease in intracellular stress is mediated by functional MdtJI transport activity and appears to be 
likely due to MdtJI catalyzed furfural efflux. This work ascribes a novel function to SMR transporters, 
and suggests that directed evolution of these transporters may be useful for enhancing tolerance 
to furan aldehydes or other inhibitors. 
Promiscuous transport systems can be effectively identified using a cheminformatics 
approach 
As stated previously, identification of transporter efflux systems is difficult using many currently 
available selection methods. Incorporation of these transporters into metabolic engineering 
regimes has been shown to enhance target product titer, productivity and yield, making 
advancement of these methods an important target for enhancing lignocellulose bioproduction (12). 
One particularly striking example has been the incorporation of efflux transporters into fungi to 
enhance L-malate production (13). E. coli has been engineered for L-malate production, however 
no known malate exporters have been discovered in this organism (14). To elucidate the native 
malate efflux system of E. coli, in Chapter 5 I used a cheminformatics approach to identify 
transporters of chemicals similar to L-malate to investigate if these transporters had promiscuous 
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activity for the target molecule. Using this approach, I identified that citrate and tartrate are the two 
most similar known di-/tricarboxylic acids that are transported in E. coli to L-malate, and inactivation 
of these transporters decreases malate production in XZ658.  This work identified that DcuA, CitT, 
and TtdT have a role in malate efflux, and demonstrated that malate efflux does not appear to be 
the current production bottleneck for XZ658. This makes sense, as work in my Appendix A
demonstrated that the current bottleneck for production of L-malate appears to be relief of allosteric 
inhibition by NADH in citrate synthase, which results in a 90% increase in titer.  However, this work 
demonstrated that using chemical similarity methods to prospect for target molecule transporters 
based on the concept of transporter promiscuity is a viable approach to rationally identify efflux 
systems. 
Future directions 
My thesis investigated multiple membrane transport associated challenges in converting 
lignocellulose to valuable products. The field of transporter engineering in general is still relatively 
nascent and a lot of fundamental transporter:substrate interactions have yet to be characterized. 
That being said, multiple intriguing questions have yet to be addressed in the future. 
In Chapter 2, I demonstrate that GalP has unknown interactions that appear to affect 
transcriptional regulation of multiple gene clusters. However, the nature of these interactions 
remain unknown and may be indicative of an unknown functional domain in sugar porters from the 
MFS. Many of the upregulated gene clusters include operons that were upregulated by the 
presence of cAMP, such as the ara, xyl, gal, and rbs operons. Another protein CstA, a carbon 
starvation regulator upregulated by cAMP and CRP, is also upregulated ~8 fold in the galP 
inactivation mutant. Thus it may be interesting to investigate the intracellular cAMP levels of both 
KJ122 and AG055, as this may be a signaling molecule affected by galP inactivation. Similarly, it 
might be interesting to investigate if this mechanism is transport dependent or if it is independent 
of this function. The mutations found thus far that enhance xylose utilization are in either a glycine 
residue (G236) that is predicted to be located on the cytoplasmic side between two intracellular 
helical (ICH) domains or an alanine (A392) in approximately the middle of TM11.  By disrupting the 
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conserved proton coupling aspartate residue between XylE and GalP (GalP D32), we could
presumably decipher whether this phenomena is dependent on transport  mediated by GalP. 
In Chapter 3, I created Glf variants resistant to glucose that appear to have at least two separate 
mechanisms for relieving glucose inhibition: 1) by disrupting coordination of the 6-hydroxymethyl 
group of glucose and 2) by altering unknown interactions in TM12. One interesting future direction 
may be to combine mutations in the best performing mutants of each mechanism, namely mutant 
GK3 and GK8. This may aid in further reducing glucose inhibition of xylose and further enhance 
the utility of these variants as xylose uniporters. I also show that variant Glf proteins work for 
enhancing transport preference towards xylose import, but I do not show an effective demonstration 
of how increased ATP conservation from transport can benefit bioproduction. Although I attempted 
to express variant Glf proteins in AG055, this only resulted in a possible slight increase in yield and 
titer (Figure 3.9). This may be due to the presence of XylFGH still on the chromosome that may be 
capable of masking the beneficial effects. The growth of AG055 expressing Glf variant GK3 is also 
decreased compared to an empty vector or wildtype Glf (Figure 3.9). This may be indicative that 
catabolite repression is still partially present in this strain and xylR* integration is needed to 
elucidate the functional benefit of these transporters. Additionally, it may be difficult to prove the 
efficacy of these transporters in a mono-culture since the presence of glucose should enhance the 
ATP supply of the biocatalyst. However, our lab has previously developed orthogonal sugar 
specialist strains that can be co-cultured to effectively ferment glucose-xylose mixtures. Utilization 
of these transporters in a xylose fermenting specialist may be able to improve the fermentation 
capabilities of these strains, as we have previously seen that a large excess of xylose specialists 
is needed to be able to compete for resources against the glucose specialist during co-sugar 
fermentation. This may be due in part to the energy burden that the xylose specialist faces in 
addition to inhibition of native xylose uptake systems (e.g. XylE) by glucose. Thus, inactivation of 
XylFGH and incorporation of a Glf variant into a xylose specialist may prove effective to increase 
co-culture fermentation robustness. 
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Although I focused on engineering Glf in Chapter 3 as an ideal xylose transporter, this is not 
the only potential route to create an energy efficient xylose import mechanism. Another interesting 
possibility would be to create a PTS transport system for xylose. Since the PTS couples 
dephosphorylation of PEP to concomitant uptake and phosphorylation of hexose sugars, this could 
potentially be exploited to catabolize pentose sugars while only utilizing one ATP-equivalent for 
pentose uptake. However, pentose sugars like xylose and arabinose often go through an 
isomerization step prior to phosphorylation (15). In order for a system like this to potentially exist, 
isomerization would need to happen post-phosphorylation of the pentose sugar to integrate the 
molecule into normal pentose metabolism. There are reports of arabinose-5-phosphate (16) and 
ribose-5-phosphate isomerases (17), although there is no evidence of these being used to create 
an alternative mechanism for utilizing xylose/arabinose through the Pentose Phosphate Pathway 
as described. If utilization of this pathway could be demonstrated, it would be interesting to see if 
PTS transporters which have been shown to have activity for pentose sugars (such as gatC) could 
be utilized for xylose/arabinose uptake and catabolism (18). Mutations in the glucose PTS 
transporter, ptsG, have also been shown to confer activity for pentose sugars, such as ribose, 
making these ideal templates to potentially further tune PTS transporter specificity to pentose 
transport (19). 
In Chapter 4, I show that a transporter library derived from the ASKA collection of E. coli ORFs 
is effective in isolating furfural resistance transporters. However, the ASKA library is known to have 
an artificial sequence at both the N- and C-terminus that may potentially affect transporter activity. 
In my own work, I have noticed that this does occasionally affect transport activity. For instance, I 
attempted to complement glucose uptake (PTS- alaE) deficient strains using 
constructs from within this library at one point, however complementation was unsuccessful. Sub-
cloning the exact same sequence into a new plasmid while omitting the artificial N- and C-terminal 
sequences however successfully complemented this phenotype. This demonstrates that some 
transporters within this library may lead to the generation of false-positives, suggesting that this 
library is only sub-optimal. A more ideal library would omit these sequences, as well as expand into 
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other families of endogenous and heterologous MDR transporters. For instance, the 
Drug/Metabolite Transporter (DMT) superfamily includes the SMR transporters, but also 26 other 
families of transporters. Some of these include probable or verified drug exporters that look similar 
to SMRs but with a variable number of transmembrane spanning regions. This includes 
transporters such as the Bacterial/Archael Transporters (BAT) and other variations of the SMR 
family (SMR2, SMR3). Likewise, the library could benefit from the inclusion of other verified MDR 
transporters from other organisms, such as the SMR transporter Mmr from Mycobacterium 
tuberculosis or YkkCD from Bacillus subtilis (11). Additionally, this work could be expanded to 
attempt to characterize the residues in SMR transporters that control specificity. Ideally , using a 
small MDR transporter like a SMR would be easier to saturate with protein engineering techniques 
to potentially enhance and broaden the efflux activity of these transporters.  These efforts would 
allow a more comprehensive screening of transporters for desired compounds and ensure that only 
the best template is used for further enzyme engineering efforts.  
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APPENDIX 
RELEASING ALLOSTERIC REGULATION OF CITRATE SYNTHASE ENHANCES L-MALATE   
PRODUCTION IN ESCHERICHIA COLI 
 
Abstract 
Malic acid is a C4-dicarboxylic acid currently produced from petroleum with applications in food 
industries and it has the potential to be produced as a value-added platform chemical from biomass 
instead of petroleum. Escherichia coli strain XZ658 was previously developed for L-malic acid 
production using the reductive branch of the tricarboxylic acid (TCA) cycle. Here, we identified the 
allosteric regulation of citrate synthase as the main metabolic constraint for malate production in E. 
coli and deregulation of this allosteric control significantly increased product titer, yield and 
productivity. By inactivating lactate export systems to further reduce side product lactate, we have 
achieved unprecedented yield (1.2 g malate g-1 glucose) for malate production, further 
demonstrating the carbon-fixation capacity of the anaplerotic enzyme for fermentative production.  
Importance 
Diverse industrial chemicals can be produced from renewable feedstocks by metabolically 
engineered microbes. However, low production metrics of engineered microbes often limit 
commercialization. Allosteric regulation of key enzymes is a primary mechanism to control cellular 
metabolic processes, thereby representing potential regulatory constraints for fermentative 
microbial production, especially for nonnative fermentation products. Our results suggest releasing 
allosteric regulation of citrate synthase in E. coli as an important approach to optimize fermentative 
production of chemicals from the reductive branch of the TCA cycle. 
Introduction 
Microbial conversion of renewable feedstocks, such as lignocellulosic biomass, into fuels and 
chemicals through fermentation-based manufacturing processes is a desirable alternative to 
petrochemicals (1-3). The top 12 value-added chemicals derived from biomass with the potential 
to replace petrochemicals were identified by the Department of Energy (4). 1, 4-C4 dicarboxylates 
such as succinate, fumarate, L-malate and L-aspartate are among these identified top commodity 
chemicals with a multibillion dollar market value (4-6). Currently, the major routes to produce these 
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compounds are still based on the petrochemical platform (5, 6). Although there are many examples 
in scientific literature regarding metabolic engineering of microbes to produce many valuable 
renewable chemicals including 1, 4-C4 dicarboxylates, the low production performance (titer, yield
and productivity) remains a significant barrier for large-scale production in a cost-effective manner 
(2, 7, 8). 
1, 4-C4 dicarboxylates such as succinate and L-malate are central metabolites without 
significant cellular toxicity even at high concentrations. Microbial production of these compounds 
has a high theoretical yield due to the carbon-fixation step of the anaplerotic enzyme (Ppc or Pck) 
during their biosynthesis as illustrated in Fig. 1. For example, the maximal theoretical yields for 
succinate and malate are 1.12 and 1.49 g per g glucose, respectively (9-11). A wide range of 
microorganisms including Aspergillus flavus (12), Aspergillus oryzae (13, 14), Zygosaccharomyces 
rouxii (15), Saccharomyces cerevisiae (16-18), Aureobasidium pullulans (19), Rhizopus delemar 
(20, 21), Thermobifida fusca (22), and E. coli (11, 23) were developed to produce malate using 
aerobic or microaerobic processes. Although high titers (100 g liter-1 or higher) have been achieved 
after production process optimization in fungal hosts such as A. oryzae (14) and A. pullulans (19), 
the yields remain much lower than the theoretical maximum, with the highest reported value being 
only 69% of theoretical maximum (14). Thus the carbon fixation capacity of the anaplerotic enzyme 
is not fully exploited yet in these microorganisms. 
Homo-malate fermentation is a redox-balanced process with net ATP generation if 
phosphoenolpyruvate (PEP) carboxykinase (Pck) is used instead of native PEP carboxylase (Ppc) 
(Figure 7.1) (11, 24). Production of each malate molecule requires the fixation of one CO2/HCO3-
meanwhile preserving all glucose carbons, thereby yielding up to 2 moles of malate per mole of 
glucose (Figure 7.1). We successfully engineered E. coli for malate production using a precursor 
strain with increased PCK activity and multiple deliberate gene delet ions to funnel metabolic flux 
into malate (11). However, the slow growth, low yield of cell mass and low production metrics 
suggest that intrinsic metabolic constraints limit malate production under oxygen-limiting 
fermentative conditions. 
  173 
Here, we hypothesize that accumulated intracellular metabolites and cofactors such as PEP 
and NADH allosterically inhibit important central metabolic pathways, thereby limiting cell growth 
and fermentative malate production. We investigated the impact of allosteric regulation associated 
with malate production, focusing on three main allosteric regulatory sites involved in metabolic 
pathways of C4 dicarboxylates production: 6-phosphofructokinase (Pfk) (25), lipoamide 
dehydrogenase (Lpd) (26, 27), and citrate synthase (GltA) (28). Pfk catalyzes the irreversible 
phosphorylation of fructose 6-phosphate at an early step in glycolysis (29). Lpd is the main 
component of the pyruvate dehydrogenase complex that catalyzes the decarboxylation of pyruvate 
to form acetyl-CoA (30). GltA catalyzes the formation of citrate from oxaloacetate and acetyl-CoA 
-ketoglutarate, a precursor 
important for amino acid biosynthesis (31, 32). In E. coli, PEP is a negative allosteric regulator for 
Pfk (25) and high intracellular levels of NADH strongly inhibits the activities of  Lpd (26, 27) and 
GltA (28). This allosteric inhibition can be mitigated by replacing these native enzymes with 
heterologous isozymes or mutants that are resistant to inhibition (26, 33-35).  
In this study, we identified GltA as a major allosteric regulation site for malate production and 
mitigation of this allosteric inhibition in a previously engineered malate producer increased malate 
titer and yield by 90% and 40%, respectively. Further deletions of lactate permeases decreased 
side product accumulation and led to a yield at 1.2 g g-1 (80% of the theoretical maximum).  
Results 
Overexpression of the mutants resistant to allosteric regulation in a malate-producing E. 
coli strain 
The genes encoding pfkA, lpd and gltA variants resistant to allosteric inhibition were cloned 
into pTrc99A with their native ribosomal binding sites and terminator regions (Table 7.1). The 
missense mutations of T125S in PfkA and E354K in Lpd were used to release the allosteric 
regulation of 6-phosphofructokinase and pyruvate dehydrogenase in a previously engineered 
malate producer XZ658 (11). There are two types of bacterial citrate synthases with distinct subunit 
arrangements and allosteric regulatory properties: the type I enzymes in Gram-positive bacteria 
and archaea; type II enzymes in Gram-negative bacteria (31, 32). NADH strongly inhibits the type 
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II citrate synthase in E. coli but has no effect on type I enzymes (28, 31, 33). To release allosteric 
inhibition of citrate synthase, two different types of variants that are insensitive to NADH inhibition 
were used: i) the mutant of E. coli citrate synthase (GltA R163L) (33) and ii) citrate synthase genes 
citZ from Bacillus subtilis and Bacillus licheniformis (35). Two concentrations of IPTG (0 and 0.1 
mM) were used to test the effect of induced expression of target genes on malate production. 
Overexpression of pfkA and lpd mutants had essentially no impact on malate production (Table 
7.2). In contrast, induced expression of either the gltA mutant or citZ from Bacillus strains increased 
malate titer and yield ranging from 40 to 55% and 45 to 60%, respectively. Even without induction, 
the leaky expression of these variant genes led to increased malate titers and yields (Table 7.2). 
This increase of malate production is correlated to the enhanced biomass yield and sugar 
consumption (Table 7.2). Titers of side products, especially the main side product D-lactate, are 
similar to the control strain with empty vector and more sugar conversion into malate led to an 
increase in malate yield (~ 1.0 g malate g-1 glucose used) (Table 2).   
Chromosomal integration of citrate synthase variants to enhance malate production 
Plasmid-based systems have several disadvantages in large-scale microbial production, such 
as genetic instability, performance inconsistency, metabolic burden and the requirement of 
antibiotics and inducers (40-42). We integrated citZ from both Bacillus strains into the frdBC locus 
on the chromosome since the frdBC operon was already deleted in the malate producing strain 
XZ658 (11) and the upstream promoter is active under anaerobic fermentation conditions (43, 44). 
GltA R163L was not used for chromosomal integration due to potential homologous recombination 
to restore the mutation and cause undefined genetic changes. Integrations of both Bacillus citZ
increased cell growth, biomass yield and malate production metrics (Table 7.3). The integration of 
B. subtilis citZ yielded the strain JB02 that produced 42 g liter-1 with a product yield of 1.1 g g-1
glucose by a simple batch fermentation. Compared to the precursor strain XZ658, this genetic 
modification increased the titer, yield, and productivity by 90%, 40%, and 90%, respectively (Table 
7.3). In addition, the replacement of native gltA with B. licheniformis citZ in XZ658 also showed 
similar positive effect, suggesting that type II citrate synthase is able to functionally replace native 
type I enzyme without noticeable growth defectiveness under fermentation conditions (Table 7.3).
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Allosteric regulation of citrate synthase in E. coli was found to limit cell growth in an ethanol 
producer (35) -ketoglutarate, 
an important precursor for amino acid biosynthesis (35). We similarly hypothesized that NADH 
accumulation caused by inefficient malate production inhibited citrate synthase, and thereby limited 
-ketoglutarate that stunts cell growth. To directly test this hypothesis, 30 
-ketoglutarate were supplemented in the medium for XZ658 fermentation, 
respectively. Both chemicals enhanced cell growth, leading to ~50% increase of malate titer and 
glucose consumption (Table 7. -ketoglutarate did not increase malate yield 
because of the increased amount of side products. Addition of citrate had no significant impact for 
JB01 (XZ658 frdBC::citZB. licheniformis) fermentation, suggesting that citZ integration and addition of 
citrate may share a common working mechanism to improve malate production (Table 7.3). 
Inactivation of lactate permeases to decrease lactate accumulation 
Although lactate dehydrogenase gene, ldhA, was deleted in XZ658, uncharacterized reduction 
of pyruvate led to lactate accumulation that uses ~30% glucose (11). The genes encoding the 
enzymes involved in lactate metabolism including Dld (D-lactate dehydrogenase)(45), LldD 
(encoding L-lactate dehydrogenase)(46), YbiC (putative alpha-keto acid  dehydrogenase) (47), 
YkgEFG (predicted lactate-related catabolism) (48) were deleted separately, but none of these 
genetic modifications essentially decreased lactate accumulation relative to XZ658 (data not 
shown).  
To direct more carbon flux towards malate production, we inactivated lactate export systems 
in XZ658 as an alternative approach to prevent lactate accumulation. There are three known 
transporters potentially involved in lactate export: LldP, GlcA and FocA (49, 50). The focA gene
was already deleted in the malate producing strain XZ658 (10, 11). Chromosomal inactivation of 
both lldp and glcA in JB02 yielded the strain AS55. Interestingly, inactivation of both known lactate 
transporters did not completely block lactate accumulation, suggesting the presence of an unknown 
lactate export system in E. coli. Lactate titer was reduced by 35% and the malate yield reached 1.2 
g g-1 (1.6 mol mol-1) in AS55. This yield is higher than previously reported results in A. oryzae (14)
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and other fungal strains (12, 17-23). This high yield shows the potential of the anaplerotic enzyme 
to fix carbon and increase total carbon conversion efficiency.  
Discussion 
The CO2 fixation step of the anaplerotic enzyme prior to the reductive branch of the TCA cycle 
(Figure 7.1) has been proposed to have high potential for carbon assimilation in terms of pathway 
kinetics and overall low energy cost (51). L-malate production takes advantage of this carbon-fixing 
step to achieve a higher yield (1.49 g g-1; 2.0 mol mol-1) than many other fermentation products, 
such as ethanol (0.51 g g-1) and lactate (1.0 g g-1). However, metabolic constraints limit malate 
production and high yields have not been achieved in the previous reports (11, 13, 14, 17-19, 23, 
52). In this study, we discovered that the allosteric regulation of citrate synthase inhibited malate 
fermentative production and cell growth in E. coli and introduction of citrate synthase variants 
insensitive to NADH inhibition significantly improved malate production. 
There are four putative metabolic routes to produce malate: 1) oxaloacetate reduction 
catalyzed by malate dehydrogenase in the reductive branch of TCA cycle; 2) pyruvate carboxylation 
by malic enzymes; 3) the oxidative branch of TCA cycle; and 4) the glyoxylate shunt with co-
production of succinate (Figure 7.1). The first route has the best kinetics and thermodynamic 
advantages (51, 53). The second route using malic enzyme to fix CO2 is limited by unfavorable 
thermodynamics and kinetics (54-56). Route 3 and 4 are not redox-balanced and produce multiple 
side-products, thereby leading to low product yields. In E. coli, the native PEP carboxylation step 
employs PEP carboxylase in a  process that loses the energy contained in PEP with the release of 
inorganic phosphate, which limits net ATP generation during anaerobic fermentation (11). Some 
bacteria living in bovine rumen such as Actinobacillus succinogenes (57-59) and adapted E. coli
for succinate fermentative production (24) use an alternative carboxylase, Pck. Use of Pck as the 
anaplerotic enzyme conserves energy in PEP by generating ATP during the PEP carboxlyation 
step (Fig. 1). This Pck-based malate production should theoretically maximize carbon yield and 
achieve a homo-malate fermentative production. Fungal malate-producing strains such as S. 
cerevisiae (17), A. oryzae (14) and A. pullulans (19) use pyruvate carboxylase to convert pyruvate 
and bicarbonate into oxaloacetate with the cost of ATP. Therefore, there is no net ATP generated 
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for the glucose to malate conversion in these fungal strains. Moreover,  the production procedures 
using these fungal strains require oxygen to provide energy for cellular growth, thereby further 
decreasing malate yield due to carbons lost in side products and biomass. In addition, CaCO3 was 
used to maintain pH and provide a CO2 source for fungal malate production (13, 14, 16, 17, 19), 
which will lead to gypsum accumulation during downstream processes, a potential disposal 
challenge for organic acid fermentative production (60). The engineered malate-producing E. coli
strain directly adds carbons from bicarbonate into the malate carbon skeleton without the 
requirement for CaCO3. If the issues associated with allosteric regulation, enzyme kinetic 
properties, side-product accumulation and product export are further addressed, this Pck-based 
malate production pathway has the potential to achieve a yield close to theoretical maximum under 
oxygen-limiting conditions. 
Allosteric regulation of key enzymes is one of the primary mechanisms that control complex 
cascades of cellular metabolic processes. Identification and deregulation of these biochemical 
controls have been found to be effective in improving microbial production, especially for nonnative 
fermentation products such as amino acids and aromatic compounds (61-63). Releasing allosteric 
regulation of citrate synthase in XZ658 not only increased cell growth but also enhanced malate 
production metrics on a per cell basis (Table 3). The increased malate production is not from the 
enhanced glyoxylate shunt pathway because succinate production in the modified strains (JB01, 
JB02 and JB03) is still negligible (< 1g liter-1) compared to the increased malate production (~15-
20 g liter-1). The released allosteric regulation presumably increases intracellular levels of citrate 
-ketoglutarate that are important for amino acid biosynthesis and other physiological 
processes. This hypothesis was further supported by the chemical supplementation experiments 
-ketoglutarate also improved fermentative cell growth and malate 
production. A similar observation was made in an ethanologenic E. coli KO11 (35). Releasing 
allosteric regulation of citrate synthase in KO11 improved fermentative cell growth and ethanol 
production when cells used xylose as the sole carbon source (35). During sugar fermentation to 
generate different products NADH molecules produced during glycolysis need to be reoxidized by 
fermentative pathways to achieve redox balance. Inefficient NADH oxidation steps at fermentation 
  178 
pathways, for example, OAA reduction by malate dehydrogenase (Fig. 1), will lead to the 
accumulation of NADH, thereby representing a potential bottleneck to different fermentative 
producing strains.  
D-lactate is the main side product for our malate-producing strain. Our previous results 
indicated that lactate is likely derived from pyruvate through an unknown metabolic route (11). 
Attempts to inactivate putative lactate metabolic enzymes including Dld, LldD, YbiC and YkgEFG 
did not decrease lactate accumulation. To mitigate the lactate accumulation by targeting its export, 
two known lactate transporters (GlcA and LldP) were inactivated and lactate concentration was 
decreased by only 35% in the resulting strain AS55. Surprisingly, the majority of lactate is st ill able 
to cross cellular membranes without these two lactate transporters, suggesting the presence of an 
unknown lactate export system in E. coli. If carbon flux from this lactate pathway (~20% sugars) is 
re-directed to produce malate, the malate yield can be further increased close to ~1.4 g/g (>90% 
of theoretical maximum). However, our incomplete understanding of microbial product export limits 
the effectiveness of this strategy to minimize side-product accumulation. The strain AS55 has a 
lower growth rate and biomass yield, thereby leading to a lower malate titer compared to its 
precursor strain JB02 (Table 7.3). It is plausible that lactate production facilitates cell growth by 
oxidizing abundant reducing power generated by glycolysis to maintain redox  balance. Further 
laboratory adaptation may be helpful to improve cell growth and malate titer.  
Materials and Methods 
Bacterial strains and plasmids  
Strains and plasmids used in this study are listed in Table 7.1. XZ658 was kindly provided by 
Dr. Lonnie (11). Other strains were constructed using either 
one-step inactivation (36) or two-step integration as previously described (37, 38). To express 
heterologous or mutant genes resistant to allosteric regulation, the ribosomal binding sites, the 
open reading frames and terminator regions were cloned into pTrc99A under the control of the 
-D-1-thiogalactopyranoside (IPTG) inducible trc promoter. The construction details such 
as used restriction sites are described in Table 7.1. 
Media and growth conditions 
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During strain construction, cultures were grown aerobically at 30 C, 37 C, or 39 C in Luria-
Bertani broth as needed. NBS (New Brunswick Scientific) mineral salts medium supplemented with 
50 g liter-1 glucose, 10 mM acetate and 100 mM potassium bicarbonate was used in batch 
fermentation as previously described (11). Ampicillin (50 mg liter-1), kanamycin (50 mg liter-1), or 
chloramphenicol (40 mg liter-1) were added as needed. 
Genetic methods 
Red recombinase technology was employed to perform seamless chromosomal deletion and 
gene replacement as previously described (37). The DNA fragments used for the first-step 
integration were obtained by PCR to amplify the cat-sacB cassette from plasmid pXW1 and primers 
provided 50 bp or longer homologous sequences to facilitate homologous recombination. The DNA 
fragments used for the second-step integration containing homologous regions (~500 bp flanking 
sequence on each side) were assembled by fusion PCR (39). Point mutations in target genes were 
also introduced using fusion PCR (39) with the relevant primers listed in Table 7.1. During strain 
construction, 5% (w/v) arabinose and -Red 
recombinase synthesis and for sacB counterselection, respectively. Positive clones from genetic 
manipulation were verified by colony PCR and Sanger sequencing of the PCR-amplified target 
regions.  
Fermentation 
All batch fermentations were performed using NBS (New Brunswick Scientific) mineral salts 
medium supplemented with 50 g liter-1 glucose, 100 mM potassium bicarbonate and 10 mM sodium 
acetate in small fermentation vessels with 300 ml as the working volume as previously described 
(11). Pre-inoculum for fermentations was started by transferring fresh colonies from NBS 2% 
glucose (w/v) plates into a shake flask (100 ml NBS medium, 2% glucose). After 16 h (37ºC, 120 
rpm), this culture was diluted into a fermentation vessel containing 300 ml NBS medium (5% 
glucose, 100 mM potassium bicarbonate, 10 mM acetate) to provide an inoculum of 0.044 g cell 
dry wt (CDW) liter-1 (an optical density value of 0.05) and batch fermentations were performed for 
144 h. Batch fermentations of strains with plasmids were operated in a similar manner with the 
supplementation of 50 mg liter-1 ampicillin and 0.1 mM IPTG to induce the expression of tested 
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genes. All fermentations were maintained at pH 7.0 by the automatic addition of base solution (2.4 
M potassium carbonate and 1.2 M potassium hydroxide) as previously described (11). 
Analyses  
Glucose and organic acids in fermentation broth were measured by high-performance liquid 
chromatography (HPLC) using an Aminex® HPX-87H column (Bio-Rad) and 4 mM sulfuric acid as 
the mobile phase (11). Cell dry weight was derived from the measured optical density at 550 nm. 
Experimental data represent an average of three or more measurements with standard deviations.
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Figures 
 
 
 
 
 
 
                    Relevant characteristics Reference 
Strains
 
KJ073 E.coli ATCC 8739 ldhA, ackA, adhE, focA-pflB 
mgsA, poxB; adapted and engineered for 
succinate production 
(10)
XZ658 KJ073 frdBC sfcA maeB fumB fumAC; 
engineered for L-malate production 
(11) 
JB01 XZ658 frdBC::citZB. licheniformis This study 
JB02 XZ658 frdBC::citZB. subtilis This study 
JB03 XZ658 gltA:: citZB. licheniformis This study 
JB04 XZ658 glcA::citZB. subtilis This study 
GX01 XZ658 dld::FRT This study 
GX02 XZ658 lldD::FRT This study 
GX03 XZ658 ybiC::FRT This study 
GX04 XZ658 ykgEFG::FRT This study 
AS55 JB02 glcA::FRT lldP::FRT This study 
Plasmids 
  
pTrc99A Ptrc bla oriR rrnB lacIq (64) 
pKD46 bla,  (Red recombinase) (36) 
pKD4 bla, FRT-kan-FRT (36) 
pPfkA T125S E. coli pfkA ORF with T125S (A to T nucleotide 
change) point mutation and its 50 bp upstream 
sequence cloned into between KpnI and XbaI sites 
in pTrc99A 
This study 
pLpd E354K E. coli lpd ORF with E354K (G to A nucleotide 
change) point mutation and its 50 bp upstream 
sequence cloned into between EcoRI and XbaI sites 
in pTrc99A 
This study 
pGltA R163L E. coli gltA ORF with R163L (G to T nucleotide 
change) point mutation and its 50 bp upstream 
sequence cloned into between EcoRI and XbaI sites 
in pTrc99A 
This study 
Table 7.1: Strains, plasmids and primers used in this work 
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pCitZB. licheniformis B. licheniformis citZ ORF and its 50 bp upstream 
sequence cloned into between BamHI and SalI in 
pTrc99A 
This study 
PcitZB. subtilis B. subtilis citZ ORF and its 50 bp upstream 
sequence into between BamHI and SalI in pTrc99A 
This study 
PXW1 The cat-sacB cassette with the sacB native 
terminator cloned into a modified vector pLOI4162 
(37) 
(38) 
Primers 
  
pfkA T125A 
cloning
CGACGGTACCCAAGAAGACTTCCGGCAACAG 
ATGGTCTAGAGTTGAGGGATTAAAAAGGCGG 
This study 
 
CCGTGCATCGGTCTGCCGGGCTCTATCGACAA
CGACATC
 
 
CCTTTGATGTCGTTGTCGATAGAGCCCGGCAGA
CCGATG 
 
Lpd E354K 
cloning CGTACGAATTCGAAAGACGACGGGTATGACCG 
GTGTTCTAGACGACTGGAAAGGTAAATTACAGA
CG 
This study 
 ATCGCCTATACCAAACCAGAAGTTG 
CAACTTCTGGTTTGGTATAGGCGAT 
 
gltA R163L 
cloning
CGTACGAATTCGTTCCGGCAGTCTTACGC 
GTGTTCTAGAGTTCAGCCATATAAAAAGAACCC
GC 
This study 
 GCCGCGTTCCTCCTGCTGTCGA 
TCGACAGCAGGAGGAACGCGGC 
 
citZB. subtilis cloning  
AGAAGTGGGATCCTGGGGGAGAGAAATACTTG
C  
TTAATGGGTCGACTCGGGTTGTTTGGTACGTTT 
This study 
   
citZB. licheniformis 
cloning GAAGTGGGATCCCAACATGCGTTGTTTTTGCTC
C 
TTAATGGGTCGACACATTTGTTTCCCCCGTTTG 
This study 
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frdBC::cat-sacB 
integration 
AGCGGATGCAGCCGATAAGGCGGAAGCAGCC
AATAAGAAGGAGAAGGCGATCGAGTGTGACGG
AAGATCA
ATACCGGTTCGTCAGAACGCTTTGGATTTGGA
TTGATCATCTCAGGCTCCTTAGCCATTTGCCTG
CTTTT 
This Study 
 TATCTACCGTACGCCGGAAC (used for 
sequencing) 
AGCAAATGTGGAGCAAGAGG (used for 
sequencing) 
 
frdBC::citZB. 
licheniformis and 
frdBC::citZB. subtilis 
integrations 
AATAAGAAGGAGAAGGCGAATGACAGCGACAC
GCGGTC 
A
TTGATCATCTCAGGCTCCTTAGGCTCTTTCTTCA
ATCGGAACGAA 
This study 
gltA::cat-sacB 5'AAATTTAAGTTCCGGCAGTCTTACGCAATAAG
GCGCTAAGGAGACCTTAATCGAGTGTGACGGA
AGATCA 
5'CCCGCCATATGAACGGCGGGTTAAAATATTTA
CAACTTAGCAATCAACCATTAGCCATTTGCCTG
CTTTT 
This study 
gltA::citZB. licheniformis
and gltA::citZB. 
subtilis integrations 
5'AAATTTAAGTTCCGGCAGTCTTACGCAATAAG
GCGCTAAGGAGACCTTAAATGACAGCGACACG
CGGTC 
5'CCGCTCTATTAAAGGCGGGTCCGGAAAGTAA
ACGGCTTAGCAATCAATCATTAGGCTCTTTCTTC
AATCGGAACGAA 
This study 
dld::FRT TGATATTTTTTCGCC
ACCACAAGGAGTGGAAAGTGTAGGCTGGAGCT
GCTTC 
TTCGGATGGCGATA
CTCTGCCATCCGTAATTTCATATGAATATCCTCC
TTAGT 
This study 
lldD::FRT GAGCATAATGAGC
ATTCGAGGGAGAAAAACGCGTGTAGGCTGGAG
CTGCTTC 
GGGAGAGGGTTAG
GGGGAGGGGGCGCAAACGACATATGAATATCC
TCCTTAGT 
This study 
ybiC::FRT CAACAAACACATAA
CATAAACAGGAGTTAACCGTGTAGGCTGGAGCT
GCTTC 
This study 
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GTTTGCCCGTCCGC
CACTGGACGGGCTTTTTTCATATGAATATCCTC
CTTAGT 
ykgEFG::FRT ATAAATGGGCATG
AAGTAATGGAGTATTAGTTGTGTAGGCTGGAGC
TGCTTC 
CTTCAGGTTTATGTC
CAGACTTCATATCTCTCCATATGAATATCCTCCT
TAGT 
This study 
 glcA::FRT AAGCATATAAAGATA
ATAAGAGACTGAACAATGTGTAGGCTGGAGCTG
CTTC 
GATGATATTAACGA
TCATCCGGCATTATTGATCATATGAATATCCTCC
TTAGT 
This study 
lldP::FRT CAACAGACTCATTA
CACGATGTGCGTGGACTCCAGGAGACCTGCAG
TGTAGGCTGGAGCTGCTTC 
CTCGTCTGACAGG
CGTCTGGGTAAAACAATCACATATGAATATCCT
CCTTAGT 
This study 
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Fermentation products 
(g liter-1) d 
Plasmids 
Maximum 
Cell mass 
(g liter-1) 
Glucose 
used (g) 
Malate 
yield (g 
g-1) c Mal Lac Pyr  Ace  For 
pTrc99Aa 0.80 ± 0.10 28 ± 4 0.72 20 ± 3 8.4 ± 1 3.3 ± 0.7 0.86 ± 0.2 1.5 ± 0.1 
pTrc99Ab 0.75 ± 0.09 29 ± 1 0.69 20 ± 2 8.5 ± 0.6 2.0 ± 0.1 0.51 ± 0.2 1.4 ± 0.3 
pPfkA T125Sa 0.84 ± 0.09 29 ± 2 0.76 22 ± 2 10 ± 2 2.2 ± 0.7 0.99 ± 0.1 1.5 ± 0.1 
pPfkA T125Sb 0.70 ± 0.2 31 ± 4 0.74 23 ± 2 9 ± 2 2.0 ± 0.1 0.81 ± 0.1 1.2 ± 0.1 
pLpd E354Ka 0.70 ± 0.2 24 ± 1 0.75 18 ± 2 8.2 ± 0.7 1.8 ± 0.4 0.92 ± 0.2 1.4 ± 0.2
pLpd E354Kb 0.80 ± 0.2 25 ± 3 0.8 20 ± 2 7 ± 2 2.2 ± 0.1 1.1 ± 0.6 1.4 ± 0.7 
pGltA R163La 1.1 ± 0.1 35 ± 3 0.74 26 ± 4 10 ± 3 3.6 ± 0.6 1.2 ± 0.4 2.3 ± 0.2 
pGltA R163Lb 0.88 ± 0.1 29 ± 2 1.0 29 ± 3 7.2 ± 0.4 3 ± 1 1.0 ± 0.4 2.1 ± 0.3 
pCitZB. subtilisa 0.70 ± 0.09 25 ± 2 1.0 26 ± 1 6.1 ± 0.9 2.5 ± 0.1 0.4 ± 0.1 1.4 ± 0.1 
pCitZB. subtilisb 0.92 ± 0.09 27 ± 4 1.0 28 ± 2 8.1 ± 1 2.9 ± 0.6 0.5 ± 0.1 1.4 ± 0.1 
PcitZB. licheniformisa 0.97 ± 0.09 26 ± 5 1.0 26 ± 1 8.6 ± 0.2 3.4 ± 0.8 0.6 ± 0.1 1.6 ± 0.1 
PcitZB. licheniformisb 0.90 ± 0.09 28 ± 3 1.1 31 ± 3 8.7 ± 0.5 3.7 ± 0.4 0.6 ± 0.1 1.4 ± 0.1 
        
Table 7.2. Effects of different plasmids on malate production in XZ658 
a 
50 g liter-1 glucose and 100 mM potassium bicarbonate for 144 hours (37 C, pH 7.0). 
b candidate genes. 
c Yield was calculated as g malate produced per g glucose consumed. 
d All data at 144 hours were shown here and SD were included. Abbreviations: Mal, malate; Lac, 
lactate; Pyr, pyruvate; Ace, acetate; For, formate.  
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Table 7.3.  Effects of chromosomal integrations and chemical supplementations on malate 
production 
Fermentation products (g liter-1) a, b
Strains 
Genotypes or 
added 
chemicals 
Glucose 
used (g) 
Maximum 
cell mass 
(g liter-1) 
Malate 
yield 
(g g-1) Mal Lac Pyr Ace For 
XZ658 Precursor 
strain 
28 ± 1 0.84 ± 0.2 0.78 22 ± 1 7.8 ± 0.5 3.0 ± 0.8 0.5 ± 0.1 1.5 ± 0.3 
JB01 XZ658 
frdBC::citZB. 
licheniformis 
38 ± 4 0.97 ± 0.04 0.95 36 ± 2 8.9 ± 1 3.2 ± 0.9 0.9 ± 0.4 3.0 ± 0.8
JB02 XZ658 
frdBC::CitZB. 
subtilis 
37 ± 2 0.95 ± 0.04 1.1 42 ± 2 11 ± 1 2.3 ± 0.2 0.5 ± 0.1 1.8 ± 0.2 
JB03  XZ658 
gltA::citZB. 
licheniformis 
35 ± 1 1.2 ± 0.04 1.1 37 ± 3 11 ± 1 2.3 ± 0.2 0.5 ± 0.1 1.8 ± 0.2 
AS55 glcA 
lldP 
29 ± 1 0.92 ± 0.04 1.2 34 ± 1 5.1 ± 0.5 1.1 ± 0.2 0.9 ± 0.1 2.0 ± 0.3 
XZ658c citrate 32 ± 5 1.0 ± 0.09 1 31 ± 2 10 ± 1 3.8 ± 0.7 1.5 ± 0.3 1.8 ± 0.6
XZ658 c -ketoglutarate 45 ± 1 1.4 ± 0.2 0.73 33 ± 2 12 ± 1 4.8 ± 0.7 0.6 ± 0.3 2.8 ± 0.2
JB01c citrate 40 ± 3 1.1 ± 0.2 0.95 38 ± 1 11 ± 1 4.4 ± 0.4 1.3 ± 0.2 1.4 ± 0.4
 
a Yield was calculated as g malate produced per g glucose consumed. 
b Fermentations were carried out in a 500 ml fleaker with 300 ml NBS mineral salts 
medium with 5% glucose, 10 mM acetate, and 100 mM potassium bicarbonate (37 C, pH 
7.0, 150 rpm). Acetate was added to improve cell growth. Abbreviations: Mal, malate; 
Fum, fumarate; Suc, succinate; Pyr, pyruvate; Lac, D-lactate; Ace, acetate. 
c -ketoglutarate. 
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  Figure 7.1. Potential metabolic allosteric regulation for malate production. The reductive 
branch of TCA cycle was engineered to accumulate malate as the sole fermentation 
product by deleting genes encoding fumarases (fumB and fumAC), fumarate reductase 
(frdABCD), and malic enzymes (maeB and sfcA). A redox-balanced malate-producing 
pathway converts one molecule of glucose into two molecules of malate. Some 
intermediate steps in glycolysis are not shown for clarity and simplicity. The malate-
producing strain contains spontaneous mutations in pck and ptsI that were important to 
enhance carbon flow in the reductive branch of TCA cycle (11). Three potential allosteric 
regulation sites are indicated in gray boxes: 6-phosphofructokinase, pyruvate 
dehydrogenase, and citrate synthase encoded by pfkA, aceEF-lpd and gltA, respectively. 
- -ketoglutarate; acetyl-CoA, acetyl-
Coenzyme A. 
  188 
References: 
 
1. Nieves LM, Panyon LA, Wang X. 2015. Engineering Sugar Utilization and Microbial 
Tolerance toward Lignocellulose Conversion. Front Bioeng Biotechnol 3:17. 
 
2. Van Dien S. 2013. From the first drop to the first truckload: commercialization of microbial 
processes for renewable chemicals. Current Opinion in Biotechnology 24:1061-1068. 
 
3. Kircher M. 2015. Sustainability of biofuels and renewable chemicals production from 
biomass. Current Opinion in Chemical Biology 29:26-31. 
4. Werpy T, and G. Petersen. 2004. Top value added chemicals from biomass.U.S. 
Department of Energy, Washington, DC. 
http://www1.eere.energy.gov/biomass/pdfs/35523.pdf. 
 
5. McKinlay JB, Vieille C, Zeikus JG. 2007. Prospects for a bio-based succinate industry. 
Appl Microbiol Biotechnol 76:727-40.
 
6. Yin X, Li J, Shin HD, Du G, Liu L, Chen J. 2015. Metabolic engineering in the 
biotechnological production of organic acids in the tricarboxylic acid cycle of 
microorganisms: Advances and prospects. Biotechnol Adv 33:830-41. 
 
7. Huang WD, Zhang YHP. 2011. Analysis of biofuels production from sugar based on three 
criteria: Thermodynamics, bioenergetics, and product separation. Energy & 
Environmental Science 4:784-792. 
 
8. Zheng YN, Li LZ, Xian M, Ma YJ, Yang JM, Xu X, He DZ. 2009. Problems with the 
microbial production of butanol. Journal of Industrial Microbiology & Biotechnology 
36:1127-1138. 
 
9. Lin H, Bennett GN, San KY. 2005. Fed-batch culture of a metabolically engineered 
Escherichia coli strain designed for high-level succinate production and yield under 
aerobic conditions. Biotechnology and Bioengineering 90:775-779. 
 
10. Jantama K, Haupt MJ, Svoronos SA, Zhang X, Moore JC, Shanmugam KT, Ingram LO.  
2008. Combining metabolic engineering and metabolic evolution to develop 
nonrecombinant strains of Escherichia coli C that produce succinate and malate. 
Biotechnol Bioeng 99:1140-53. 
 
11. Zhang X, Wang X, Shanmugam KT, Ingram LO. 2011. L-malate production by 
metabolically engineered Escherichia coli. Appl Environ Microbiol 77:427-34. 
 
12. Battat E, Peleg Y, Bercovitz A, Rokem JS, Goldberg I. 1991. Optimization of L-Malic Acid 
Production by Aspergillus-Flavus in a Stirred Fermenter. Biotechnology and 
Bioengineering 37:1108-1116. 
 
13. Knuf C, Nookaew I, Brown SH, McCulloch M, Berry A, Nielsen J.  2013. Investigation of 
Malic Acid Production in Aspergillus oryzae under Nitrogen Starvation Conditions. 
Applied and Environmental Microbiology 79:6050-6058.
 
14. Brown SH, Bashkirova L, Berka R, Chandler T, Doty T, McCall K, McCulloch M, 
McFarland S, Thompson S, Yaver D, Berry A. 2013. Metabolic engineering of Aspergillus 
oryzae NRRL 3488 for increased production of L-malic acid. Applied Microbiology and 
Biotechnology 97:8903-8912. 
 
  189 
15. Taing O, Taing K. 2007. Production of malic and succinic acids by sugar-tolerant yeast 
Zygosaccharomyces rouxii. European Food Research and Technology 224:343-347. 
 
16. Zelle RM, De Hulster E, Kloezen W, Pronk JT, van Maris AJA. 2010. Key Process 
Conditions for Production of C-4 Dicarboxylic Acids in Bioreactor Batch Cultures of an 
Engineered Saccharomyces cerevisiae Strain. Applied and Environmental Microbiology 
76:744-750. 
 
17. Zelle RM, de Hulster E, van Winden WA, de Waard P, Dijkema C, Winkler AA, Geertman 
JMA, van Dijken JP, Pronk JT, van Maris AJA. 2008. Malic acid production by 
Saccharomyces cerevisiae: Engineering of pyruvate carboxylation, oxaloacetate 
reduction, and malate export. Applied and Environmental Microbiology 74:2766-2777. 
 
18. Chen XL, Wang YC, Dong XX, Hu GP, Liu LM. 2017. Engineering rTCA pathway and C4-
dicarboxylate transporter for L-malic acid production. Applied Microbiology and 
Biotechnology 101:4041-4052. 
19. Zou X, Zhou YP, Yang ST. 2013. Production of polymalic acid and malic acid by 
Aureobasidium pullulans fermentation and acid hydrolysis. Biotechnology and 
Bioengineering 110:2105-2113. 
 
20. Wang HT, Yang Y, Wang HL, Sun T, Liu Y, Pan LJ, Li XJ. 2014. Improvement of the 
Tolerance to Toxic Inhibitor for Rhizopus Delemar Producing Malic Acid from Crop Straw 
Hydrolyte. Basic & Clinical Pharmacology & Toxicology 115:8-9. 
 
21. Li XJ, Liu Y, Yang Y, Zhang H, Wang HL, Wu Y, Zhang M, Sun T, Cheng JS, Wu XF, 
Pan LJ, Jiang ST, Wu HW. 2014. High levels of malic acid production by the 
bioconversion of corn straw hydrolyte using an isolated Rhizopus delemar strain. 
Biotechnology and Bioprocess Engineering 19:478-492. 
 
22. Deng Y, Mao Y, Zhang XJ. 2016. Metabolic engineering of a laboratory-evolved 
Thermobifida fusca muC strain for malic acid production on cellulose and minimal treated 
lignocellulosic biomass. Biotechnology Progress 32:14-20. 
 
23. Dong XX, Chen XL, Qian YY, Wang YC, Wang L, Qiao WH, Liu LM. 2017. Metabolic 
engineering of Escherichia coli W3110 to produce L-malate. Biotechnology and 
Bioengineering 114:656-664. 
 
24. Zhang X, Jantama K, Moore JC, Jarboe LR, Shanmugam KT, Ingram LO. 2009. 
Metabolic evolution of energy-conserving pathways for succinate production in 
Escherichia coli. Proc Natl Acad Sci U S A 106:20180-5. 
 
25. Babul J, Robinson JP, Fraenkel DG. 1977. Are Aerobic and Anaerobic 
Phosphofructokinases of Escherichia-Coli Different. European Journal of Biochemistry 
74:533-537. 
 
26. Kim Y, Ingram LO, Shanmugam KT. 2008. Dihydrolipoamide dehydrogenase mutation 
alters the NADH sensitivity of pyruvate dehydrogenase complex of Escherichia coli K-12. 
J Bacteriol 190:3851-8. 
 
27. Kim Y, Ingram LO, Shanmugam KT. 2007. Construction of an Escherichia coli K-12 
mutant for homoethanologenic fermentation of glucose or xylose without foreign genes. 
Appl Environ Microbiol 73:1766-71. 
 
  190 
28. Danson MJ, Harford S, Weitzman PDJ. 1979. Studies on a Mutant Form of Escherichia-
Coli Citrate Synthase Desensitized to Allosteric Effectors. European Journal of 
Biochemistry 101:515-521. 
 
29. Kotlarz D, Garreau H, Buc H. 1975. Regulation of the amount and of the activity of 
phosphofructokinases and pyruvate kinases in Escherichia coli. Biochim Biophys Acta 
381:257-68. 
 
30. Sahlman L, Williams CH, Jr. 1989. Lipoamide dehydrogenase from Escherichia coli. 
Steady-state kinetics of the physiological reaction. J Biol Chem 264:8039-45. 
31. Weitzman PD. 1967. Allosteric fine control of citrate synthase in Escherichia coli. Biochim 
Biophys Acta 139:526-8. 
 
32. Duckworth HW, Anderson DH, Bell AW, Donald LJ, Chu AL, Brayer GD. 1987. Structural 
basis for regulation in gram-negative bacterial citrate synthases. Biochem Soc Symp 
54:83-92.
 
33. Stokell DJ, Donald LJ, Maurus R, Nguyen NT, Sadler G, Choudhary K, Hultin PG, Brayer 
GD, Duckworth HW. 2003. Probing the roles of key residues in the unique regulatory 
NADH binding site of type II citrate synthase of Escherichia coli. J Biol Chem 278:35435-
43. 
 
34. Auzat I, Lebras G, Garel JR. 1994. The Cooperativity and Allosteric Inhibition of 
Escherichia-Coli Phosphofructokinase Depend on the Interaction between Threonine-125 
and Atp. Proceedings of the National Academy of Sciences of the United States of 
America 91:5242-5246. 
 
35. Underwood SA, Buszko ML, Shanmugam KT, Ingram LO.  2002. Flux through citrate 
synthase limits the growth of ethanologenic Escherichia coli KO11 during xylose 
fermentation. Appl Environ Microbiol 68:1071-81. 
 
36. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-5. 
 
37. Jantama K, Zhang X, Moore JC, Shanmugam KT, Svoronos SA, Ingram LO.  2008. 
Eliminating side products and increasing succinate yields in engineered strains of 
Escherichia coli C. Biotechnol Bioeng 101:881-93. 
 
38. Sievert C, Nieves LM, Panyon LA, Loeffler T, Morris C, Cartwright RA, Wang X.  2017. 
Experimental evolution reveals an effective avenue to release catabolite repression via 
mutations in XylR. Proc Natl Acad Sci U S A 114:7349-7354. 
 
39. Higuchi R, Krummel B, Saiki RK. 1988. A general method of in vitro preparation and 
specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic 
Acids Res 16:7351-67. 
 
40. Ow DSW, Nissom PM, Philp R, Oh SKW, Yap MGS. 2006. Global transcriptional analysis 
of metabolic burden due to plasmid maintenance in Escherichia coli DH5 alpha during 
batch fermentation. Enzyme and Microbial Technology 39:391-398. 
 
41. Keasling JD. 2008. Synthetic biology for synthetic chemistry. ACS Chem Biol 3:64-76. 
 
  191 
42. Jarboe LR, Zhang X, Wang X, Moore JC, Shanmugam KT, Ingram LO.  2010. Metabolic 
engineering for production of biorenewable fuels and chemicals: contributions of synthetic 
biology. J Biomed Biotechnol 2010:761042. 
 
43. Ruch FE, Kuritzkes DR, Lin EC. 1979. Use of lac operon fusions to isolate Escherichia 
coli mutants with altered expression of the fumarate reductase system in response to 
substrate and respiratory controls. Biochem Biophys Res Commun 91:1365-70. 
 
44. Lohmeier E, Hagen DS, Dickie P, Weiner JH. 1981. Cloning and Expression of the 
Fumarate Reductase Gene of Escherichia-Coli. Canadian Journal of Biochemistry 
59:158-164.
 
45. Matsushita K, Kaback HR. 1986. D-lactate oxidation and generation of the proton 
electrochemical gradient in membrane vesicles from Escherichia coli GR19N and in 
proteoliposomes reconstituted with purified D-lactate dehydrogenase and cytochrome o 
oxidase. Biochemistry 25:2321-7. 
46. Dong JM, Taylor JS, Latour DJ, Iuchi S, Lin EC. 1993. Three overlapping lct genes 
involved in L-lactate utilization by Escherichia coli. J Bacteriol 175:6671-8.
 
47. Sevin DC, Fuhrer T, Zamboni N, Sauer U. 2017. Nontargeted in vitro metabolomics for 
high-throughput identification of novel enzymes in Escherichia coli. Nat Methods 14:187-
194. 
 
48. Pinchuk GE, Rodionov DA, Yang C, Li X, Osterman AL, Dervyn E, Geydebrekht OV, 
Reed SB, Romine MF, Collart FR, Scott JH, Fredrickson JK, Beliaev AS.  2009. Genomic 
reconstruction of Shewanella oneidensis MR-1 metabolism reveals a previously 
uncharacterized machinery for lactate utilization. Proc Natl Acad Sci U S A 106:2874-9. 
 
49. Nunez MF, Kwon O, Wilson TH, Aguilar J, Baldoma L, Lin EC.  2002. Transport of L-
Lactate, D-Lactate, and glycolate by the LldP and GlcA membrane carriers of Escherichia 
coli. Biochem Biophys Res Commun 290:824-9. 
 
50. Wang ZW, Saini M, Lin LJ, Chiang CJ, Chao YP. 2015. Systematic Engineering of 
Escherichia coli for d-Lactate Production from Crude Glycerol. J Agric Food Chem 
63:9583-9. 
 
51. Bar-Even A, Noor E, Lewis NE, Milo R. 2010. Design and analysis of synthetic carbon 
fixation pathways. Proc Natl Acad Sci U S A 107:8889-94. 
 
52. Liu JJ, Xie ZP, Shin HD, Li JH, Du GC, Chen J, Liu L. 2017. Rewiring the reductive 
tricarboxylic acid pathway and L-malate transport pathway of Aspergillus oryzae for 
overproduction of L-malate. Journal of Biotechnology 253:1-9. 
 
53. Bar-Even A, Noor E, Milo R. 2012. A survey of carbon fixation pathways through a 
quantitative lens. Journal of Experimental Botany 63:2325-2342. 
 
54. Ye XT, Honda K, Morimoto Y, Okano K, Ohtake H. 2013. Direct conversion of glucose to 
malate by synthetic metabolic engineering. Journal of Biotechnology 164:34-40. 
 
55. Stols L, Donnelly MI. 1997. Production of succinic acid through overexpression of 
NAD(+)-dependent malic enzyme in an Escherichia coli mutant. Applied and 
Environmental Microbiology 63:2695-2701. 
 
  192 
56. Bologna FP, Andreo CS, Drincovich MF. 2007. Escherichia coli malic enzymes: Two 
isoforms with substantial differences in kinetic properties, metabolic regulation, and 
structure. Journal of Bacteriology 189:5937-5946. 
 
57. Kim P, Laivenieks M, Vieille C, Zeikus JG. 2004. Effect of overexpression of 
Actinobacillus succinogenes phosphoenolpyruvate carboxykinase on succinate 
production in Escherichia coli. Applied and Environmental Microbiology 70:1238-1241. 
 
58. Laivenieks M, Vieille C, Zeikus JG. 1997. Cloning, sequencing, and overexpression of the 
Anaerobiospirillum succiniciproducens phosphoenolpyruvate carboxykinase (pckA) gene. 
Applied and Environmental Microbiology 63:2273-2280.
 
59. Podkovyrov SM, Zeikus JG. 1993. Purification and Characterization of 
Phosphoenolpyruvate Carboxykinase, a Catabolic Co2-Fixing Enzyme, from 
Anaerobiospirillum-Succiniciproducens. Journal of General Microbiology 139:223-228. 
 
60. Eggeman T, Verser D. 2005. Recovery of organic acids from fermentation broths. Appl 
Biochem Biotechnol 121-124:605-18. 
 
61. Frost JW, Draths KM. 1995. Biocatalytic Syntheses of Aromatics from D-Glucose - 
Renewable Microbial Sources of Aromatic-Compounds. Annual Review of Microbiology 
49:557-579. 
 
62. Li K, Mikola MR, Draths KM, Worden RM, Frost JW. 1999. Fed-batch fermentor synthesis 
of 3-dehydroshikimic acid using recombinant Escherichia coli. Biotechnology and 
Bioengineering 64:61-73. 
 
63. Wendisch VF. 2014. Microbial production of amino acids and derived chemicals: 
Synthetic biology approaches to strain development. Current Opinion in Biotechnology 
30:51-58. 
 
64. Amann E, Ochs B, Abel KJ. 1988. Tightly regulated tac promoter vectors useful for the 
expression of unfused and fused proteins in Escherichia coli. Gene 69:301-15. 
